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Abstract
Apples are a major dietary source of polyphenols in the Western diet and contain
procyanidins, hydroxycinnamic acids, flavanols, dihydrochalcones and flavonols. Despite
their abundance and familiarity very little research into their metabolism has been performed;
research is required to elucidate the metabolic products of these polyphenols and characterise
their absorption and excretion pathways. A human intervention study was designed
specifically to investigate the absorption, metabolism, excretion and biokinetcs of apple
polyphenols. Male volunteers (n = 9) consumed a supermarket apple juice substituted with
water as the control phase, and the same apple juice substituted with a high polyphenol cider
apple extract as the test phase. Blood samples were taken over 0-24 h and urine samples were
collected at 0-4 h, 4-8 h and 8-24 h. A rapid, validated and novel single LCIESIIMSIMS
method was developed and validated for the analysis of a wide range of polyphenols and their
metabolites in these urine and plasma samples (after sample preparation). Apple polyphenol-
related metabolites were identified using LCIMSIMS and MS2; nine urinary metabolites and
seven plasma metabolites were identified, mostly for the first time after apple consumption.
Data on the excretion, bioavailability and biokinetics of these metabolites, including products
of the colonic micro flora, were obtained. In urine, the major apple-related polyphenolic
metabolites identified were dihydroxyphenyl valerolactone sulfate and 5- (3', 4'-
dihydroxyphenyl) -y- valerolactone glucuronide; both colonic bacterial metabolites which
appear at their maximum concentrations 4-8 h post apple ingestion. Minor metabolites
included (-) epicatechin sulfate and glucuronide conjugates. In plasma, 3, 4-
dihydroxyphenylacetic acid, 5- (3', 4' -dihydroxyphenyl) -y- valerolactone glucuronide and
dihydroxyphenyl valero lactone sulfate predominate; Tmaxvalues of 5-6 h were observed.
Minor plasma metabolites included phloretin (Cmax291 ± 175 nM) and p-coumaric acid (Cmax
634 ± 225 nM). In conclusion, the project has identified apple-related polyphenol metabolites
in human urine and plasma; many for the first time after apple consumption. Important
biokinetic parameters have also been reported for these metabolites.
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Chapter One
Introduction to Polyphenols, their
Metabolism in Humans and Existing
Analytical Methodology for their
Determination
Summary
This chapter introduces polyphenols and flavonoids, and their metabolism in humans. A
literature review of analytical methodology for the determination of polyphenols in food
stuffs, and for the determination of polyphenols and their metabolites in human biological
fluids, has been compiled. Justification for the proposed research has been given, in addition
to the aims and objectives of the research.
1.1 Introduction to Polyphenols
Polyphenols are a diverse class of plant secondary metabolites, characterized structurally by
the presence of one or more six-carbon aromatic rings and two or more phenolic hydroxyl
groups [11. Polyphenol nomenclature is illustrated in Figure 1.1 [2,31.
POLYPHENOLS
Phenolic acids Phenolic
alcohols Stilbenes Licnans
Hydroxybenzoic
acids
Hydroxycinnamic
acids
Figure 1.1 Classes of polyphenols
Flavonoids
Flavanones
Anthocyanins
Flavonols
Flavanols
Isoflavones
Flavones
These ubiquitous compounds have various functions in the plants themselves, not all of which
are fully understood, However, one undisputed function of polyphenols in plants, is their
role in protection against microbial invasion [41; they act as antibacterial and antifungal agents
[51. Mechanisms for this action include the high affinity of the hydroxyl groups on the
aromatic rings for proteins, which bind to fungal enzymes and prevent their attack [51,
Polyphenols also contribute to the colour of flowers and fruit, for example the blue colour seen
in many species of flowering plants is achieved by the presence of the anthocyanidin,
delphinidin [41; the same compound gives blueberries their name. They are also responsible
for many of the organoleptic properties of fruit and vegetables [61.
1.2 Introduction to Flavonoids
The largest group of polyphenols are the flavonoids of which more than four thousand
individual flavonoids have been characterised [3, 71, The general structure of a flavonoid is
shown in Figure 1.2.
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Figure 1.2 General structure and numbering pattern for flavonoids. Few exceptions exist but for
most flavonoids, ~,-H, Rs_OH and ~-H. Additional individual flavonoids within
each subclass are characterized by unique functional groups at R3, R3" and Rs,l21
Intakes of flavonoids by individuals are estimated to be about l g a day according to Kahle et
al. [8], however estimations by other authors vary from 28 mg [9] to between 30 mg and 2300
mg a day [6], It is inherently difficult to provide an accurate figure for the level of consumption
of polyphenols due in part to limited food composition data [10]. Food composition data that is
available, may not be representative as it does not always take into account the variety, season,
stage of ripening, agroclimatic conditions, storage, processing and the cooking of the food [6,
I I]. Each of these factors can also influence the class of flavonoid differently, for example
phenolic acid concentrations in foods decrease during ripening, whereas concentrations of
anthocyanins appear to increase [12]. The simple action of peeling a fruit or vegetable can
eliminate a significant proportion of its polyphenol content. Other factors involved in the
difficulty of assessing the level of consumption of polyphenols, lie in the vast variations of
food preferences which can be due to nationality, socio-economic group and gender. For
example, Nijveldt et al. [13] report that the lowest intakes of flavonoids (-2.6 mg/day) are
found among the population of Finland and the highest intakes (-68.2 mg/day) are found
among the Japanese. Overall, flavonoids account for two thirds of the daily intake of
polyphenols, and phenolic acids make up the final third [8], Some flavonoids are found in a
wide variety of foods, for example quercetin which is present in onions, apples, tea and
broccoli, whereas others are limited to only a few foods, such as apigenin found only in
parsley and celery. The flavonol quercetin represents one of the most abundant flavonoids in
food [14,15], in addition to chlorogenic acid [16].
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Table 1.1 Occurrence of flavonoids in common foods [3,7]
Class of Flavonoid Major Food/Beverage Sources
Flavanones Citrus fruit, tomatoes, mint
Cherries, grapes, blackcurrants, blackberries, cabbage, beans
Onions, broccoli, apples, berries, tea, red wine
Apples, blueberries, tea, chocolate, apricots, red wine
Soybeans, legumes
Parsley, thyme, celery
Anthocyanins
Flavonols
Flavanols
Isoflavones
Flavones
Evidence for the health benefits of polyphenols is constantly accumulating. Epidemiological
studies indicate that fruit and vegetable consumption is inversely related to cancer [17-19) and
coronary heart disease mortality [8, 17,20,211, and researchers have suggested that this reduction
is not solely due to increased levels of vitamins and fibre (20), but to the additional presence of
polyphenols [171. Activities observed in vitro with doses of dietary polyphenols higher than
predicted physiological levels are not likely to represent the in vivo status because of the
limited colonic and systemic availability of polyphenols [8, 17,221. There are many difficulties
in extrapolating data from cell culture experiments to in vivo cancer prevention, due to lack of
knowledge of the possible metabolites and mechanisms of metabolism [171, which is why
human intervention studies are important. Knowledge of the bioavailability and metabolism
of dietary polyphenolics in vivo is essential to understanding their role in disease prevention
(23)
1.2.1 Flavonoid Functions in Humans
One of the most studied attributes of flavonoids is their ability to act as antioxidants.
According to literature [1,24), the 'antioxidant hypothesis' was first proposed by Gey in 1987
(25). Summarised, this states that 'small molecules' in the diet act as antioxidants in vivo.
preventing the oxidation of plasma and consequently lowering the incidence of some diseases
induced by oxidative stress. However, metabolic modifications of flavonoids will alter their
'classical' antioxidant nature [261 and polyphenols do not appear to be present in the plasma at
high enough concentrations to contribute to the total antioxidant capacity [I). This suggests
that radical scavenging by flavonoids is unlikely to be the mechanism by which diets rich in
fruits and vegetables have shown to protect against chronic diseases [61.
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Gey also reports that synergistic actions between dietary antioxidants could be more important
than the value of individual ones, a suggestion still relevant today. Researchers have been
looking for the 'magic bullet' of phytochemicals - a key compound or combination of several
compounds that can be produced as a dietary supplement, which would have beneficial effects
on human health [271. However, isolated phytochemicals do not have the same effects as when
they are present in a whole food. The additive and synergistic effects of phytochemicals in
fruit and vegetables appears to be responsible for their potent antioxidant and anticancer
activities, and that the benefit of a diet rich in fruit and vegetables is attributed to the complex
mixture of phytochemicals present in whole foods [27, 281.
Recent increasing interest in flavonoids is due to the elucidation of their broad range of
pharmacological activities, such as antimicrobial, antiallergic, anti-inflammatory and antiviral
[291. Flavonoids and their metabolites have been shown to exert modulatory actions in cells
through actions at protein kinase and lipid kinase signalling pathways [261. However, much of
this work has been carried out in vitro. A small number of studies undertaken in rodents
provide limited in vivo data but the situation in humans is still largely unknown.
Another recent emerging role of polyphenolic compounds is concerned with the treatment of
neurodegenerative diseases, such as Alzheimer's and Parkinson's [30, 311. In these diseases,
polyphenolic compounds have been shown to decrease or block the death of neurons. In
addition, they seem to exert beneficial effects through different pathways such as signalling
cascades, anti-apoptotic processes or the synthesis/degredation of the amyloid J3 peptide [321;
this peptide is toxic to nerve cells when it deposits in the brain and forms fibrils. The main
polyphenolics responsible for these effects are the flavanols found predominately in green and
black teas [33, 341. In the literature, epigallocatechin gallate (EGCG) is the most potent green
tea-derived constituent against neurodegeneration [33-351. EGCG has several possible
mechanisms of action, such as the inhibition of lipid peroxidation and the inhibition of
xanthine oxidase which reduces oxygen free radical production in the body [341. The latter is
fundamental as reactive oxygen species are known to be instigators in many physiological
diseases. These polyphenolic compounds may not only influence the mechanisms of the
disease, but may also delay its progression [351.
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1.2.2 Flavonoid Metabolism in Humans
Most of the flavonoid glycosides present in food resist acid hydrolysis in the stomach and
arrive intact in the duodenum [Ill. Five to ten percent of polyp henoIs in the diet are absorbed
from the duodenum [61, such as aglycones [Ill, certain cinnamate conjugates [361 and some
flavonoid glycosides (the sugar moiety affects the absorption, for example glucosides can be
absorbed this way but rutinosides cannot; they must reach the colon where hydrolysis by
bacterial rhamnosidases occurs [11,37,381). Glycosylation with rhamnosides results in less rapid
and less efficient absorption than glycosylation with glucosides, due to the smaller surface
area of the site of absorption (the colon compared to the small intestine) and lower density of
transport systems [Ill.
A number of mechanisms are involved in the absorption from the duodenum, not all of which
have been characterised [II. One suggested mechanism for uptake of some flavonoid
glycosides utilises the p-glycosidase enzyme lactase phloridzin hydrolase, present in the brush
border membrane of the small intestine [38, 391. Hydroxycinnamate absorption from the small
intestine is rapid, and the same process of glucuronidation and conjugation occurs that is
observed with flavonoids. However, most of the hydroxycinnamic acids in the plant materials
we consume are esterified, and this affects their absorption. They may be esterified to simple
acids or polysaccharides in plant cell walls. Human tissues and biological fluids do not
possess the esterases capable of hydrolysing the ester bonds in the hydroxycinnamates;
however, the colonic microflora may have such capability. Just as observed for some of the
glycosylated flavonoids, the extent of absorption of these esterified hydroxycinnamic acids is
greatly reduced [Ill. One key example of the esterification of hydroxycinnamates to
polysaccharides is the binding of ferulic acid to arabinoxylans in cereal husks where it plays
an integral role in cell wall structure, shape and defence against microbial attack [401. Of the
five to ten percent of polyphenols absorbed from the upper gastrointestinal tract, five to ten
percent is excreted as unchanged plant phenols and the remainder as conjugates [61.
Flavonoid metabolism occurs primarily in the liver and the colon, where transformations may
be extensive. As flavonoids are absorbed by the upper digestive system, they enter the hepatic
portal system and are carried though the portal vein to the liver; if absorption occurs further
down the digestive tract, then the products of metabolism can be absorbed directly into the
systemic circulation. Polyphenols are said to undergo extensive first pass metabolism, where
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their concentrations are greatly reduced before they reach the systemic circulation. The
metabolism that takes place in the liver and colon, accounts for ninety to ninety-five percent of
polyphenols ingested in the diet. There is evidence for O-methylation, sulphation and
glucuronidation of hydroxyl groups in the liver [71 and removal of sugars, phenolic hydroxyl
groups and bacterial ring fission of flavonoids in the colon [61. A study conducted by Sesink et
al. [391 concluded that when subjects consumed quercetin-3-glucoside or quercetin-4' -glucoside
in separate oral administrations, neither these intact glucosides or much of the aglycone were
found circulating in the plasma; they had all been converted into glucuronides. Contradictory
evidence suggesting phloridzin and quercetin rutinoside are present as these glycosides in
human plasma is provided by Paganga and Rice-Evans [41]. Further evidence by Aziz et al. [421
indicates the flavonol glycosides isorhamnetin-4' -O-beta-glucoside and quercetin-4' -O-beta-
glucoside accumulated in plasma as intact glycosides and Mauri et al. [431 also observe intact
plasma flavonoid glycosides after ingestion of tomato extract.
Degradation products of bacterial ring fission in the colon, such as phenolic acids, can be
reabsorbed by active transport mechanisms and are found in urine of animals [6, 71. It is the
phenolic metabolites formed in the small intestine and hepatic cells and products of the
colonic microflora that travel in the circulatory system and reach the tissues beyond the gut.
Bacterial ring fission by the colonic micro flora breaks the heterocyclic structure of the
aglycone at different points depending on the class of flavonoid involved (see Figure 1.3).
The human colon consists of more than five hundred bacterial species, of which the majority
are anaerobic (> 99 %) [441. Habitual bacteria are both commensal and detrimental to health;
the balance between the species is fundamental to the overall health of the individual.
Polyphenols have been shown to modify gut bacteria, in a way beneficial to health [441. The
major metabolites produced by the population of microorganisms in the human gut resulting
from polyphenol intake, are 3, 4-dihydroxyphenylacetic acid, 3-(3-hydroxyphenyl) propionic
acid and 3-(4-hydroxyphenyl) propionic acid. These acids can be conjugated with glycine,
glucuronic acid or sulfate and/or further metabolised into derivatives of benzoic acid [Ill. The
products of colonic metabolism also depend on the bacterial population, which varies among
individuals.
7
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Figure 1.3 Some of the major metabolites produced by the colonic microflora; the differences are
due to the variations in structure across the flavonoid classes 111,45,461
Plasma metabolite concentrations are highly variable, depending on the subclass of polyphenol
involved and the consumption matrix [6], and also on the individual [47]. For example,
following an intervention study where subjects consumed 0.37 to 0.67 mg/kg (1300 to 2300
nmol/kg) of (+) catechin (via a reconstituted extract of red wine), Bell et al. [47] observed
maximum plasma concentration of between 30 to 130 nmollL, I h after ingestion. Individual
subjects showed a variation of between 15 and 65 fold increases in total plasma (+) catechin
concentrations; after 8 h, the levels had decreased to approximately 20 nmol/L. Studies
undertaken with small numbers of volunteers such as the study by Hollman et al. [48] may not
be so valuable due to this large inter-subject variation. In this study, two volunteers were
given 64.2 mg of quercetin (as the aglycone) in a meal of fried onions. The mean peak plasma
level of quercetin was observed 2.9 h after ingestion (196 ng/ml or 0.6 J.lM),and had a half life
of between 0.71 and 1.02 h. Quercetin was still detectable in the plasma 48 h after ingestion,
when the level had decreased to 10 ng/ml. McAnlis et al. [49] report that after a dose of 50.4
mg of quercetin from fried onions, peak plasma concentrations were obtained after 2 h ( 248
ng/ml). The greater peak concentration observed in this study, compared to the one executed
by Hollman et al. [48], after a smaller initial dose of quercetin from the same type of dietary
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source, could be down to inter-subject variation, differences in onion variety, place of onion
harvest and/or method of preparation of the meal.
In the literature, maximum concentrations of polyphenol derived compounds observed in
human plasma were not greater than 10 ).lMin total, and no more than approximately 1 ).lMfor
total aglycones. Tmax values range from 1 to 2.5 h for compounds absorbed in the duodenum,
and up to 5 to 12 h for compounds where microbial action is a prerequisite. Elimination half
lives vary from 1 to 20 h. Owing to the difficulties in detecting dietary polyphenols in the
plasma, as either conjugates or aglycones, due to low levels, lack of synthetic standards and
the use of (3-glucuronidase and/or sulphatase to hydrolyse the conjugates in plasma or urine,
data on the pharmacokinetics of these compounds is limited [6].
As mentioned previously, the different classes of flavonoids undergo different mechanisms of
metabolism. There is speculation as to whether the metabolism of larger more complex
flavonoids, such as the procyanidins, results in them remaining intact or being depolymerised
before absorption. Data in the literature support the concept that the dimers can be absorbed in
vivo, although to a lesser extent than the monomer subunits of the depolymerized dimers [50-521.
In a study by Holt et al. [50], five subjects were given a drink containing 26.4 g cocoa, which
provided 323 mg of monomers and 256 mg of dimers. Two hours after consumption, a peak
mean plasma dimer B2 concentration of 41 nmollL was observed. This dimer represented less
than one percent of the circulating nonmethylated flavanols compared with an average plasma
(-) epicatechin (monomer) concentration of5.92 umol/L at the same time point. In the cocoa
drink, the ratio of (-) epicatechin to (+) catechin was 1:1, however in the plasma (-)
epicatechin was the predominant flavanol, with plasma (+) catechin concentrations only
accounting for three percent of the total plasma (-) epicatechin concentration. Rein et al. [51]
demonstrate after a meal of chocolate supplying 557 mg of procyanidins, it is the (-)
epicatechin levels which show a marked increase after 2 h. Plasma levels range between 100
and 800 nmollL among volunteers, which even for the lower value is still a ten fold increase in
the observed baseline levels. Once again, high inter-subject variability is observed. From
further studies investigating the metabolism of flavanol polymers and monomers, it seems that
if ingested in dimer form, significant proportions of unmethylated and unconjugated
monomeric flavanols will be produced (in addition to small amounts of O-methylated dimer),
but if ingested in the monomeric form, O-methylated and conjugated forms of flavanols
predominate in the plasma [521. This could be explained by high concentrations of the dimer
v
inhibiting phase I and phase II enzymes and so preventing the biotransformation (such as 0-
methylation) of any free (-) epicatechin produced.
Baseline levels of flavonoids in the plasma of individuals are also highly variable. For
example, in a study involving 13 volunteers [51), eleven of the subjects had baseline (_)
epicatechin levels that were measurable, with values between 10.3 and 80.3 nmollL. The
other two volunteers had levels below the limit of detection in this method. These participants
were only instructed to abstain from vitamin supplements, alcoholic beverages and caffeine- or
theobromine-containing foods for 24 h before the test day, so this may be representative of
baseline levels on consumption of a relatively normal diet. In a study by McAnlis et al. [49)
mean baseline quercetin levels of 28.4 ng/ml were observed in five volunteers after an
overnight fast, with no dietary restrictions pre intervention.
Data on the metabolism of polyphenols in humans is limited, which is why it is important for
further intervention studies to be undertaken, and also for them to include a larger number of
test subjects. Researchers investigating the pharmacokinetics of phytochemicals in humans
have observed substantial variation, as demonstrated by some of the articles cited in this
chapter. One source of variation could be due to gut physiology; physiological parameters
such as pH, intestinal fermentations and transit times can all vary [II). These can vary due to
the heath status of the individual, environmental exposures and the diet consumed. Diet also
influences the population and activity of microorganisms in the gastrointestinal tract, as well
as the genes expressed by an individual. In addition, it is likely that genetic variation in the
pathways which affect absorption, metabolism and distribution of phytochemicals in tenns of
biotransformation enzyme expression, stability and activity, also affects the exposure of
tissues to phytochemicals and their metabolites [53]. Variations in the receptors and signal
transducers that interact with phytochemicals also have the potential to affect responses to
these plant constituents at the tissue level. Figure 1.4 gives a diagrammatical representation of
some of the factors that can yield inter-individual variation.
1.2.3 Bioavailability of Flavonoids in Humans
It is very difficult to give an exact definition of bioavailability as the area of research can
influence the terms meaning. For example, some nutritionists, will assess bioavailability by
how much of an orally administered phytochemical appears in urine [54). The rationale behind
this thought is that the compound has to enter the blood before it can be transported to the
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kidney for excretion. If the compound is present in the blood it must have had access to all the
tissues of the body, and hence the greater the proportion of the dose found in the urine, the
more bioavailable the compound must be. This theory appears to have two major flaws.
Firstly, if the compound appears in the urine rapidly after dosing then it has not be retained by
the tissues or had much chance to provide beneficial effects. Secondly, the amount of
compound available to the body depends on the rate of reabsorption by the proximal tubules of
the kidney after initial filtration by the renal glomeruli. A compound which is completely
reabsorbed will not appear in urine, so by this definition will be poorly bioavailable.
'--__=F-" Not absorbed __,;;....-r _,COlon
t Gut microflora
-HydrolySiS
-Fermenta_tion Feca I
Absorption~ excretion
Figure 1.4 Sources of variation in phytochemical metabolism and disposition 1531
A further definition of bioavailability, more relevant to pharmacologists, compares the
changes in area under the plasma concentration-time curve (AUC) when the compound under
investigation is administered orally and intravenously. After the latter form of administration,
the compound has direct access to the blood system and so can distribute directly to all the
tissues of the body. The area under the curve for the time-dependent change in blood
concentration gives a measure of oral bioavailability. However, in certain circumstances this
may an underestimate of true bioavailability, as if a compound is taken up from the small
intestine and excreted into bile, the proportion of unmetabolised parent compound in the blood
is low, but the metabolites may have been utilised site-specifically in local tissues.
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The most abundant flavonoids in the diet are not necessarily the most active; it depends on the
processes of absorption, metabolism and excretion. Indeed, the process of metabolism greatly
alters the native forms of flavonoids, and their resulting metabolites may differ in biological
activity compared to the parent compounds [11]. It is generally accepted that the bioavailability
of phenolics is rather low [22, 55, 56].
The food matrix itself has an effect on the bioavailability of polyphenoIs [11] and consumption
of polyphenols with other food and drink items in the diet affects their bioavailabilty. There is
conflicting information in the literature that suggests the consumption of tea with milk reduces
the absorption of catechins. Van het Hof et al. [57], report that there is no significant effect on
the (+) catechin levels observed in blood after the addition of milk to black tea. The authors
suggest that the earlier findings of Serafini et al. [58], which indicated a reduction in the
antioxidant activity observed when black tea was consumed with milk, compared to its
consumption alone, are due to the larger amounts of milk added to the tea, which were
generally unrepresentative of the population preferences. There is also the possibility that the
milk reduced the absorption of other compounds contributing to the antioxidant activity of tea,
and just did not affect the catechins. Work by Hollman et al. [48], confirmed that the increase
in plasma concentrations of quercetin were also unaffected by the addition of milk.
Consumption of tea with food such as cookies in a study by Warden et al.[59], suggested that
the absorption of gallated catechins could have been affected by this food.
1.2.4 Polyphenol Metabolism Studies in Humans detailed in the Literature
Both in vitro and in vivo polyphenol metabolism studies are detailed in the literature. In vitro
studies involve the application of varying concentrations of polyphenol standards to certain
cell cultures to see the resulting physiological effects and metabolites produced [60-65]. In vivo
animal feeding studies are also reported, mostly with rats, some using the individual
polyphenol compound [66-69], some using whole foods [70] or mixed preparations and some
involving perfusion [71]. A small number of studies have also been performed on people after
surgical procedures, such as ileostomy patients [8, 36, 72], to determine the way in which
polyphenols from food stuffs are metabolised when there are significant alterations to gut
morphology.
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Some of the relatively few studies of metabolism and bioavailability of polyphenols in healthy
humans have been carried out after consumption of food and drink items such as tea [45, 59, 70,
73-77], coffee [78,79], fruit juices [80] cocoa [50,81-83], onions [15,23,42,48,84-86] and cider [72,87]; none
detail the effects when apples are consumed, A few studies have also been carried out using
other food substances, such as artichoke [88, 891, oregano [901, endive [911, blackberries [921,
soybean [93] herbal plants [94, 95] and specific flavonoid-rich preparations [96, 971. One study by
Rechner et al. [98], also investigates the metabolic fate of dietary polyphenols when a
polyphenol rich meal is ingested, i.e. the meal contained a mixture of polyphenols from
different sources. Due to the presence of quercetin and flavanols in the majority of food items
investigated, any information on plasma and urine conjugates and ring fission metabolites is
generally limited to these flavonoid classes. Table 1.2 details some of the most useful
metabolism studies carried out in humans.
Summarised, it is easy to observe a lack of information in the literature on the ring fission
metabolites of polyphenols and their conjugates, biokinetic and bioavailability data and
quantification of metabolites. The same sources of polyphenols are investigated repeatedly;
tea, cocoa and onions being the most studied. Thus, the same classes of polyphenol are
researched; predominately the flavanols (catechin, epicatechin and EGCG) and flavonols
(quercetin). Only two intervention studies using alcoholic cider could be sourced for
information on the metabolism of apple polyphenols in healthy human subjects [72, 87].
However, the presence of alcohol in the cider, as well as the production method will have
affected the metabolism compared to consumption of apples. No conjugated or ring fission
metabolites were detected by DuPont et al. [87], except for hippuric acid, which was quantified.
In addition, concentrations of aglycones were too low for pharmacokinetic parameters to be
calculated. Marks et al. [72], provide more comprehensive information on one conjugated
metabolite, reporting rare biokinetic data, but lack evaluation of ring fission metabolites. The
only other studies reporting usage of apples or apple products as their source of polyphenols,
involve the consumption of cloudy apple juice by ileostomy subjects [8, 99], which provide
either none or limited details of conjugated or ring fission metabolites.
There is a requirement for a well designed human intervention study to be carried out, to detail
the metabolism of apple polyphenols. Particular focus is needed with regards to the
metabolism of the dihydrochalcones and the phenolic acids, in addition to quantitative
13
information on conjugated metabolites. A greater emphasis on identification of the ring
fission metabolites of apple polypheno1s and their conjugates would also contribute greatly to
the knowledge.
1.3 Polypbenols in Apples
Apples (Malus domestica Borkh.) are a major source offlavonoids in the Western diet [65,100l,
in addition to onions, berries, tea, coffee, wine and cocoa [lOll. "An apple a day keeps the
doctor away" is the old adage which has prompted many researchers to look for the 'magic'
ingredient which lends truth to this saying [18,21, 102l, Consumption of apples has been linked
with a reduction in the risk of lung cancer, asthma, type-2 diabetes and heart disease [18, 103l,
The most important commercial varieties of apple are Red Delicious, Golden Delicious,
Granny Smith and Fuji [lOll,
Sraebum
Gokfeo Oelk:ious
Jonagotd Mclntosh PaaflC Rose Paula Rod wealthy
Figure 1.5 Some of the many varieties of apple *
The main classes of polyphenols in apple flesh are procyanidins, hydroxycinnamic acids,
monomeric flavan-S-ols and dihydrochalcones, whereas flavonols and anthocyanins are found
almost exclusively in the peels [I04l The phenolic profile is further complicated by the
polymerisation of flavan-f-ols and glycosylation of other polyphenolics [I02l The
predominant sugar involved in glycosylation in apple is galactose, followed by glucose,
rhamnose, xylose, and arabinose, with the disaccharide rutinose also being associated with the
phenolics [21l, Cider apples contain the same polyphenols as table varieties, but their
concentrations are generally much higher [104l, and unripe apples have a significantly higher
proportion of procyanidins than ripe apples [9l, Despite the range of varieties of apples, the
polyphenol profiles are practically identical; it is the concentrations that differ [Ill,
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According to Barth et al. [17] the most promismg candidates among bioactive apple
constituents are the procyanidins which were shown to modulate cancer related processes in
vitro and in vivo. These compounds were also shown to effectively inhibit colonic cancer cell
growth mediated by activated MAPK pathways and activation of apoptosis-related caspase-3.
The effects may be derived from absorption of active metabolites in the small intestine [17], or
these metabolites reaching the colon [17] and there is also some evidence to suggest
polyphenols modulate the bacterial contents ofthe colon [108].
In a study by Hollman et al. [37], after a single supplement of apple sauce and apple peel
containing 325 ~M of quercetin, peak concentrations of the aglycone in the plasma were
observed at 2.5 h (0.30 ~M or 92 ng/ml) post supplementation. Levels of quercetin remained
detectable for 36 h post dose at approximately 0.03 ~M. In this study, they compared the
absorption of quercetin from onions (Tmax 0.7 h), quercetin from apple and quercetin
rutinoside (Tmax 9 h) and concluded that the bioavailability of apple quercetin and quercetin
rutinoside were both thirty percent that of onion quercetin. The variation in the time taken to
reach the maximum plasma concentration indicates the site of absorption. For example, the
short time taken for the quercetin from onions to peak suggests absorption from the small
intestine as intact glucosides, whereas the longer time taken for the quercetin rutinoside
suggests absorption from the colon, after hydrolysis of the rutinoside. Urinary excretion of
quercetin was 1.39 %, 0.44 % and 0.35 % after ingestion of onions, apples and quercetin
rutinoside, respectively. The observed differences in the bioavailability of quercetin from the
food sources, is related to the variation in glycosidic moieties; the glycosides in onions being
mostly glucosides which are rapidly absorbed. Factors such as differences in cell wall
structure, location of glycosides in cells or binding to other cell components, could also
influence the absorption and bioavailability.
The world produces a large quantity of apple residues (apple pomace) from juice processing
[20], which could be exploited by the food industry and incorporated into dietary supplements
[18], in tum improving the health of the population. Apple pomace is already utilised as a
commercial source of pectin, used in the production of jams and fruit jellies [Ioq].
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1.4 Analysis of Polyphenols in Plant and Food Related Products
Historically, polyphenol analysis methods have evolved from the paper chromatography
techniques of the 1950s and 1960s to the HPLC techniques of the 1970s and 1980s (Fisher and
Wheaton were the first to use the technique of HPLC for the determination of polyphenols in
1976 [110]) to the current trend in the use of mass spectrometry. Recent advances in MS have
enabled further progress of the elucidation of polyphenols in plants and food related products
in this current decade, just as the development of paper chromatography did several decades
ago [111].
The literature contains many articles detailing analysis of polyphenol standards [112.114], in
addition to the polyphenolic profiles of a wide variety of fruits [115-119], vegetables [117, 120-125]
and plants [126-131], as well as their products such as tea [132, 133], coffee [134], chocolate [135, 136],
fruit juices [101,137,138], wine [133,139] and honey [140]. Apples (both table and cider varieties) and
their products have been subjected to polyphenol profiling [20, 101, 141, 142], but in general their
composition has not been studied in as much detail as that of tea and cocoa. Table 1.3 details
conditions of some of the analysis methods used for the determination of polyphenols in
plants, food stuffs and beverages. The aqueous mobile phases utilised are almost always
acidified; common acids used include formic acid and acetic acid. Organic solvents include
MeCN and MeOH, or combinations of the two and are sometimes acidified. For
determination of the polyphenols in apples, MeCN is preferred. Although the types of
solvents remain fairly constant, there is variation in the percentage composition of solvent
systems [143]; gradient elution is more commonly employed than isocratic. LC columns are
nearly always composed of a C18 stationary phase and analysis times are usually in excess of
twenty min. Some reported methods include time for the re-equilibration of the system prior
to the next analysis, which is important as it is part of the time taken for the complete analysis,
however other authors do not mention it.
Those studies which utilise LC/MS for the determination of polyphenols in plants, food stuffs
and beverages generally use the negative ionisation mode, with capillary voltages of between
2 and 3.5 kV and temperatures of between 200 and 400°C. It has been reported that positive
ionisation mode results in rich fragmentation patterns, compared to limited fragmentation with
negative mode, but negative mode provides the highest sensitivity for flavonoids [130, 140].
18
According to Abad-Garcia et al. [137], the reluctance of polyphenolic compounds to fragment
in negative mode requires the use of higher cone voltages, particularly for flavonoid
glycosides as the glycosidic linkages require more energy to break. Recent LC/MSIMS
studies have been detailing specific members of a flavonoid class and attempting to identify
members which differ structurally. For example, the determination of the fragmentation
patterns for chlorogenic acids where esterification occurs on different carbons [134], or the
analysis and separation of chiral flavonoids [144].
In general, approaches for the analysis of polyphenols in plants, food stuffs and beverages are
quite comprehensive. More recent papers also profile the complex glycosylated polyphenols,
previously neglected due to limitations in the instrumentation used. However, weak points of
these methodologies include long analysis times and poor validation data. There is also a
shortage of fully comprehensive methods for the determination of all classes of polyphenols in
anyone food item or beverage; research groups tend to focus on a particular class or
individual.
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1.5 Justification for the Proposed Research
As mentioned previously, there is a requirement for a well designed intervention study to
investigate the metabolism of apple polyphenols in healthy human volunteers. Only four
studies could be found in the literature detailing the metabolism of apple polyphenols in
humans; polyphenol sources were cider and apple juice. Three of the studies involved the use
of subjects with an ileostomy which will produce different findings to studies with healthy
humans; in effect these studies only report half the story. Data is mainly provided for
caffeoylquinic acid derivatives, one phloretin conjugate or aglycones; no information is given
on conjugation of other apple components or metabolites of microbial origin produced in the
gastrointestinal tract. Some of this information is provided by studies using alternative
polyphenol sources, for example human intervention studies using tea and cocoa can be used
to extrapolate some information; but differences will exist.
In addition to the intervention study, there is also a requirement for a fast, sensitive and
validated method for the analysis of polyphenols, their conjugated metabolites and their ring
fission products in biological matrices, all within one analytical run. Existing methodologies
are generally not validated and involve lengthy run times of over forty min. A new
hyphenated LC/MSIMS method will combine sensitivity with selectivity, in a time conscious
and reproducible manner.
Discussion of available literature in this chapter highlights the lack of knowledge and
understanding that exists for the metabolism of apple polyphenols in humans. Absence of fast
and validated methods for biological sample preparation and instrumental analysis, a tendency
for enzyme deconjuagtion experiments through which metabolite detail is lost, and an
inclination to concentrate on one particular class of polyphenol or individual member, all
contribute to the void in our comprehension. Apples are a familiar and popular food item and
yet they have not been studied to the same extent as tea and cocoa.
This study will be the first to investigate the metabolism of apple polyphenols from a high
polyphenol cider apple extract, in healthy human volunteers. Immediate and frequent blood
sampling will enable as many metabolites to be detected and identified as possible and help to
provide good biokinetic data for those that are identified. Attention to detail in all aspects of
sample collection, sample processing, sample analysis and data processing will provide strong
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evidence for the metabolic fate of the polyphenols present in apples. Comprehensive
metabolite profiling by LC/MS/MS will encompass all classes of polyphenols in apples and
their resulting metabolites, so a complete picture can be built.
1.6 Aims and Objectives of the Research
The aim of this project is to identify and quantify flavonoids and their metabolites in the
plasma and urine of healthy humans after consumption of a high polyphenol cider apple
extract. Information on the biokinetics of these metabolites will hopefully be obtained.
Specific objectives required to fulfil this aim are as follows:
1. To plan and execute a human dietary intervention study, including compiling
appropriate documentation to gain suitable ethical approval for such an experiment and
recruitment of suitable volunteers.
2. Development of suitable biological preparation methods for human urine and plasma
which enable the metabolites of interest to be removed from the matrix unchanged for
analysis.
3. Development of a new hyphenated liquid chromatography-mass spectrometry method
for the quantitative analysis of the biological samples collected from volunteers
participating in the afore mentioned intervention study.
4. Analysis of urine and plasma samples from the human intervention study to determine
biokinetic information for absorbed polyphenols.
5. Identification of polyphenoI metabolites, in particular bacterial ring fission metabolites
and conjugates, to increase our understanding of the metabolism of apple polyphenols
in humans.
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Chapter Two
Development of an LC/MS/MS
Method for the Quantitative Analysis
of Polyphenols in Human Plasma and
Urine
Summary
This chapter details the development of a novel LCIMSIMS method for the analysis of
polyphenols and their metabolites in human urine and plasma samples. Initially, an LC-UV
method was developed for the separation of a range of polyphenol standards; MS parameters
were investigated for each of these polyphenol standards. Finally, LC/MSIMS experiments
were performed with the polyphenol standards and some conjugates, to optimise the method.
Extraction methods for human urine and plasma were then developed, optimised and validated
and the method was applied to pooled study urine samples.
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2.1 Introduction
Analytical methods documented in the literature for the determination of polyphenols from
plants, plant products and biological fluids include HPLC with UV detection, HPLC with
fluorescence detection, HPLC with electrochemical detection, LCIMS and LC/MS/MS. The
literature also contains information on the way polyphenol standards behave when analysed by
MS, for example fragmentation pathways and common fragments produced across the classes
[I14, 147-149]. LC in tandem with MS is a popular method of analysis combining the advantages
of high speed separation with high selectivity and sensitivity [150, 151]. The interface between
LC and MS is predominately reported to be electro spray ionisation (ESI) with a small number
of studies using atmospheric pressure chemical ionisation (APCI).
When dealing with biological samples, the majority of the studies reported in the literature,
involve deconjugating the metabolites using sulfatase and f3-glucuronidase enzymes prior to
analysis [14, 74, 76, 80, 85, 87, 89-91, 152] to remove the sulfate or glucuronide conjugates; this gives
information on the total aglycone constituents of the metabolites, but it means a loss of the
detail on the degree and ring position(s) of conjugation. Biological samples such as plasma
cannot be assayed directly, but require a pretreatment to remove endogenous proteins,
carbohydrates, salts, and lipids [153]. HPLC columns are packed with small-sized particles
which are not designed to handle large volumes of biological fluids, therefore it is essential to
remove matrix components that might contaminate or block the system [154] or go on to cause
ion suppression in the MS reducing sensitivity. The sample preparation step of the analysis is
fundamental to the performance of the method [54]. Acidified plasma extracted with solvent is
a common approach to polyphenol extraction; acetonitrile (MeCN) [23, 72, 78, 84] is the most
common solvent used. Solid phase extraction (SPE) has also been performed [81].
The urine matrix can also cause ion suppression in the MS, due to its high salt content; adduct
formation during the electrospray process causing production of non volatile components, is
another problem frequently encountered with urine, which leads to rapid deterioration of
instrument performance [154]. However, urine extraction procedures are time consuming and
some sample information may be lost due to the process. Common methods tend to be simple
to reduce the negative effects of processing the samples; methods include filtering or
centrifugation [72,78,82], addition of solvents [73,77,84,86] and SPE [971.
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2.1.1 Introduction to the Principles of High Performance Liquid Chromatography and
Mass Spectrometry (HPLCIMSIMS)
Reversed Phase HPLC operates on the principle of hydrophobic interactions, which result
from repulsive forces between a polar eluent, the relatively non-polar analyte, and the non-
polar stationary phase. The retention time of the analyte will vary depending on the
interactions between the stationary phase, the molecules being analysed, and the solvent(s)
used. In addition, the structural properties of the analyte molecule are fundamental to its
retention characteristics. In general, the less water soluble the analyte (i.e. the more non-polar
it is), the better the retention on the column, and the greater the retention time.
Mass spectrometry is an analytical technique that identifies the chemical composition of a
compound or sample on the basis of the mass to charge ratio (mlz) of charged particles (ions).
In order for this to occur, the analyte is ionised and the charge and mass of the ion are
measured. The ratio of charge to mass of these resulting particles is deduced by passing the
particles through electric and magnetic fields in the mass analyser of the MS.
There are various possible interfaces between the HPLC and MS. The technique of
electrospray ionisation (ESI) involves the analyte solution passing through a narrow capillary,
at a flow rate ranging from a few nanolitres per min to several hundred microlitres per min.
The capillary has a high voltage applied to it, generating an electric field gradient between the
capillary and the entrance to the MS. As a result, a spray of charged droplets (of the same
polarity as the applied voltage), is forced from the capillary in the shape of a cone (the Taylor
cone) (66). As the droplets are exposed to high temperatures in the space between the capillary
and the entrance to the MS, solvent evaporation occurs, shown circled in Figure 2.1.
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Figure 2.1 Schematic representation of an ESI source. A cone shaped spray of charged droplets is
forced from the capillary; high temperatures causes solvent evaporation 11551
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The droplets reduce in size until they reach a critical point where their surface-charge density
reaches a maximum, known as the Rayleigh limit (Figure 2.2). Coulombic explosion occurs
and the droplet is split apart to produce smaller particles, as illustrated in Figure 2.1. The mass
to charge ratio of a charged droplet determines the fraction of its solute molecules that can
become free ions 11561•
Cone
ana~
molecule
+ ++ 'i
-ce Iorrblc' ., -, \+~ I
u ~ +
explOSIon + +
::.:~;:t.~ ,+~ I
mlAlply "lOS
charged droplet
C;WI Rry
Figure 2.2 Schematic representation of the mechanism of ion formation in ESI 11551• Free ions are
formed from solvent droplets reducing in size; these enter the MS.
Considerable variation in the electrospray ionisation response is observed among small polar
molecules and often a great deal of time is required to optimise the specific analytical
conditions for a particular analyte [74]. Many researchers have sought to study the factors that
dictate the responsiveness of analytes to certain conditions. The ability of the ion to become
charged is critically important in the process, and the response is also dependent upon the
other molecules present in the sample matrix. This adds complexity to the detection of
analytes in biological samples in particular, where matrix effects can be substantial.
There are many types of MS in existence. A quadrupole mass analyser consists of four
parallel rods that have a fixed direct current (which can be positive or negative, depending on
the analytes of interest) and alternating RF potentials applied to them. Ions produced in the
source of the instrument are focused and passed along the middle of the quadrupoles. Their
motion will depend on the electric fields so that only ions of a particular mlz that have been
selected for will be in resonance and thus pass through to the detector. In a triple quadrupole
mass analyser, three of these quadrupoles exist; the first acts as a filter in detecting ions of
interest; the second acts as a collision cell where collision induced dissociation (CID) of the
precursor ion occurs; the third quadrupole detects the product ions for the precursor ion of
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Figure 2.3 Schematic representation of the function of the three quadrupoles in a triple quadrupole
MS
In recent years, HPLC coupled to ESI/MSIMS has become a widely used technique for the
analysis of pharmaceutical and biological analytes, owing to its specificity, reliability and
selectivity for molecules in the low mass range [¥- 7<r~. The combination of the two
\I) ) "-
techniques is a powerful analytical tool. (') s c.r.r:r
3 Q e <rj
2.1.2 LCIMS/MS Methods for the Analysis of Polyphenols 6 I r fr
As mentioned previously, HPLC was first used for the determination of 10 ypi~ols in 1976
by Fisher and Wheaton [157]. However, the gold standard for the analysis of synthetic or plant
derived products in both the pharmaceutical product and in body fluids and tissues today,
involves the use of highly specific and quantitative, hyphenated chromatography-mass
spectrometry techniques [54, 154]. Although gas chromatography-mass spectrometry was the
first hyphenated chromatography-mass spectrometry technique to be implicated (developed
during the 1950s), the introduction of suitable ionisation interfaces has led the majority of
analysis of polyphenols in recent years to be carried out using LCIMS [158]. Polyphenols have
been studied using the technique of MS since the 1970s [43, 159, 160]. Despite the high selectivity
of tandem mass spectrometric detection, there are only a few examples of flow injection
analysis (FIA) in bioanalysis and chromatographic separation still plays a key role [154].
In the literature, columns chosen for the determination of polyphenols in plant material and in
biological fluids are almost exclusively composed of a Cl8 stationary phase [143]. An exception
to this is the use of CI2 columns with LC/MSIMS for the analysis of quercetin and its
conjugated metabolites in human plasma and urine [14,85]; the authors reported a reduction in
peak broadening/tailing, and shorter run times with these coloumns compared with CI8
columns.
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Many of the polyphenol profiling methods reported in the literature have long analysis times,
in excess of 50 min. For example, Hong and Mitchell [86] developed a method taking over 100
min for the separation of flavonol metabolites in human urine after consumption of onions.
Separation of coffee chlorogenic acids by Stalmach et al. [78] involved a 70 min analysis time,
or 40 min for plasma and urine. Sang et al. [73], also employ a 70 min analysis time for the
separation of tea polyphenols in urine. Further details of these and other methods are
summarized in Table 2.1. In contrast to these long analysis times, a few groups have reported
success with shorter run times of less than 20 min [80-83]. Again, full details of the conditions
are summarised in Table 2.1.
The majority of the LCIMSIMS methods detailed in the literature use common solvents for
mobile phases, including methanol (MeOH), MeCN, formic acid, acetic acid and H20 in
varying combinations and concentrations. This is because solvents suitable for ESIIMS must
permit the formation of ions in solution and allow for easy nebulisation and desolvation [128].
The choice of solvent can have marked effects on efficiency. For direct ESIIMS in the
positive mode, MeOH gave the highest sensitivities for flavonoid glycosides and MeCN
provided the highest sensitivities in the negative ion mode [128]. However, MeCN was
preferred for LCIESIIMS due to a lower background noise. Wang et al. [14], reported higher
background noise using acetic acid, compared to formic acid, and higher ion suppression when
using trifluoroacetic acid (TFA), compared to either of the other acids. The use of TFA is
reported to provide more efficient reversed-phase separations of certain flavonoids than other
acids [112, 161], but not for flavonoid glycosides [128]. It is universally agreed in the literature
that the best separations for flavonoids are obtained by acidifying the mobile phase, because
the hydroxyl groups are kept in their acidic form. This increases their retention on the column
and decreases peak broadening, which can occur in the presence of the deprotonated form.
The literature reports the use of both positive and negative ionisation modes for the analysis of
polyphenolic compounds and their metabolites, although the general consensus is that better
sensitivity is achieved in negative ion mode. Wang et al. [14], report better sensitivity with
negative ion for the analysis of the flavonol, quercetin. Mullen et al. [84], report that when
quercetin-3-glucuronide is analysed as a standard, similar responses are observed with both
negative and positive ionisation. However, when the standard was 'spiked' into unne,
detection in negative mode was ten times more sensitive.
30
4i
-=...
.9
]
..
Q
CI.
4i
..
'"~
e
-=...
4i
E!
-;
~;:
~
-;
=III
....
Q
C
III
E!
E!
=~
=e
=
~
U
--00
II II
<co
~
-
o
N
o
e
§
o
1;;
"0
u
o
..s::
U
o
1;;
"0
u
o
..s::
U
z
9.~
::t:~
s:: s::._ ._
"0"0
'u '0
'" '"u u
o§"§
tEtE
'Cf!!.'$.
- -00
II II
<co
'"ou
o
U
o
£
.S
"0
·0
'"u
.§
tE
~Z
.....u
o 0
o~
II II
<co
u
o
Cl.o
"'N
u-
a(!
o
1;;
"0 '"u 0
o u
..s:: 0
uu
o
.....
"0
o
o
as
<Il
s::
.a
u
o
1;;
U
<Il
oS
..s::
u
o
1U
U
5'
t:..
00
- r-oo
Q\ .....
::t:::t:
00
o 0
~~
00
££
II II
<co
o
'"s::
:2
u
o
1;;
U
r.
U
=B
=Q
u
.,.,
.,.,
Zq,~
::t::E
.S .S
"0"0
'0 '0
<II <II
c..> c..>
'§ '§
<8<8
'if!!.~
...... ......
00
II II
<~
II)
Q.g.
.q
:::l II)
o .~
- :::lU.--,
z
~
00
££
.S .S
"0"0
'0 '0
<II <II
c..> c..>
'§"§
<8<8
~~
............
00
II II ~
<~.;.;
'":::lo
'fa
>
~
U
<"'"l
I
tI)
Q
o
o
a
OIl
~
o
~
'So
s
Z
.,.,
on
=e
::I
-;
U
'"s
8
- -II II
<~
.,...
.,...
e-
Zz
Uu
'-I-l II)
~~
00
££
.= .5
-e-e
'<3 '<3
ctI ctI
(.) (.)
'§ '§
tEtE
ae.ae.
- _0
II II ":I:
<~~
II)
I':
·c
;J
'""0
I':
o
>
ctI
f:i:
'"§
8
'"§
8
5
>
'So
-oZ
Z
ql~
::c~
I': I':._ ._
-e-e
'0 '0
ctI ctI
(.) (.)
"£ .~
(.) (.)
ctI ctI
~~
.,... .,...
00
00
II II
<~
c
o
.~
~
~
o
00
00
c
..:.(
ctI
~
I
o
>o
Z
'"::s
o
.~
:>
I
"0
1':-
II) ctI
..c II)
~E
_ ..c
o (.)
~ -c
2.1.3 Method Validation
Bioanalysis is one of the branches of analytical science that requires method validation [154] to
generate confidence in the results. Analytical methods developed for the quantitative
evaluation of compounds and their metabolites must be reliable and reproducible for their
intended use. Table 2.2 illustrates the parameters to be considered during validation of a
quantitative method.
Table 2.2 Parameters to be considered during quantitative method validation in bioanalysis,
adapted from Hartmann et al, 1157)
Parameters Short description
Accuracy How close the experimental value (determined from standards) is to the valuedetermined by replicate analysis of 'spiked' samples
Precision Determined by variation in the accuracy
Linearity Ability of the method to obtain results proportional to the concentration in the
'spiked' sample
Selectivity Ability to determine the analyte(s) in the presence of other compounds
Recovery Percentage of the analyte(s) extracted from the 'spiked' samples
Ion Suppression The effects of the sample matrix on the ionisation of components
Limit of detection Lowest sample concentration that can be detected
Limit of quantitation Lowest sample concentration that can be quantified
A minimum of three concentrations are required for determining the values for accuracy and
precision, preferably at the low, medium and high ranges of the expected concentrations of the
analytes in the samples.
2.1.4 Anticipated Problems in Development of an Analytical Method
Several problems can be foreseen in developing a rapid and validated method for the analysis
of polyphenols in biological samples. Firstly, suitable extraction/sample preparation methods
need to be developed for the anlaysis of the urine and plasma. This is fundamentally
important to accurate analysis, and is a determinant in the success of the whole method. Urine
contains many metabolites; the analytical approach has to be fairly targeted to avoid unwanted
interference from substances not of polyphenol origin. As mentioned earlier, there are also the
problems of high salt concentrations in the samples, which degrade the chromatography, cause
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high system back pressure and deposit on the MS, reducing sensitivity. However, sample
clean up procedures need to be as simple as possible to avoid initiating changes to the
metabolite profiles and reduce associated errors and losses, and are also required to be rapid to
increase usefulness. A compromise will need to be reached between these factors.
Compromises will also have to be made for the selection of solvents for the extraction
procedures and for the solvents used for mobile phases. Although there is structural similarity
across the different classes of polyphenols, they are analytically distinct. Many papers report
the characterisation of members of the same class of flavonoid, but studies across the classes
are rarer. Flavonoids possess phenolic hydroxyl groups which are weak acids and require
conditions above their pKa of -8-10 to become fully ionised. Phenolic acids possess
carboxylic acids and are stronger acids than flavonoids; for ionisation pH must be above their
pKa of -3-5. This adds complexity to the conditions required for optimum ionisation,
retention and extraction of both groups of polyphenols. Structural similarity among the
flavonoids also causes problems in differentiating between individuals [114] if for example the
molecular masses are identical; this effect can be overcome to some degree by the use of LC.
In addition to the compromises made between the choice of solvents for extraction and the
choice of solvents for LC analysis of different polyphenols, one set of MS parameters is
unlikely to suit all compounds. Currently there are no references to the specific identification
and quantification of apple poylphenols and their conjugated and ring fission metabolites in
healthy humans, using the technique of LCIMS/MS, so initial work was based on methods that
had been applied to biological samples collected after ingestion of polyphenols from other
sources, such as cocoa and tea.
The detection of multiple metabolites in anyone sample is complex and problems are likely to
anse. Firstly, these metabolites need to have been extracted from the biological matrix
successfully; secondly the method has to be sensitive enough to detect the very low levels
likely to be present; and thirdly the method is required to differentiate between likely
metabolite isomers. If baseline resolution is not apparent between all peaks
chromatographically or significant retention time differences do not exist between the isomers,
MS fragmentation patterns are needed to distinguish between metabolites. The ring position
of glycosylation or conjugation, impacts on the fragmentation pathways of the compounds and
helps to identify the unknowns.
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Further problems can be seen in developing a method to identify metabolites because of a lack
of available polyphenol standards for the possible metabolites; it is impossible to
unequivocally identify and quantify unknowns in biological samples without reference
standards. Calibration curves can be constructed for those standards that are available, and
subsequently quantification can be achieved for aglycones and some metabolites.
Comparisons can be made for some metabolites, if they have a similar structure or have
similar functional groups/positions, but definitive proof of identity and concentrations cannot
be reported.
To eliminate some of the uncertainty associated with results from methods of this kind, due to
all the problems discussed above, validation is performed. The process of validation imparts a
way of defining whether a working method has been devised for the analysis of polyphenols
and their metabolites in biological samples. The literature is predominately absent of fully
validated LCIMS/MS methods for such analysis, as the task is complex and time consuming.
Validation procedures also take into account the effect of the biological matrix (ion
suppression/enhancement effects) on the analysis of the sample, which is an extremely
difficult parameter to account for as each individual plasma or urine matrix will affect the
analysis differently.
To summarise, an assessment of the anticipated problems in developing a validated
LC/MSIMS method for the analysis of polyphenols and their metabolites in biological samples
has been detailed. There are many difficulties associated with this type of research, but it is
important to achieve the aims proposed for the progression of knowledge and the complete
understanding of absorption, metabolism and excretion of apple polyphenols in humans.
2.1.5 Aim of the Chapter
To develop and validate a hyphenated liquid chromatography tandem mass spectrometry
method for the measurement of polyphenols and their metabolites in human urine and plasma
samples.
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2.2 Materials
Chemicals for Chromatography
HPLC grade MeCN (far UV) and MeOH were purchased from Fisher Scientific UK Ltd
(Loughborough, UK). Formic acid was obtained from Sigma Aldrich (Dorset, UK) and stored
at ca. 4°C. TFA and dimethylhexylamine (DMHA) were both purchased from Sigma-Aldrich
(Dorset, UK) and stored at RT. All water used was purified using a MilliQ water purification
system. Standards (listed in Table 2.3) were purchased mainly from Sigma Aldrich (Dorset,
UK) with the exception of isorhamnetin-3-g1ucoside and kaempferol-3-glucoside purchased
from Apin Chemicals (Oxon, UK) and taxifolin, (-) epicatechin gallate, (-) gallocatechin and (-
) gallocatechin gallate, purchased from MP Biomedicals (London, UK). Polyphenol
conjugates were supplied by Paul Needs (Phytochemicals and Health department, Institute of
Food Research, Norwich).
Chemicals for Extraction and Experimental Procedures
Ethyl acetate and ammonium acetate were purchased from Fisher Scientific UK Ltd
(Loughborough, UK). Ammonium hydroxide was purchased from Sigma-Aldrich (Dorset,
UK). p-glucuronidase (Type lX-A from E. coli) and sulfatase (from Helix pomatia) were
purchased from Sigma-Aldrich (Dorset, UK) as solids and stored at -20°C (NB the sulfatase
also has glucuronidase activity).
HPLCILCIMS Columns
Initial analysis used a HiChrom (Berkshire, UK) Hypersil CI8 column of dimensions 150 x 4.6
mm (5 urn particle size). Further development was carried out with a Phenomenex
(Macclesfield, UK) Luna CI8 column of dimensions 150 x 4.6 mm (5 urn particle size).
Optimisation of the method involved using Phenomenex (Maccelsfield, UK) Gemini CI8
columns of dimensions 100 x 3.0 mm (3 urn particle size) and 100 x 2.0 mm (3 urn particle
size). All columns were fitted with a Phenomenex guard column and cartridges of the same
material as the column.
General Equipment
Compounds were weighed on a Mettler AE 163 balance. Gilson pipettes and an Eppendorf
multi pipette were used for all liquids. A Cyclone vortex mixer and sonicator were used for
sample preparation. A Jouan centrifugal evaporator was used for sample evaporation.
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LC equipment consisted of:
Hewlett Packard 1090 instrument, complete with autosampler, column oven, tertiary
pumping system and diode array detector (DAD). Mobile phases were sparged with
helium gas before and during use. Conditions are detailed in section 2.2.3.
Agilent 1100 series HPLC instrument, complete with temperature controlled
autosampler (G1367A), degasser (G1379A), column oven (G1316A) and quaternary
pumping system (G1376A); this was coupled with a Waters Micromass Quattro Ultima
(details below). Conditions are detailed in section 2.2.3.
Shimadzu HPLC instrument, complete with temperature controlled autosampler (SIL-
HTc), degasser (DGU-14A), column oven (CTO-IOAvp) and binary pumping system
(LC-1OADvp); this was coupled with an Applied BiosystemslMDS Sciex Model 4000
Q-TRAP (details below). Conditions are detailed in section 2.2.3.
Mass spectrometry instrumentation consisted of:
Waters Micromass Quattro Ultima, a triple quadrupole with an electron spray
ionisation (ESI) probe. Direct infusion experiments were performed with a syringe
pump (Semat International) and 5 mL syringe (Fisher Scientific, Loughborough, UK)
to optimise precursor and product ions of the polyphenol standards.
Applied BiosystemslMDS Sciex Model 4000 Q-TRAP, a hybrid triple quadrupole!
linear ion trap instrument with an ESI probe. Direct MS infusion experiments were
performed with a syringe pump (Semat International) and 100 ul, syringe (Fisher
Scientific, Loughborough, UK) to optimise precursor and product ions of the
polyphenol standards.
Data Processing
Quattro - Results obtained from LC/MS/MS analysis were processed by Mass Lynx™ Global
Mass Informatics V4.0, Waters Micromass Ltd.
Q-TRAP - Results obtained from LCIMSIMS analysis were processed by Analyst Software
1.4.1, Applied Biosystems; the algorithm applied was IntelliQuan. Sample peaks were
automatically integrated by the software. All results were checked manually, and manual
integration was performed if necessary. The strategy applied to data processing was to ensure
everything was analysed in the same way; for example, a standard with a characteristic
shoulder would be integrated with or without that shoulder every time it was analysed.
Manual integrations were necessary on occasion and care was taken to make sure this would
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not introduce error. Quantitation methods were created for the analysis of standards in the
mobile phases, urine and plasma, and analytes in the urine and plasma; these were applied to
samples accordingly. Using this strategy it was hoped that data processing was consistent.
Extracted ion chromatogram peak areas were taken from Analyst and transposed into Excel,
where further data processing (means, standard deviations, etc) was undertaken. Graphs were
also constructed in Excel.
2.3 Methods
2.3.1 Preparation of Polyphenol Standard Solutions
All standards were supplied as solids; appropriate amounts were weighed into Eppendorf tubes
and dissolved in either MeOH: H20 (50:50) or MeOH:MeCN (70:30) according to their
solubility, to make 1 mg/ml stock solutions (Table 2.3). These solutions were stored at ca. -20
°C.
Stock solutions were diluted with mobile phase for HPLC and MS analysis (initially 0.01 %
formic acid: MeOH: MeCN 80:8:12 v/v/v for early development and 0.01 % formic acid:
MeCN 80:20 v/v for the final method and subsequent analysis). Taxifolin was used as an
internal standard and was prepared in the same way as the other polyphenol standards. A 3.3
J.1Msolution was prepared to 'spike' study samples. A 50 J.1Msolution of all the polyphenol
standards was prepared using the appropriate volumes of the 1 mg/ml stock solutions; this was
further diluted and used in calibration and validation procedures.
2.3.2 Mobile Phase Preparation
Mobile phases were prepared in volumetric flasks and filtered using Whatman membrane
filters (0.45 J.1m)before use. Details of the different mobile phases used throughout the
method development process are given in the section RP-HPLC later in this chapter.
2.3.3 Optimisation of RP-HPLC
Initially, two mobile phases were utilised in a gradient system; 0.1 % formic acid in H20 (A)
and MeOH (B). A Hypersil CI8 (HiChrom, Berkshire UK) column was maintained at a
temperature of 25°C with a mobile phase flow rate of 1.0 ml/min and wavelengths were
monitored at 280 nm and 365 nm. The gradient was as follows: (0, 10), (15, 10), (30, 90), (31,
10) (time in min, % B); total analysis time was 35 min. Changes were made to the mobile
phases, gradient, flow rate, and column temperature. A Luna CI8 (Phenomenex, Macclesfield
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UK) and Gemini CIS (Phenomenex, Macclesfield UK) column were also investigated. Further
changes to the LC conditions were made when LCIMS/MS was performed (detailed in section
2.2.5).
Table 2. 3 Concentrations and compositions of the stock solutions of the polyphenol standards.
Compounds reported to be present in apples, or reported metabolites of apples are shown
by an asterix (this data was taken from literature studies detailing the composition of
apples and metabolism studies using foods containing the same polyphenols).
Compound MW Concentration Composition(mM)
Caffeic acid" 180 5.56 MeOH: H2O
Chlorogenic acid" 354 2.82 MeOH: H2O
Ferulic acid 184 5.43 MeOH: H2O
Sinapic acid 224 4.46 MeOH: H2O
p-Coumaric acid" 164 6.10 MeOH: H2O
Gallic acid 170 5.88 MeOH: H2O
Vanillic acid 168 5.95 MeOH: H2O
p-Hydroxybenzoic acid 138 7.25 MeOH: H2O
Syringic acid 198 5.05 MeOH: H2O
Protocatechuic acid 154 6.49 MeOH: H2O
Genistein 270 3.70 MeOH: H2O
Daidzein 254 3.94 MeOH: H2O
Procyanidin B1• 578 1.73 MeOH: H2O
Procyanidin B2· 578 1.73 MeOH: H2O
Phloridzin" 482 2.07 MeOH: H2O
Phloretin" 274 3.65 MeOH: H2O
(+) Catechin" 290 3.45 MeOH: H2O
(-) Epicatechin" 290 3.45 MeOH: H2O
(-) Epigallocatechin gallate 458 2.18 MeOH: H2O
(-) Catechin gallate 442 2.26 MeOH: H2O
(-) Epicatechin gallate 442 2.26 MeOH: H2O
(-) Gallocatechin 306 3.27 MeOH:MeCN
Myricetin 318 3.14 MeOH:MeCN
Kaempferol 286 3.50 MeOH:MeCN
Kaempferol-3-glucoside 448 2.23 MeOH:MeCN
Quercetin" 302 3.31 MeOH:MeCN
Quercetin-3-glucoside· 464 2.16 MeOH:MeCN
Quercetin-3-galactoside· 464 2.16 MeOH:MeCN
Quercetin-3-rhamnoside· 448 2.23 MeOH:MeCN
Quercetin-3-rutinoside· 610 1.64 MeOH:MeCN
Quercetin-3-glucuronide· 478 2.09 MeOH: H2O
Quercetin-3' -glucuronide" 478 2.09 MeOH: H2O
Quercetin-3' -sulphate" 382 2.62 MeOH: H2O
Isorhamnetin • 316 3.16 MeOH:MeCN
Isorhamnetin-Svglucoside" 478 2.09 MeOH:MeCN
Isorhamnetin-Jsglucuronide" 492 2.03 MeOH:MeCN
Naringin 580 1.72 MeOH:MeCN
Naringenin 272 3.68 MeOH:MeCN
Hesperetin 302 3.31 MeOH:MeCN
Hesperidin 610 1.64 MeOH:MeCN
Luteolin 286 3.50 MeOH:MeCN
Apigenin 270 3.70 MeOH:MeCN
Taxifolin (IS) 304 3.29 MeOH: H2O
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2.3.4 Optimisation of MS Parameters
Initially, individual polyphenols standards were infused at a flow rate of 200 ul/min (400
ml/min on the Quattro) using both positive and negative ESI to establish optimum conditions.
This involved varying ion spray voltage (termed capillary voltage in the software used with
the Quattro), source temperature and gas flow rates/ temperatures. These parameters represent
those which will have the greatest effects on ionisation, and were applied globally to all
compounds. Collision energy and declustering potential (termed cone voltage in the software
used with the Quattro) also have significant effects on the ionisation of compounds, but these
were established individually for each compound. Minor parameters for investigation
included resolutions, ion energies and entrance/exit potentials. The effect of the solvent
present in the infusion solution was also investigated; TFA was compared with MeCN.
2.3.5 Optimisation of LCIMSIMS Method
Preliminary Development Work
The effect of different concentrations of TFA in the mobile phase was investigated.
Concentrations of 0.001 % (PH 4.2),0.002 % (PH 3.7), 0.005 % (PH 3.3) and 0.01 % (PH 3.1)
were all investigated compared to the original mobile phase of 0.05 % TFA (PH 2.4).
Investigations were also performed to establish which organic solvent gave the best results;
MeOH and MeCN were compared. Experiments using the two solvents together in different
proportions were also undertaken. In addition, the effect of formic acid on the signal
intensities and chromatography was compared with TFA; concentrations of 0.05 %, 0.01 %,
0.005 % and 0 % formic acid in H20 were investigated. This also required further gradient
changes to be applied to the method; (0, 20), (4, 40), (5, 46), (8, 48), (8.1, 98), (9, 98), (9.1,
20) (time in min, % B), total analysis time was 12 min.
Further Development Work
Changes to the LC methodology were necessary after initial experiments with the polyphenol
metabolite conjugates. A change to the organic mobile phase was incorporated, MeCN
replaced MeCN:MeOH (60:40), and 20 % MeOH was added to the aqueous mobile phase of
0.01 % formic acid. Many alterations were also made to the gradient, flow rates and
temperatures before the final optimised conditions were decided upon (Table 2.4).
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Table 2.4 Final optimised conditions for LCIMSIMS analysis of polyphenol standards and their
metabolite conjugates. Phenomenex Gemini Cl8 column 100 x 3.0 mm (3 I'm particle
size); temperature was 65°C. Mobile phase A: 0.01 % formic acid in H20, mobile phase
B: MeCN
Time (min) Event Parameter
0 %B 10
4 %B 40
5 %B 46
8 %B 48
8.1 %B 100
11 Total flow 0.225 Ill/min
11.1 Total flow 0.850 Ill/min
12 Total flow 0.850 Ill/min
13 Total flow 0.225 Ill/min
13.1 %B 100
17 %B 0
17.1 %B 10
20 Stop
2.3.6 Development of Sample Extraction Procedures for Human Plasma
Liquid-liquid extractions and SPE were evaluated as methods to prepare the plasma for
LCIMS/MS analysis. Initially, different solvents and in varying volumes were investigated.
The use of an internal standard was also considered. Extracts were subjected to
filtering/centrifugation techniques also. Whatman VectaSpin Micro™ filters (manufactured
from polypropylene with a membrane pore size of 0.45 um) and Millipore YM3 Microcon
filters were compared.
Liquid-Liquid Extractions
Plasma samples (0.5 ml) were 'spiked' with a mixture of polyphenol standards to give a
concentration of 10 J,lM. The samples were extracted with solvent (Table 2.5), vortex mixed
(1 min) and centrifuged (13,000 rpm for 3 min at 4°C). All extractions used a 3: I ratio of
solvent to plasma. The supernatant was decanted into a clean Eppendorf tube and evaporated
to dryness using nitrogen. A second extract (and third in the instance of methods J, K and L)
were both performed in exactly the same way, with the addition of a sonication step (10 min)
after vortex mixing. This/these extract(s) were combined with the first and evaporated to
dryness. All extracts were reconstituted in MeOH: H20; formic acid (10:89: 1), however, 20 %
(method H) and 50 % MeOH (method I) were also evaluated on some supernatants (produced
from method F). Reconstitution involved vortex mixing (1 min) and centrifugation (13,000
rpm for 3 min at 4°C), before decanting the supernatant into an HPLC vial for analysis.
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Table 2.5
Method
Methods used for the optimisation of tbe extraction of polypbenol standards from
plasma (n = 3)
Solvent
A
B
C
D
E
F
G
J
K
L
1% acidified ethylacetate (formic acid)
MeOH
MeCN
50 % MeOH. 50 % MeCN
1 % acidified MeCN (formic acid)
0.1 mM ~OH in MeCN
30 % MeOH, 70 % MeCN
3 extractions with 2 % acidified MeCN (formic acid)
3 extractions with 0.1 mM N140H in MeCN
2 extractions with 2 % acidified MeCN (formic acid)
followed by 1 extraction with 0.1mM N140H in MeCN
Method K was used for the preparation of all plasma samples collected from the human
intervention study.
Solid Phase Extractions
Hydrophilic-liphophilic balance (HLB) cartridges (Oasis, Waters) were used; these had a
particle size of 30 urn and a pore size of 80A. The cartridge was preconditioned with 1 ml of
MeOH, followed by 1 ml of H20. 1 ml of plasma 'spiked' with a mixture of polyphenols
reported to be present in apples and some of the known metabolites of apples (see Table 2.1)
was loaded onto the cartridge. Three methods were performed, each in triplicate. Extracts
were combined for each method, evaporated to dryness using a centrifugal evaporator and
reconstituted in 25 J.lIMeOH and 225 J.lIof 1% formic acid in H20.
Wash 1: 1ml 5 % MeOH in H20; wash 2: 1ml 2 % formic acid in MeOH: H20,
(v/v 50:50); wash 3; I ml2 % NR.OH in MeOH: H20, (v/v 50:50).
Wash 1: 1ml MeOH: H20, (v/v 50:50); wash 2: Iml ethyl acetate acidified with
2 % formic acid; wash 3: I ml MeOH.
Wash 1: 1ml 5 % MeOH in H20; wash 2: I ml 25 % MeOH in H20; wash 3: 1
ml 50 % MeOH in H20; wash 4: 1ml 2 % formic acid in MeOH: H20, (v/v
50:50).
Method 1:
Method 2:
Method 3:
2.3.7 Urine Preparation
Blank urine (0.4 J.lI) was centrifuged (13,000 rpm for 3 min, at 4°C) and compared to urine
treated with 5 volumes of MeCN before centrifugation at the same speed and for the same
length of time.
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Enzyme Treatment of Non-Study Urine - Preparation of Solutions
Ammonium acetate buffer (100 mM) was prepared and adjusted to pH 5 by the dropwise
addition of acetic acid (approximately 1.1 ml). Sulfatase was supplied at a concentration of
14,400 units/g; 0.20 g was added to 2.9 ml of ammonium acetate buffer to give the desired
concentration for the experiments. p-glucuronidase was supplied at 1,134,600 units/g; 0.05 g
were added to 455 ul of ammonium acetate buffer. Both enzyme solutions were vortex mixed
to aid dissolution and used on the day of preparation.
Enzyme Treatment of Non-Study Urine - Method
Urine (200 ul) was incubated at 37°C for 2 h with 100 fll of ammonium acetate buffer (100
mM, pH 5), 20 ul of enzyme solution (sulfatase or p-glucuronidase) and 10 fll of the internal
standard taxifolin (3.3 flM). Concentrated formic acid (2 ul) was added to stop the reaction.
The sample was vortex mixed, centrifuged (13,000 rpm for 3 min at 4°C) and the supernatant
was decanted into an HPLC vial before LCIMSIMS analysis. Suitable controls without
enzymes present were incubated along with the test samples.
Human Intervention Study Urine - Pooling Procedure
Details of urine collection procedures are given in chapter 3. Samples were removed from -80
°C storage and allowed to defrost at room temperature. Vials were shaken occasionally to aid
defrosting. Pools were made of each time point for all the volunteers, for each of the two
phases (n = 8) and samples were stored at -80°C. Pools of 0 - 24 h samples were also
prepared for each of the two phases of the study. Aliquots of all pooled samples were
centrifuged (13,000 rpm for 3 min, at 4°C), and the supernatants decanted for injection and
analysis by LCIMS/MS. These pooled urine samples were also enzyme treated, following the
same procedure as detailed above and analysed by LCIMSIMS.
Further pools were made using equal quantities of urine from each time-point for each of the
volunteers, hence 0 - 24 h pools for each volunteer were created (n = 9). These pools were
enzyme treated as detailed above, and analysed by LCIMS/MS. These enzyme deconjugation
experiments were undertaken to obtain values for the total aglycones excreted by each
volunteer.
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Human Intervention Study Urine - Individual Sample Analysis
Study urine collected which had not been defrosted before, was removed from storage at -80
°C and allowed to defrost at room temperature. An aliquot (400 ul) was removed and placed
in an Eppendorftube. The sample was centrifuged (13,000 rpm for 3 min, at 4°C) and 200 ~l
of the supernatant was aliquoted into an HPLC vial. 30 ~l of the internal standard Taxifolin
was added, and the sample was inverted. Injections (20 ul) were made onto the LC/MSIMS.
All results from these analyses are given in chapters 3 and 4.
2.3.8 Validation Procedures
Using a 50 ~M solution of a mixture of polyphenol standards (prepared as detailed in section
2.3.1), a set of six calibration standards ranging in concentration from 25 nM to 1.0 ~M were
prepared in blank urine (pooled baseline samples) on the same days as the analysis of study
urine samples. These samples were analysed at the start and at the end of the sample table.
Peak area values for each of the polyphenol standards were plotted against concentration to
give calibration graphs; a value for linearity could then be determined. In addition, blank
urine was 'spiked' to give three different concentrations along these calibration graphs; low
(0.09 ~M), medium (0.277 ~M) and high (0.83 ~M). Samples were prepared in duplicate and
centrifuged to represent the treatment of study samples. Accuracy values were calculated
using actual peak areas produced from the analysis of these low, medium and high
concentration 'spiked' urine samples, and calculated values from the calibration graphs. Mean
(n = 7) accuracy values were calculated for each polyphenol standard, and a value for
precision was determined by dividing the standard deviation by the mean.
Recovery was determined using data from two experiments: (I) blank urine (n = 6) was
'spiked' with a mixture of polyphenol standards to give the same low, medium and high
concentrations as used previously, and centrifuged (same treatment as used for the study
samples), before LCIMS/MS analysis. (2) Blank urine (n = 6) was centrifuged (same treatment
as used for the study samples) and then 'spiked' with a mixture of polyphenol standards to
give the same low, medium and high concentrations as previously, before LC/MS/MS
analysis. Peak areas from the 'spiked' and then extracted samples were divided by peak areas
from the extracted and then 'spiked' samples, and the value multiplied by a hundred to give a
percentage recovery for each of the polyphenol standards in the mixture. Matrix effects were
calculated at the medium and high concentrations by comparing the ratio between the low,
medium and high concentrations with the ratio between the peak areas obtained for each of the
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polyphenol standards. If the ratios were the same, the matrix was not affecting the MS
response for the compounds, if the ratios differed then the MS response was either being
suppressed or enhanced. Ratio values were used to calculate an expected peak area (which
would be detected if the matrix was blank). The actual peak area detected was divided by the
calculated peak area and multiplied by a hundred, to give the percentage of the response that
was suppressed (negative value) or enhanced (positive value).
Procedures used for the validation of the method for the extraction of polyphenols from human
plasma were the same as those used for the urine. The differences were that the set of six
calibration standards prepared for linearity measurements ranged in concentration from 2.5
nM to 0.2 J.lM, and also the values for the low, medium and high concentrations of 'spiked'
plasma were 0.05 J.lM,0.10 J.lMand 0.20 J.lM,respectively.
2.4 Results and Discussion
The strategy undertaken for the development of a new LCIMSIMS method to quantify apple
polyphenols and their metabolites in human urine and plasma was firstly to develop an HPLC-
UV method which could separate the selected polyphenol standards. Following this, optimum
MS parameters were investigated for each of these polyphenol standards. Further method
development was performed via LCIMSIMS, using polyphenol standards and some conjugated
polyphenol standards. Initial biological sample preparation was executed using blank urine
and plasma, 'spiked' with polyphenol standards and qualitative assessments were made to
highlight methods for further investigation; validation procedures were undertaken on the final
methods. The optimised and validated method was then applied to pooled study urine samples
to gather preliminary data to aid analysis of the individual study samples.
2.4.1 HPLC-UV and LCIMSIMSMethod Development
Systematic changes to the mobile phases, gradients, flow rates, column, column temperatures
and total analysis times were made in order to optimise the separation of the polyphenol
standard mixture. Figure 2.4 (A) shows a chromatogram from the early development work
with a HiChrom (Berkshire, UK) Hypersil CIS column (150 x 4.6 rom, 5 urn particle size).
These columns have previously been used in the literature for the determination of
polyphenols [8,921. The peaks observed at 8.7, 11.5, 12.5 and 18.5 min show characteristic
tailing, probably caused by the ionised silanols and metal ions on the surface of the silica used
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to pack the column. Hypersil columns are manufactured using an older style of silica, which
has been superseded by a modem purer type of silica that lacks the impurities and therefore
reduces these interactions, producing better chromatography.
A Phenomenex (Macclesfield, UK) Luna CIS column (150 x 4.6 mm, 5 urn particle size) was
also evaluated (Figure 2.4, B) and the polyphenol peaks observed with this column were much
sharper with no peak tailing. However, for a mixture of eight polyphenols, only seven peaks
were observed, and these were not satisfactorily resolved, so additional gradient, flow rate and
temperature (40 °C) changes were made. The best separation achieved from these early LC-
UV experiments was suitable to begin work on the MS optimisation.
Further LCIMSIMS method development required the use of a column with smaller
dimensions; a Phenomenex (Maccelsfield, UK) Gemini CIS column (100 x 3.0 mm, 3 urn
particle size) was utilised. Preliminary ESI infusion experiments on the Micromass Quattro
Ultima showed ion suppression effects when TFA was present in the standard mix infusion
solution when compared to MeCN alone. Although TFA has proven to be more efficient in
the separation of flavonoids in reversed-phase systems, compared to acetic or phosphoric acid
[112.161], TFA generally causes reduced signals for these compounds in the MS in negative
mode [141. To improve signal intensities, experiments to reduce the percentage of TFA in the
infusion solution and in the mobile phase were undertaken; a compromise was made between
signal intensities, resolution and peak shape. Concentrations of 0.001 %, 0.002 %, 0.005 %,
0.01 % and 0.05 % were investigated. The greatest ion signal intensities were observed at the
lowest concentrations of TFA, but peak resolution was poor; e.g. a mixture of four
polyphenols standards, which were resolved under the original TFA concentration of 0.05 %,
co-eluted using 0.001 % TFA (Figure 2.5, A). The same concentration of 0.001 % TFA was
added to mobile phase B to see if this could improve the resolution of the compounds, but only
a slight change to the separation was observed. Experiments comparing MeOH and MeCN as
the organic mobile phase resulted in MeOH providing resolution of these four polyphenolic
standards at the same concentration ofTFA (Figure 2.5, B).
However, analysis of some of the other polyphenolic standards using MeOH, such as gallic
acid, resulted in broader peaks than observed with MeCN. Experiments were carried out with
a combination of the two organic solvents in different ratios until resolution, peak shapes and
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retention times were all optimised. This was achieved with a combination of MeCN and
MeOH in the ratio of 60:40.
Despite significantly reducing the concentration of TFA in the mobile phase, a reduction in
sensitivity was still observed in the MS. TFA was substituted with formic acid, which did not
incur any losses in resolution or peak shape at the initial concentration of 0.1 %. However,
retention times decreased, so a final change to the gradient was made. Presence of formic acid
in the mobile phases utilised for LC/MSIMS analysis still caused a reduction in ionisation;
0.01 % formic acid gave the best signal intensities (Figure 2.6). Some previously unresolved
peaks were also resolved at this lower concentration of formic acid, so a good compromise
between resolution and ion signal intensities had been achieved.
2.4.2.1 Direct Infusion Experiments
Optimum MS conditions for individual compounds were established by direct infusion of the
polyphenol standards in the mobile phases. Both negative and positive ionisation modes were
investigated; with negative mode producing the best signal intensities for the greatest number
of compounds. Table 2.6 details the optimised Q-TRAP parameters.
Table 2.6 Optimised global Q-TRAP MS parameters
Parameter Value and units
Ion Spray Voltage
Temperature
Curtain Gas
Collision Gas
Ion Source Gas 1
Ion Soure Gas 2
-4.5 kV
225°C
10.0 psi
6.0 psi
19.0 psi
10.0 psi
Preliminary experiments revealed that some of the standards had the same mass pairs, for
example procyanidin B I and B2, (+) catechin and (-) epicatechin, (-) catechin gallate and (-)
epicatechin gallate and quercetin-3-glucoside and quercetin-3-galactoside. For the first three
pairs, each compound in the pair had a different retention time (although the peaks for (-)
catechin gallate and (-) epicatechin gallate are not baseline resolved) and so could be
distinguished. However, the glycosides of quercetin had identical retention times, and no
differences were observed in their fragmentation patterns so unfortunately these glycosides
could not be distinguished by this method.
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2.4.2.2 Atmospheric Pressure Chemical Ionisation (APCI)
The technique of APCI in both positive and negative modes was investigated for the
polyphenol standards producing weak ion signal intensities using ESI, such as phloridzin,
procyanidin Bland B2 and (-) gallocatechin. However, no significant improvements to the
signal intensities were achieved compared with ESI.
2.4.2.3 LCIMSIMS - Analysis of Polyphenol Standards (Non-Biological)
Figure 2.7 shows the extracted ion chromatogram for a mixture of the polyphenol standards,
represented three dimensionally. Experiments using polyphenol metabolite conjugates in the
polyphenol standard mix indicated some problems with the chromatography. Although the
glucuronides of quercetin and isorhamnetin had earlier retention times compared to their
aglycones, the quercetin-3' -sulfate standard appeared not to elute during the analysis time.
Considerable time was spent problem solving, trying to ascertain whether the MS was
detecting an impurity in the synthesised standard or whether poor compound ionisation or
degradation was to blame for its lack of appearance.
After consulting the original method used for the identification of quercetin-3' -sulfate during
synthesis, it was observed that elution resulted following a period of 100 % MeCN. MeCN is
a much stronger solvent for decreasing retention of compounds on reversed phase columns.
However, the method also had increased formic acid concentration and increased total analysis
time, both undesirable conditions. Experiments using 100 % MeCN as mobile phase B and
increasing the temperature and flow rate, instead of increasing formic acid concentration and
analysis time, worked to reduce retention and elute quercetin-3' -sulfate within a 20 mm
analysis time; quercetin-3' -sulfate eluted at 17.3 min.
Table 2.7 details the retention times, precursor and product ions, optimised collision energies
and declustering potentials for all of the polyphenolic standards evaluated. These parameters
were used to construct the multiple reaction monitoring (MRM) method for the polyphenol
standards, data from which was used for the construction of the calibration graphs. More
polar polyphenolics such as the hydroxybenzoic acids, eluted at the beginning of the
chromatogram followed in order by flavanols, hydroxycinnamic acids, coumarins, flavanones,
dihydrochalcones, flavonols and flavones. This order is in agreement with published
literature [136, 137, 164, 1651. Within the same class of polyphenol, the functional groups also play
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an important role in retention. The greater the numbers of hydroxyl groups present on the
molecule, the less the compound is retained, for example compare gallic acid with three
hydroxyl groups (t, 1.91 min) and protocatechuic acid with two hydroxyl groups (t, 2.65 min).
This is observed across all the classes in this study. The presence of apolar substituents, such
as methoxy groups, also increase the retention time (compare quercetin t, 6.68 min and
isorhamnetin t, 7.68 min, isorhamnetin differs in structure by the presence of a methyl group).
This pattern is also seen with other polyphenols such as the hydroxybenzoic acids; gallic acid
has three hydroxy groups present, when two of these are substituted for methoxy groups as in
the case of syringic acid, the retention time increases from 1.91 min to 4.61 min. Retention
times given by Abad-Garcia et al. [137] for a range of polyphenolic standards with and without
methyl groups also supports this.
The retention times of the procyanidins Bland B2 are an example of how the orientation of
the functional groups also affects the retention time, as they differ only in the planar direction
of a single hydroxyl group and this is the difference between t, 2.12 min observed for Bland
2.88 min recorded for B2. The later retention time for procyanidin B2 has also been reported
by other authors [101, 137]. A further example of orientation affecting retention times is seen
with the compounds (+) catechin (tr 3.65 min) and (-) epicatechin (t, of 4.32 min). These two
flavanols are isomers, differing only in their orientation of the B ring about the C ring;
retention time is critical for their identification as they are difficult to distinguish by other
techniques. Supporting evidence for the elution order of flavanols is present in the literature
[101]
If the compound has a sugar attached, the glycosylated form elutes before the aglycone
(compare hesperidin tr 5.07 min and hesperetin tr 7.57 min; hesperidin contains glucose) under
these conditions. This fmding is supported by literature which also reports that if the sugars
are acylated, this increases the retention time [126, 136]. Glycosylation affects retention times
differently based on the nature of the sugar and the bond position; if compounds are
glycosylated in the same bond position, the elution order is diglycoside, galactoside,
glucoside, rutinoside, neohesperidoside and rhamnoside [I37] (compare quercetin-3-glucoside t,
5.19 min and quercetin-3-rutinoside t, 5.76 min). Alterations to this order may be observed
with different LC conditions; Kahle et al. [101] report the elution of quercetin-3-0-rutinoside
before other O-glycosides. However, it is the position of the sugar moiety that is more
important than the nature of the sugar [137]; glycosides in the 7 position elute before those on
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the 4' or 3 positions, and C-glycosides elute before O-glycosides [136]. Since the glycoside
moieties on the flavonoids included in this method are all present on the 3 position, this aspect
cannot be discussed.
The retention of conjugates is also influenced by the nature of the conjugate (methylated,
sulfated or glucuronidated) and the position on the molecule. Isorhamnetin-3-glucuronide
elutes after the glycoside (isorhamnetin-3-glucoside), but before the aglycone. This pattern is
seen with quercetin-3-glucuronide also, however, the 3' -glucuronide elutes after both the
glycosides and the aglycone. This elution pattern applies to the analysis of these compounds
in biological matrices also; Mullen et al. [23], reported a t, for quercetin-3-glucuronide as 28.4
min and a tr for quercetin-3'-glucuronide as 36.3 min in human urine and plasma. However,
elution of the aglycone in plasma was observed after all glycosides and glucuronides of
quercetin. This may be due to differences in the LC conditions used for the analysis; a much
higher concentration of formic acid is utilised in the mobile phases, or it may be due to other
components in the plasma matrix.
When conjugated with a sulfate, the retention time of quercetin increased; t, of aglycone was
6.68 min compared to tr of quercetin-3'-sulfate 17.3 min. No other sulfated polyphenol
standards were available for comparison in this study. Mullen et al. [23], also report the elution
of quercetin sulfates after the aglycone, glucosides and glucuronides, in human urine and
plasma. No methylated standards were purchased as standards for this present work, and so
the effect of this type of conjugation cannot be considered. Literature indicates that
methylation of polyphenols increases the retention time; Gonzalez-Manzano et al. [166], report
tr of (+) catechin to be 16 min, with 5-0-methylcatechin, 3'-0-methylcatechin, 7-0-
methylcatechin and 4' -O-methylcatechin eluting after this time, in the order stated.
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Table 2.7 Retention times and optimised precursor and product ions, collision energies and
declustering potentials for the polyphenolic standards. LC/MSIMS conditions were as
described in Table 2.4.
Standard
Retention Precursor Ion Product Ion Collision Declustering
Time (min) (mlz) (mlz) Energy (eV) Potential (V)
Caffeic acid 4.24 178.9 135.0 ·22 -60
Chlorogenic acid 4.21 353.1 190.8 -24 -47
Ferulic acid 5.44 193.0 134.0 -22 -45
Sinapic acid 5.49 223.0 148.9 -28 -48
p-Coumaric acid 5.02 162.9 118.9 -20 -41
Gallic acid 1.91 169.0 124.9 -22 -56
Vanillic acid 4.39 167.0 107.9 -26 -40
p-Hydroxybenzoic acid 3.50 136.0 107.9 -27 -90
Syringic acid 4.61 197.0 181.9 -18 -50
Protocatechuic acid 2.65 152.9 109.0 -21 -41
Procyanidin Bl 2.12 577.2 288.9 -34 -70
Procyanidin B2 2.88 577.2 407.1 -32 -90
(+) Catechin 3.65 289.0 109.1 -36 -62
(-) Epicatechin 4.32 289.0 109.1 -36 -70
(-) Epigallocatechin gallate 4.32 457.0 169.0 -26 -80
(-) Catechin gallate 5.09 441.1 169.0 -27 -62
(-) Epicatechin gallate 5.09 441.1 169.0 -26 -94
(-) Gallocatechin 2.16 305.0 124.9 -28 -61
Genistein 7.30 269.1 133.0 -42 -80
Daidzein 6.49 253.1 132.0 -56 -92
Phloridzin 5.85 481.1 273.0 -33 -32
Phloretin 7.16 273.1 167.0 -24 -68
Naringin 5.60 579.3 271.0 -44 -101
Naringenin 7.22 271.0 119.1 -34 -57
Hesperetin 7.57 300.9 151.0 -30 -111
Hesperidin 5.07 609.3 300.9 -35 -78
Luteolin 6.70 285.0 133.2 -49 -71
Apigenin 7.33 269.0 117.0 -50 -89
Myricetin 5.89 317.0 150.9 -32 -89
Kaempferol 7.42 285.0 116.9 -56 -94
Kaempferol-3-glucoside 4.90 447.1 222.9 -12 -24
Quercetin 6.68 301.0 106.9 -40 -71
Quercetin-3-gl ucoside 5.19 463.0 270.9 -63 -77
Quercetin-3-galactoside 5.19 463.1 300.2 -40 -81
Quercetin-3-rhamnoside 5.65 447.1 300.1 -37 -90
Quercetin-3-rutinoside (Rutin) 5.76 609.2 300.1 -54 -94
Quercetin-3-glucuronide 5.70 477.0 301.0 -32 -85
Quercetin-3' -glucuronide 6.90 477.1 300.9 -31 -66
Quercetin-3' -sulphate 17.3 381.0 300.9 -28 -45
Isorhamnetin 7.68 315.1 300.1 -31 -93
Isorhamnetin-3-glucoside 5.72 477.1 314.2 -37 -87
Isorham netin -3-glucuronide 6.22 491.0 315.0 -26 -123
54
..;
N
aJ
Z
..s
~
.5
"0
aJ
.c
·c
c.;
'"aJ
"0
'"..s
aJ
10
aJ
~
'"
=0
;::
:a
=0
c.;
rJ:J
E
rJ:J
E
u
~
,;,
"0
10
..s
"0
=..s
.-
'"
"0
=~ V)
-=Q. V)
»
"0
Q.
aJ
-=.-
....
0
aJ
e
0
'"....
0
aJ
10
=.-;<
·s
..s
....
0
e
..s
10
Qi)
0
.-
..s
e
0
10
-=c.;
=
.~
"0
aJ
.-
c.;
..s
10
.-
;<
aJ
Q
I"l
e-
N
aJ
10
=I:f)
~
I
- (;1
11
11
o
6
8
2.4.3 Optimisation of the Extraction of Polyphenols from Human Plasma
A qualitative survey of a range of extraction methods was used to assess which methods were
worthy of further detailed investigation. Preliminary investigations eliminated a number of
potential approaches. LCIMSIMS analysis of SPE extracts showed no peaks for the expected
compounds, which may have been a result of low extraction recoveries. Itwas also observed
that the low percentages of organic solvent used for the SPE methods may not have fully
precipitated all the proteins in the plasma, and these could be the cause of the deterioration in
the chromatography observed. The cartridges utilised were Waters HLB cartridges, as these
had shown reasonable recoveries for some polyphenols in articles in the literature [156, 167] and
solvents chosen also reflected those reporting successful extraction of polyphenols from
biological samples, for example MeOH and ethyl acetate [70].
A ratio of 3: 1 (solvent to plasma) appeared to be the best selection for liquid-liquid extractions
to ensure all the protein constituents of the plasma had been removed. The literature details
the use of volumes of between two and four times that of the plasma for liquid-liquid
extractions [14,69,84, 163, 168]; a 3:1 ratio is generally preferred. Extracts were subjected to
filtering/centrifugation techniques to enhance the plasma preparation. The rationale behind
the use of centrifuge filters relates to better sample clean-up, eliminating other components in
the matrix which may cause ion suppression. Results indicated that due to the very small pore
size of the Millipore YM3 Microcon filters, much of the 50 ul extract was lost on the filter
membrane; for this reason their use was discontinued. Perhaps use on larger sample sizes
would have proved more successful. Whatman VectaSpin Micro™ filters also caused much
of the sample to be lost on the filter membrane. The filtrate that did pass through did not show
enough of an improvement in chromatography or ion signal intensities to warrant the high
costs of the filters.
In the literature, mostly MeCN (see next paragraph), MeOH [8,99] and formic acid [83] are used
for the extraction of polyphenols from plasma and other biological fluids. To avoid the need
for the addition of ascorbic acid which many research groups use to preserve the sample and
stabilise the polyphenols at neutral or alkaline pH [46), sample handling times were kept to a
minimum in these investigations. It was thought the presence of ascorbate in the sample may
obscure analytes present in small quantities, in terms of the response of the MS, and may
cause further interactions between metabolites.
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After initial preliminary experiments, optimisation of the plasma extraction method was
performed. The methods detailed in Table 2.5 were evaluated and percentage recoveries for
all methods are shown in Tables 2.8 and 2.9. Comparing methods A - D, method C using
MeCN produced the highest extraction recoveries for 40 % of the compounds analysed.
Methods A, B and D contributed to the remaining 60 % equally. In the instances where
method C did not produce the highest extraction recovery for a particular compound, the value
was not usually much lower than the greatest value achieved. For these reasons, method C
was chosen as the solvent to continue method development. The rationale behind the
successful use of MeCN for extraction of polyphenols is due to their physio-chemical
properties. Polyphenols are polar and water soluble and so they dissolve completely in
MeCN. Protein in the sample is precipitated on contact with MeCN and some lipids are also
extracted, so there is a small amount of selectivity. Many of the papers detailing the extraction
of polyphenols from plasma use MeCN as the extraction solvent [23. 72. 78. 84. 106]. However,
very few papers quote the extraction efficiencies for the polyphenols under investigation; the
average recovery for phloridzin from plasma was quoted as 65 % by Marks et al. [72], and the
average recovery for (-) epicatechin for plasma was typically 55 % reported by Mullen et al.
[106], both of these values are close to those obtained here with MeCN. Mata-Bilbao et al. [70],
report a much higher recovery for (-) epicatechin of between 80.6 % and 119.75 % using 70 %
DMF containing 0.1 % formic acid.
Increasing and decreasing the pH of the MeCN, with a base and an acid respectively, and also
MeCN in combination with MeOH were investigated (methods E - G) for plasma extraction.
Although initially looking at the data, acidified MeCN (method E) provided the highest
percentages of recovery for the majority of compounds (57.5 %), MeCN containing 0.1 mM
N~OH (method F) appeared superior for most of the compounds specifically found in apples,
for example the procyanidins, catechins and dihydrochalcones. The literature supports the
acidification of the plasma before extraction, which would achieve a similar effect to
acidifying the extraction solvent, but there are no references to the use of alkaline extraction
solvents in the literature. Where the acidified MeCN offered the greater extraction
efficiencies, the value for the extraction efficiency using MeCN containing 0.1 mM NH40H
was not usually much lower. For these reasons, it was decided to proceed with method F - 0.1
mM N~OH in MeCN to continue method development.
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It is possible that the solvents used for reconstitution could also have an effect on the values
for the extraction efficiencies and so this was investigated (comparing methods H and I). The
results show that there were no improvements to the recoveries by increasing the proportion of
MeOH in the reconstitution step (20 % and 50 %); all the extraction efficiency values were
lower than for the reconstitution using 10%MeOH. The final experiment on the optimisation
of the plasma extraction method combined the extraction with acidified MeCN (method E)
and MeCN containing 0.1 mM NHtOH (method F). Extracting the plasma a third time was
also investigated (methods J - L). When both acidified MeCN and alkaline MeCN were used
in combination, extraction efficiencies overall improved, but the extracts obtained were not as
clean as those prepared when using each of the solutions on their own. It was also noted, that
for the majority of the apple components, 0.1 mM NH40H in MeCN alone still gave the
greatest recoveries. Extracting the plasma twice improved the recoveries, but no improvement
in extraction efficiencies was noted with a third extract. This would unnecessarily increase the
time taken for sample preparation, with no observed benefits.
The only paper in the literature to date, which deals with the extraction of procyanidins from
biological fluids is by Tanaka et al. (68); the authors measure the levels of procyanidins B2 and
B3 in rat plasma after oral administration of the polyphenols. Recoveries were between 73.7
and 93.8 % for concentrations between 125 nM and 2000 nM; full method validation was not
performed. The extraction methodology presented here did not produce the same high
recoveries as reported in this paper (2: I MeCN: plasma, reconstituted in 50 % MeOH); the
best recoveries for the procyanidins B I and B2 were 58.3 % and 56.5 %, respectively and
were produced by extraction with 0.1 mM N~OH in MeCN.
In summary, the data shows that for the majority of compounds, method L, i.e. the
combination of acidified MeCN and N~OH in MeCN, produced the greatest recoveries.
However, for six of the compounds found in apples, the method using only NH40H in MeCN
appeared more effective. Noting this, and acknowledging that an extraction with just one
solvent is much easier to execute than with the combination of the two, and also considering
that when the extraction efficiencies are improved with the treatment of acid and alkali
together, the actual values for the recoveries are not significantly more than when NH40H is
used alone; method K was used to extract all the plasma samples collected from the human
intervention study.
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The liquid-liquid extraction method using a 3: 1 ratio of 0.1 mM NH.OH in MeCN to plasma
generally gave extraction recoveries greater than 50 % for the 40 polyphenols investigated. It
is important to mention that recoveries for metabolites of apple polyphenols (the majority of
which are not included in the standard solution) may be different to those of the standards.
Also, where recoveries for some standards are low, quantitative data produced for the
absorption and excretion of metabolites may be underestimated. The extraction efficiencies of
certain polyphenols were compromised for others in these experiments, to attempt to find one
method to suit all. The range of polyphenols under investigation adds a great deal of
complexity to finding just one method that can be applied to all compounds. This method
provides a simple, fairly rapid way of preparing plasma for LCIMSIMS analysis, which is not
specific for polyphenols, although has proven to be suitable for members of the polyphenol
family, regardless of class. A method more specific to the extraction of polyphenols, or some
of the more difficult classes of polyphenol could also have been investigated.
2.4.4 Optimisation of the Extraction of Polyphenols from Human Urine
The resulting pellets formed at the bottom of the Eppendorf tubes from urine centrifuged
compared to urine treated with 5 volumes of MeCN before centrifugation with the same
conditions, indicated that the treatment with MeCN gave no benefit of increased removal of
endogenous materials over centrifugation alone. Thus, all urine was centrifuged before
analyses and this was the only sample preparation performed. This is in agreement with the
majority of studies using polyphenols detailed in the literature [72,74,78,82). A few exceptions to
this involved acidifying the urine with acetic acid before extraction with ethyl acetate [80] (no
metabolite detection/identification performed), treating the urine with dichloromethane prior
to centrifugation [77) and treating the urine with MeCN [73) both methods used for the
identification of metabolites of tea.
Simple sample preparation such as used presently, also reduces the chances of altering the
metabolite composition of the fluid, which may occur with extraction procedures. Small
volumes of urine were analysed to avoid salt and contaminants which will not have been
removed via this method, accumulating on the analytical column and reducing sensitivity in
the mass spectrometer.
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2.4.5 Validation of the Methods for the Extraction of Polyp henoIs from Human Urine
and Plasma
Values for linearity showed that for the concentrations under investigation, the response of the
MS was on the whole proportional to the concentration of the analyte in the sample.
Calibration graphs constructed from 'spiked' urine samples, for three of the polyphenols in the
mixture are shown in Figure 2.8. Values for the linearity of the MS response to polyphenol
standards in the urine were all above 0.99, with the exception of two polyphenols (Table 2.10).
In plasma, the responses were not as linear as for the urine, but R2 values were generally
above 0.97 (Table 2.11). As 'blank' samples for both urine and plasma were baseline
volunteer samples and not synthetically prepared matrices, they contained some endogenous
levels of the compounds under investigation; this explains an intercept value of greater than
zero.
Values for the recovery of polyphenols from the urine, was generally above 85 % and below
102 %, with a few exceptions. Recoveries from plasma were higher; generally between 92
and 120 %, with a few exceptions below and above these values. Values for recovery were
generally better at the higher concentration compared with the low concentration. Evaluation
of so many polyphenols using just one extraction method results in a loss of recovery of
certain compounds to benefit the increased extraction of others. Mostly, literature presents
methodology for the extraction of one class of polyphenol (for example catechins [57,74,771)or
even a specific member of one class, for example the reporting of the conjugates produced
from (-) epicatechin [81, 971or quercetin [231.
Matrix effects were investigated in both urine and plasma; the percentages calculated represent
the proportion of the actual response observed compared to the expected response if the matrix
was blank. For example, a value for the matrix effect in urine of -3.8 % as in the case of
chlorogenic acid, indicates that only 96.2 % of the expected MS response for that particular
polyphenol has been observed; there is 3.8 % suppression is due to other components in the
matrix. Where a negative value is quoted, this represents a decreased MS response, and where
a positive value is given it represents signal enhancement, where the matrix components have
either been suppressed to allow the polyphenol to dominate or the matrix components have
improved the degree of ionisation of the polyphenol, producing a better signal. In general,
mostly ion suppression is observed. For those values which are not calculable, it is due to a
high endogenous level of the polyphenol (or something with the same mass pair and retention
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time), which obscures the results. In some cases, the endogenous level is greater than the
lowest concentration used for the validation procedures.
Variation of the MS response for the same polyphenol in the same sample matrix on the same
day should be minimal, if the method is precise. In urine, interday precision was generally
less than 20 % for the lowest concentration (except for kaempferol, 22.1 %), and mostly below
15 % for the medium and high concentrations. Day to day variation of the MS response for
the same polyphenols in the same sample matrix is greater, although intraday precision in
urine was also generally less than 20 % for the lowest concentration, and below 15 % for the
medium and high concentrations. However, there were a few more exceptions than noted for
interday precision. Accuracy for interday experiments was generally between 85 and 100 %,
with a few values falling below or above this range. Intraday accuracy was generally between
95 and 110 %. For plasma, interday and intraday values for precision were generally below 20
% for the lowest concentration and below 15 % for the high concentration, except for a few of
the polyphenol standards. Interday and intraday accuracy values were generally between 80
and 110 %. Values for the effect of ion suppression show that the greatest effects were
noticed at the lower concentrations, as expected.
The ability to report values within universally accepted ranges for some of the key parameters
required for validation demonstrates that a working method has been developed; this method
can be applied to both urine and plasma samples from humans. Although the purpose of the
method was to identify some of the major metabolites of apples in humans, the method may
also be successful for determining metabolites from consumption of other foods and
beverages, indicating a much wider application.
Few studies documented in the literature contain any validation data, especially for those
studies investigating polyphenols and their metabolites in biological fluids. Ito et al. [801,
report validation of their method to quantify polyphenollevels in human urine after the intake
of six different polyphenol-rich beverages. Sixteen polyphenol standards belonging to the
hydroxycinnamic acid, hydroxybenzoic acid, flavonol, flavanone and dihydrochalcone classes
were shown to have good linearity (r 0.986 - 0.999) in concentrations ranging from 0.5 to 50
J.1M (not all polypheno I standards were validated over the same concentration range).
Accuracy values varied from -4.1 to 3.2 % and intraday and interday variabilities were lower
than 10.1 and 10.3 %, respectively. Roura et al. [811, report partial validation of their method
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to quantify (-) epicatechin metabolites in human plasma after ingestion of cocoa. Linearity
was good (~0.999) between concentrations of 15 and 300 ug/L 'spiked' into plasma, however
precision and accuracy values were only obtained for variation in retention times. Recovery
from 'spiking' into water was 93.5 %, whereas recovery from the blank human plasma was 71
%. The lower recovery in the matrix was hypothesized to be caused by the complexity of the
matrix interfering with the ionisation of (-) epicatechin metabolites and/or interactions of
phenols with plasma components such as protein, which can occur during the process of
extraction.
One article which combines partial validation for both urine and plasma, shows the lower
sensitivity achieved from 'spiking' polyphenol standards into plasma compared to urine; again
this can be attributed to matrix components [76]. Intraday and interday variations are below
10.7 % for all three catechins measured, although only one concentration appears to have been
investigated, and this is not stated. Recovery for (-) epicatechin from plasma was 79 - 91 %
and from urine was 90 - 106 %. One disadvantage of the paper is the deconjugation of the
urine and plasma samples using enzymes to cleave the conjugates, so information on the
metabolites is not provided. Validation reported by Urpi-Sarda et al., [105] for microbial
metabolites of cocoa after intake in humans and rats uses synthetic urine (which will be
consistent throughout analysis, unlike actual urine) and gives values for recovery similar to
those established here; e.g. caffeic acid 95 - 109 %, ferulic acid 87.2 - 96.8 %, (-) epicatechin
84 - 90 %. Once again, only values for one concentration are given and the paper concentrates
on the simple phenolic acids and breakdown products of the compounds present in cocoa; it
does not deal with the more complex conjugates or wider range ofpolyphenolics in cocoa.
One limitation associated with LCIMSIMS methods such as this, developed for the
quantitative analysis of biological samples, is that the biological matrices can affect the
ionisation process resulting in either signal suppression or enhancement, as mentioned
previously. The change in signal intensity observed is caused by the co-elution of endogenous
compounds such as salts, amines, fatty acids, or triglycerides, as not all of these endogenous
compounds will have been removed by the sample preparation methods. These effects are
strongly compound-dependent, affecting each one differently and are also more pronounced
with ESt than with APCI [154]. These effects also alter the efficiency and reproducibility of the
analyte ionisation within the ion source and thus may be especially complex when analysing
multiple analytes from a biological sample in a single analytical run [94], such as in this case.
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Ion suppression effects are usually greater in unne than in plasma, as unne IS a highly
changeable matrix, varying between individuals and among one individual; the composition of
plasma is much more constant.
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Figure 2.8 Calibration graphs for the polyphenol standards gallic acid (A), (-) epicatechin (B) and
phloretin (C) when 'spiked' into human urine at various concentrations. R2 values are
0.9989,0.9963 and 0.9986 for the three polyphenol standards, respectively.
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2.4.6 LCIMSIMS - Preliminary Analysis of Polyphenols in Biological Matrices
Enzyme Treatment of Non-Study Urine
Extracted ion chromatograms of enzyme treated and control urine were compared and
tentative identities were assigned to the peaks in the chromatogram. Initial experiments were
performed to see if a working method had been developed and to see if metabolites could be
detected/identified. These results, a complete study of the structures of the flavonoid
classesllikely fragmentation patterns and information on any apple, cocoa and tea metabolites
reported in human urine and plasma in the literature, helped to construct a list of possible
apple polyphenol metabolites; consisted of around 400 possibilities. These mass transitions
were divided into three methods, to increase sensitivity for each mass transition.
Human Intervention Study Pooled Urine Samples
The enzyme treatment of non-study urine was repeated with pooled urine samples from the
human intervention study. Figure 2.9 shows the extracted ion chromatograms from the
analysis of control and test pooled urine, with and without enzyme treatment. Analysis of the
pooled 0-24 h control and 0-24 h test urine samples from the human intervention study, gave
preliminary information on the mass transitions that would be detected in the individual urine
samples and extracted plasma samples. Comparison of the two sets of pooled samples also
indicated which mass transitions were going to show the largest differences between the
control and the test samples, i.e. those of greatest interest. Results from the pooled samples
allowed the LCIMS/MS MRM method of over 400 mass transition possibilities to be refined
to a smaller number of mass transitions (Tables 2.l2, 2.13 and 2.14) for the analysis of the
individual urine (and subsequent plasma) samples from the human intervention study. Table
2.12 details mass transitions from the polyphenol standard mix which showed significant
increases in the test urine samples compared to the control urine samples. Table 2.13 details
mass transitions from possible conjugated metabolites and Table 2.14 details mass transitions
from possible ring fission metabolites. The method containing all these MRM transitions was
applied to the urine and plasma samples from the human intervention study. Enhanced
Product Ion (EPI) spectra were also acquired for the mass transitions of interest in the urine
and plasma (this is explained in chapter 3). Comparison of retention times and the fragment
ions produced for the standards, identities were proposed for the analytes (all detailed in
chapter 3).
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Figure 2.9 Extracted ion chromatograms of pooled 0-24 h control urine, no enzyme treatment (A)
and 0-24 h test urine, no enzyme treatment (B); 0-24 h control urine after treatment with
sulfatase (C) and 0-24 h test urine after treatment with sulfatase (D); 0-24 h control urine
after treatment with JJ-glucuronidase (E) and 0-24 h test urine after treatment with JJ-
glucuronidase (F).
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Table 2.12 MRM transitions which showed significant increases between pooled control urine
samples and pooled test urine samples, when analysed using the MRM method for
polyphenol standards.
m/z
T, in Urine T, in Plasma Possible Identity(min) (min)
1691 125 1.9 7.1 Gallic acid
137/108 2.3 2.0 Hydroxybenzoic acid
353/191 3.6 4.4 Chlorogenic acid conjugate
1531 109 4.1 2.4 Protocatechuic acid
179/135 4.6 4.1 Caffeic acid
167/108 4.3 4.3 Vanillic acid
163/119 5.1 4.9 p-Coumaric acid
193/134 5.4 5.4 Ferulic acid
609/301 6.0 5.8 Quercetin rutinoside
3011 107 6.7 7.6 Quercetin
2731 167 7.1 7.2 Phloretin
289/109 16.0 3.7 (-)/(+) (Epi)/Catechin conjugate
577 1289 16.1 4.0 Procyanidin BIIB2 sulfate conjugate
271 1 119 7.2 & 16.9 7.2 Naringenin conjuagte
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2.5 Conclusions
The LCIMSIMS and sample preparation methods developed herein represent a significant step
forward in the timely analysis of biological samples for conjugated and ring fission
metabolites of apple polyphenols. Although the literature contains articles on the analysis of
different varieties of apples and apple products, such as juice and cider, there are no
comprehensive methods to provide identification for the full range of metabolites produced in
human biological fluids after consumption of these materials. Thus, there is an absence of
quantitative information on the metabolism and bioavailability of polyphenols consumed from
apples in healthy humans. To develop a complex method which can detect not only
polyphenol conjugates but also products of bacterial action in the gut, and their conjugates is a
significant achievement. The short analysis time required to perform this task is also a unique
aspect of this novel method. This method may also be applied for the analysis of polyphenols
in biological fluids after consumption of other foods and beverages, showing wider
applications.
In summary, this chapter details the process of development of an LCIMSIMS method to
detect polyphenols and their metabolites (conjugated, ring fission and ring fission conjugates)
in the urine and plasma of humans. Preparation methods for human urine and plasma have
also been reported, and more importantly validated. Validation supports the fact that this
method is reproducible, reliable, sensitive and accurate for the purpose.
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Chapter Three
Identification of Apple Polyphenol
Metabolites in Human Urine and
Plasma
Summary
The following chapter details the process of identification of some of the major polyphenolic
metabolites, detected in human urine and plasma after the consumption of the control apple
juice and high polyphenol cider apple extract (test phase). Identification involved comparing
the retention times and EPI spectra of unknown metabolites with polyphenol standards and
available information in the literature. Using the LC/MSIMS method detailed in chapter 2,
conjugated, ring fission, conjugated ring fission and aglycone metabolites of apple
polyphenols have been detected in urine and plasma; identities have been proposed for these
metabolites. Time course data for these metabolites will be provided in chapter 4.
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3.1 Introduction
Human intervention studies, using patients and healthy volunteers, have predominately
focussed on the metabolism of tea, cocoa and onions; identifying polyphenolic aglycones
(after deconjugation with enzymes) and conjugated metabolites. Recent research [83) has
started to consider the identification of ring fission metabolites of polyphenols (and their
conjugates), which are produced by the microflora present in the human gastrointestinal tract.
Literature on the extent of microbial action on polyphenols is scarce, but there is a requirement
for this information to enable a more comprehensive understanding of the metabolism of these
reported 'health promoting compounds'.
There are four reports of apple metabolism in humans in the literature which use LC/MSIMS
techniques for analysis; Marks et al. [72), DuPont et al. (87) and Kahle et al. [8,99] None of these
studies report any validation data. Using ileostomy patients, Kahle et al. [8) report data on the
quantity of polyphenols reaching the colon after consumption of apple juice, in their paper
published in 2005. They follow the time course of the excretion of hydroxycinnamic acid
derivatives, dihydrochalcones, (-) epicatechin and quercetin-3-rhamnoside in ileostomy fluid.
and also compare the quantities of hydroxycinnamic acids, flavanols and flavonols in the
cloudy apple juice and in the ileostomy fluid. All compounds detected in biological fluids
were already present in the cloudy apple juice ingested; only one new metabolite was reported;
phloretin glucuronide. Biokinetic data reported is discussed in chapter 4. Work published by
DuPont et al. (87), identified small amounts of methylquercetin glucuronide and caffeic acid in
plasma and hippuric acid and phloretin in urine, after the consumption of alcoholic cider in
healthy human volunteers. A limited amount of quantitative data is also reported for these
metabolites and is discussed in chapter 4.
The paper published by Kahle et al. (99) in 2007, analysed the samples collected from their
previous human study (using ileostomy patients) by LCIESIIMS/MS, The aims of this paper
were to report on new polyphenol metabolites present in the ileostomy fluid; six new
metabolites were identified in addition to the detection of phloretin. Fragmentation patterns
were provided for each of these new metabolites, as were time courses for their excretion in
ileostomy fluid (details given in chapter 4). D-(-) quinic acid was identified as the most
abundant metabolite, followed by 3-caffeoylquinic acid and other hydroxycinnamic acid
derivatives. Trace amounts of phloretin and phloretin-2' -glucuronide were also detected.
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Marks et al. [72], published a paper on the absorption, metabolism and excretion of
dihydrochalcones in healthy human volunteers and ileostomy patients, after the consumption
of cider. Plasma, ileal fluid and urine were all analysed by LCIMS/MS in negative ionisation
mode. Six metabolites of phloretin were identified (two sulfates, three glucuronides and one
sulfoglucuronide); retention times and fragmentation patterns were given. All metabolites
identified were present in the ileal fluid, four were present in the urine (the three glucuronides
and the sulfoglucuronide) and only one was found in the plasma; phloretin-2' -O-glucuronide.
Phloretin-2' -glucuronide was identified as the major metabolite in urine also. In ileal fluid, the
metabolites detected were phloretin glucuronides, phloretin sulfoglucuronide and phloretin
sulfates. Two glycosides of phloretin present in cider were also detected in the ileal fluid;
phloretin-2' -0-(2" -O-xylosyl) glucoside and phloretin-O-( O-xylosyl)hexoside. Another major
phloretin glycoside found in cider, phloretin-2' -O-glucoside, was absent from ileal fluid
suggesting it is more readily absorbed, than the previously mentioned glycosides.
Although literature reporting the identification of the metabolites of apple polyphenols found
in human urine and plasma is limited, information on the metabolites of some of the apple
polyphenols which are also found in tea, cocoa and onions can provide some details on
possible metabolites. Studies concerning the metabolism and fate of polyphenols from tea,
both black and green, dominate the literature. Tea contains a high proportion of flavanols,
including (-) epicatechin, (-) epigallocatechin (EGC), (-) epigallocatechin gallate (EGCG) and
(-) epicatechin-3-gallate (ECG). Of these compounds, (-) epicatechin is the only one found in
apples and apple products, and so information on its metabolism established from tea studies
can be evaluated to aid identification of (-) epicatechin metabolites produced post apple
consumption.
Urinary metabolites have been reported more frequently than metabolites in plasma,
presumably because a greater volume of urine is produced and the analytes are present in
higher concentrations. (-) Epicatechin metabolites identified in human urine post tea
ingestion, include (-) epicatechin glucuronide [73,77], (_) epicatechin sulfate(s) [73,76.77. 1691,
methyl (-) epicatechin sulfate(s) [73,77,169] and methyl (_) epicatechin glucuronide(s) [73.76.1691.
Research by Lee et al. [76], reports than (-) epicatechin from tea was found exclusively in the
conjugated form in the urine; sulfate and glucuronide forms were present at a 2: 1 ratio, but no
structural conformations are proposed. In general, the absence of synthetic standards for all
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possible metabolites has resulted in the proposal of tentative structural conformations,
however, (-) epicatechin-3' -glucuronide has been reported to be the major urinary glucuronide
of(-) epicatechin in humans [731. Conjugation with a sulfate on the 3' and 4' positions has also
been reported to be most likely conformation of (-) epicatechin sulfates detected [731. The
major methylated metabolites of (-) epicatechin in humans have been detailed as 4' -O-methyl-
epicatechin and 3' -O-methyl-epicatechin, with the former being the most abundant one [731.
Methylated and glucuronidated epicatechin has also been described, with three possible
conformations; 4' -O-methyl-epicatechin-3' -glucuronide, 4' -O-methyl-epicatechin-5-
glucuronide and 4'-O-methyl-epicatechin-7-glucuronide [73]. Research carried out by Meng et
al. [741 identified some methylated and ring fission products of tea catechins, in human urine.
Several metabolites were identified, but only one related to the (-) epicatechin consumed from
the tea; this was the ring fission metabolite 5- (3', 4' -dihydroxyphenyl) -y- valerolactone.
Maximum levels of this metabolite were identified in the 3-6 h urine sample. Four volunteers
were involved in this study, each consuming the tea solids as their initial phase and pure
EGCG as their second phase, but only one volunteer was given a high dose of EGCG, EGC or
(-) epicatechin.
In plasma, Lee et al. [761, found (-) epicatechin from tea present exclusively in the conjugated
form in the plasma, with approximately two thirds sulfate and one third glucuronide. No
details on structural conformations are given, and no details on possible ring fission
metabolites are explained. Van Het Hof et al. [571, determined the bioavailability of tea
catechins (including (-) epicatechin) in the blood of healthy human volunteers, after
consumption of black and green tea, with and without milk (biokinetic data discussed in
chapter 4). No conjugated catechin metabolites or ring fission metabolites were considered in
this paper; only compounds measured in the original tea preparations were identified.
Therefore, this work does not give a complete account of the bioavailability of these flavanols.
Similarly to tea, flavanols are found in high proportions in cocoa. Studies investigating the
metabolism of (-) epicatechin from cocoa can also have relevance to the metabolism of (-)
epicatechin from apples. Previously identified urinary metabolites post cocoa consumption
include (_) epicatechin sulfate(s) [81,83,106], (-) epicatechin-3'-glucuronide [81, 1061, epicatechin
glucuronide(s) [831, methyl epicatechin sulfate(s) [81,83, 1061, methyl epicatechin glucuronide(s)
[81,831 and methyl epicatechin sulfoglucuronide [811; the same metabolites detected after tea
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consumption, with the addition of the methyl sulfoglucuronide. Non-methylated sulfate,
glucuronide and sulfoglucuronide forms were present in the highest concentrations [81, 1621.
Previously identified plasma metabolites post cocoa consumption include (-) epicatechin
glucuronide [811, (-) epicatechin sulfate [106] and methyl epicatechin sulfate (106); the latter
methylated conjugate has not been reported in the plasma after consumption of tea. Mullen et
al. (106], reported that additional metabolites seen after the consumption of green tea, were
detected in samples after cocoa consumption, but since the (-) epicatechin intakes were higher
in the green tea studies, the levels of these additional metabolites were too low to quantify.
Structural elucidation work carried out by Urpi-Sarda et al. [831, indicated that (-) epicatechin
glucuronidation occurred at the 7 and 3' positions whereas sulfation occurred at the 7 or 5
positions.
Natsume et al. [97], performed structural elucidation work on the conjugates of (-) epicatechin,
and reported that 3'-methyl-epicatechin, 4'-methyl-epicatechin-5 or 7-glucuronide and 4'-
methyl-epicatechin-3' -glucuronide were present in human urine after intake of an (-)
epicatechin preparation. The authors did not detect the presence of any sulfate conjugates,
contrary to other literature. (-) Epicatechin-3' -glucuronide was also shown to be present in
human plasma after ingestion of this flavanol preparation.
Three articles in the literature detail the identification of microbial metabolites of polyphenols,
in urine, after the consumption of chocolate [821 and cocoa [83, 105] by healthy human volunteers.
Compounds identified include: dihydroxyphenylvalerolactone", methoxy
hydroxyphenylvalerolactone, 3,4-dihydroxyphenylpropionic acid", 3-hydroxyphenylpropionic
acid", 4-hydroxyphenylpropionic acid, m-coumaric acid, p-coumaric acid", caffeic acid",
ferulic acid", 3,4-dihydroxyphenylacetic acid", 3-methoxy-4-hydroxyphenylacetic acid, 3-
hydroxyphenylacetic acid", protocatechuic acid", phenylacetic acid", vanillic acid", 3-
hydroxybenzoic acid, 4-hydroxybenzoic acid", 3-hydroxyhippuric acid", 4-hydroxyhippuric
acid. and hippuric acid. Compounds marked with an asterix were also reported to be present
in plasma [831. In the recent publication by Urpi-Sarda et al. [831, conjugates of some of these
ring fission products were also identified, which is the first report of metabolites of this kind.
In urine, glucuronide and sulfate conjugates of dihydroxyphenylvalerolactone and methoxy
hydroxyphenylvalerolactone were identified; in plasma only the glucuronide conjugates were
present.
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Apples contain quercetin glycosides; human intervention studies performed with onions which
also contain quercetin glycosides can be used to extrapolate some information on how these
polyphenols are metabolised, although the precise glycoside profiles are different in the two
food stuffs. Mullen et al. [231, reported the presence of the following quercetin metabolites in
the plasma of volunteers post ingestion of fried onions; quercetin diglucuronide, quercetin
sulfoglucuronide, quercetin-3-glucuronide, quercetin-3' -glucuronide, quercetin-3' -sulfate,
quercetin sulfate, isorhamnetin-3-glucuronide and isorhamnetin-4' -glucuronide, in addition to
the aglycone. Urinary metabolites included quercetin diglucuronides, quercetin-3-
glucuronide, quercetin-3' -glucuronide, quercetin-4' -glucuronide, methyl quercetin
diglucuronides, quercetin glucoside glucuronides, quercetin glucoside sulfates, quercetin-3'-
sulfate, quercetin sulfoglucuronides, isohamnetin-3-glucuronide and isorhamnetin-4'-
glucuronide. Some pharmacokinetic data are given in this paper, which is reported and
discussed in chapter 4.
To summarise, literature available on the metabolism of apple polyphenols in healthy humans
is very limited. However, information on the metabolism of the polyphenols in apples, from
other food sources, can be used as a guide to the identification of novel apple metabolites.
Absolute identification of metabolites was not possible, because of a lack of synthetic
standards. Using the literature, information on available standards, retention times and
fragmentation patterns of unknowns, tentative identities were proposed for the analytes
detected in urine and plasma.
Aim of the Chapter
To identify apple polyphenol metabolites in human urine and plasma samples, using the
LC/MS/MS method developed in Chapter 2.
3.2 Materials and Methods
3.2.1 The Human Dietary Intervention Study
A human dietary intervention study can provide valuable in vivo data on metabolism. This
dietary intervention study was approved by the Human Research Governance Committee
(HRGC) of the Institute of Food Research (lFR) and the Norfolk Research Ethics Committee
(NREC). All documentation to support the approval for this research and the Protocol are
supplied on CD with this thesis, and were been written and submitted by myself.
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Volunteer Recruitment
Volunteers were recruited from the database held at the Human Nutrition Unit (HNU). In total
81 people were sent the Volunteer Information Sheet and letter of invitation. Interested
individuals contacted study personnel for an interview. 20 people attended a one to one
interview with myself, the Chief Investigator, to explain the study in person. In total, sixteen
interested participants were given an appointment for a screening test. This comprised of a
urine dipstick test, a health questionnaire (including height, weight, 8MI, blood pressure and
pulse rate) and a blood sample, tested for total blood count, fasted glucose level and kidney
function. Volunteers whose screening test results were within standard ranges and the study
inclusion criteria were given study day appointments. All screening results were sent with a
letter to the volunteer's GP. Volunteers excluded on grounds of results outside of normal
ranges were informed and advised to contact their GP for an appointment, if appropriate.
The Intervention
Coressence Ltd. cultivates high yielding apple varieties that have specific flavan-Lol profiles.
These Evesse™ apples were freeze dried to produce apple granules which were then taken
through an extraction procedure to produce the test material Evesse™ Fructose (referred to as
the high polyphenol cider apple extract). Simply, this extraction involved adding water (at
100°C) to the granules and placing in a water bath for 15 min, shaking at timed intervals.
Once cooled, the extract was filtered and the aqueous portion retained. This was subjected to
various filtration procedures and a stage to reduce the extract to 70 % of its original volume.
The extract was buffered to pH 3.5 with solid ascorbic acid, before being frozen for use.
Approximately 60 or 70 g (depending on the batch) of defrosted high polyphenol cider apple
extract was dissolved into 250 mL of a supermarket apple juice (Tesco Pure Apple Juice,
batch: 8048 1909) to provide one serving of the test drink. Water replaced the apple extract,
for the control phase of the study. Exact weights of test material and test drinks were
recorded. The drink was served in a coloured glass to disguise the red colour of the
concentrate when added to the apple juice (Figure 3.1).
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Figure 3.1 Test drink preparation by an HNU Nurse, involving weighing 60 or 70 g of the
high polyphenol cider apple extract and dissolving into 250 mL of 'Tesco' pure
apple juice.
Ten apparently healthy male volunteers aged between 39 and 60 (with BMI values of between
21 and 29) participated in this study. The volunteers followed a low polyphenol diet absent of
certain fruits and vegetables, tea, coffee, chocolate, apples and alcoholic drinks for 48 h prior
to the intervention and for 24 h after. Controlling polypheno1 intake prior to the intervention
will reduce the complexity of polyphenols from other dietary sources affecting the metabolism
of the test material. Volunteers arrived fasted and baseline urine samples were collected
before volunteers were cannulated. A baseline blood sample was taken (20 mL into Lithium
Heparin tubes). 4 ml was prepared and sent to BUPA for cholesterol analysis and the
remainder was immediately centrifuged at 3000 g for 10 min. 1 ml aliquots of the plasma
were decanted into cryovials which were immediately frozen using liquid nitrogen and stored
at -80°C until analysis.
The volunteer was given breakfast (two slices of toast with butter) followed by one of the test
drinks. Test drink preparation was carried out by the diet cooks at the HNU, as explained
above. A new carton of 'Tesco' pure apple juice was opened for each volunteer and 6 vials
(approx. 60 g weighted exactly) of the high polyphenol cider apple extract (batch 1, expiry
date: 20.08.08) or 7 vials (approx. 70 g weighed exactly) of the high polyphenol cider apple
extract (batch 2, expiry date: 09.10.08) were removed from -20°C storage approximately 30
min before required. [Analysis of the second batch of the apple extract indicated that 7 vials
would be necessary to provide the same concentration of (-) epicatechin as the first batch].
For control test drinks, 60 g or 70 g of water was used to replace the apple extract. 190 g of
the 'Tesco' apple juice was used to make up the required volume of test drink. The drink was
stirred to aid dissolution. Volunteers consumed the drink within 3 min; once the drink had
been consumed by the volunteer, the empty glass weight was recorded to give the actual
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weight of test drink consumed. Water was allowed ad libitum, two hours after consumption of
the test drink.
Blood samples (10 ml) were collected at selected time-points after test drink consumption (20,
30, 40 and 60 min, then every half an hour until 4 h post dose (when lunch was provided), and
then every hour until 8 h post dose). Lunch consisted of a sandwich, either tuna and
mayonnaise or cheese, and natural yoghurt with honey. Blood samples were collected into
Lith. Hep. vacutainers, and processed as for the baseline sample. All urine produced after
consumption of the test drink was collected (0-4 h, 4-8 h and 8-24 h) into containers
containing 1 ml of 4M HCl. After collection, an appropriate amount of HCI was added to the
urine to give a pH lower than 4.0. The total volume of urine produced was recorded and three
20 ml portions were frozen at - 80°C. Following a wash-out period of at least two weeks, the
same volunteers were given the alternative test drink and the same blood and urine
measurements were obtained.
3.2.2 Analysis of the "Teseo' Pure Apple Juice and High Polyphenol Cider Apple
Extract
Analyses of the "Tesco' Pure Apple Juice, the high polyphenol cider apple extract and the test
drinks were carried out by Christina Moyle, at IFR. Triplicate 300 J.lIaliquots of apple juice
were diluted with 700 J,llMeOH and 50 J.lIof internal standard. Galangin was used as an
internal standard (1 mg/ml in MeOH). Samples were centrifuged at 1300 g for 10 min, and
the supernatant filtered using a 0.22 um Whatman filter. The filtrate was portioned into two
vials. Each filtrate was analysed using two HPLC methods [170]: The first method involved
RP-HPLC with UV DAD and the second NP-HPLC with Fluorescence Detection. Once the
required weight of apple juice was removed from the carton on the morning of the study day, a
20 ml sample was taken and stored at 4 °C until analyis. This procedure was repeated three
times.
Triplicate 100 J.1l aliquots of defrosted high polyphenol cider apple extract were diluted using
900 J.lIMeOH and 50 J.1l of galangin (0.1 mg/ml in MeOH). Samples were prepared as for the
"Tesco' Pure Apple Juice, and analysed with the same two methods. Two batches of the high
polyphenol cider apple extract were required for the study, each was analysed on receipt for
polyphenol content.
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190 ul of'Tesco' Pure Apple Juice was mixed with 60 ul of the high polyphenol cider apple
extract, and triplicate 100 I,d aliquots were diluted using 900 ul MeOH and 50 JlI of galangin
(0.1 mg/ml in MeOH). Samples were prepared as for the 'Tesco' Pure Apple Juice, and
analysed with the same two methods.
3.2.3 LCIMSIMS Methodology
Development of the methodology for the analysis of the human urine and plasma samples is
discussed in chapter 2. In summary the mobile phases used were 0.0 I % formic acid in H20
and MeCN, initial flow rate was 0.225 ul/min, increasing to 0.850 ul/min at 11.1 min for 2
min, and the column temperature was 65°C. The gradient was as follows (0, 10), (4,40), (5,
46), (8, 48), (8.1, 100), (13.1, 100), (17, 0) and (17.1, 10) (time in min, % B). Urine and
plasma samples were analysed using the MRM method detailed in chapter 2 (Tables 2.12 -
2.14). In total, 115 mass transitions were monitored for in each and every sample. Analyst
produced values for the peak areas for each of these transitions and those mass transitions
showing the greatest increases, when test sample data were compared to control sample data,
were investigated further.
The advantages of using a hybrid triple quadrupole linear ion trap MS for the identification of
metabolites in plasma and urine, include MS3 capabilities, multiple scan functions and more
informative spectra. Triple quadrupole scan functions such as precursor ion scan, product ion
and constant neutral loss are maintained, along with and in combination with the trap scan
modes [1711. The ion trap can hold more ions than a conventional 3D ion trap, reducing space
charge effects and leading to better spectra which can be regarded with more confidence in
determining identification [1721. Not only do these hybrid instruments possess the capacity for
greater ion storage, but they are also attributed with a higher trapping efficiency. The first
quadrupole selects the precursor ion of interest; this is then accelerated into the pressurized
collision cell (Q2), which induces fragmentation. Fragment ions are transmitted into the third
quadrupole, acting as the linear ion trap, where they are mass selectively scanned out towards
the detector, and at the same time ions are accumulated. This is known as an enhanced
product ion (EPI) scan, and is unique to the Q TRAP instrument.
Enhanced Product Ion Spectra (EPI)
Functions regarded as 'enhanced' refer to the Q3 acting as a linear ion trap [1711. In a
quadrupole collision cell (Q2), ions undergo multiple collisions and the fragment ions formed
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become reactivated and undergo further fragmentation. In a 3D ion trap, fragmentation occurs
from excitation of the precursor ion only; product ions are generally too cool to undergo
further fragmentation. In a Q TRAP in the EPI mode, the precursor ion selected for in Q 1 is
fragmented in Q2 and subsequent fragmentation is isolated within the ion trap, giving the next
generation of precursor ions. This produces a full spectrum for the fragmentation of the
original precursor ion selected for in Q1.
Summary of Identification Strategy
The strategy employed for the identification of some of the major metabolites of apple
polyphenols in human urine and plasma was derived from a series of experiments. Firstly,
mass transitions showing the greatest increases between control samples and test samples were
investigated in more detail; comparisons were made using peak area measurements. EPI
spectra were generated and mass transitions with the same retention times were compared to
eliminate the likelihood of more than one mass transition representing the same analyte.
Tentative identifications of the metabolites were made from retention times and spectral
fragments (comparisons were made with standards were appropriate), in both urine and
plasma. Time course data for these metabolites is presented in chapter 4.
3.3 Results and Discussion
3.3.1 Analysis of the 'Tesco' Pure Apple Juice and High Polyphenol Cider Apple
Extract
Table 3.1 details the average mg of phenolics per litre for the "Tesco' Pure Apple Juice and the
high polyphenol cider apple extract. Tables 3.2 and 3.3 show the quantity of phenolics
ingested by the individual volunteers after consumption of the control drink and test drink.
respectively. The test drink supplied over six times the amount of chlorogenic acid, forty-nine
times the amount of phloretin, eleven times the amount of (-) epicatechin and forty-one times
the amount of quercetin (as glycosides), compared to the control drink.
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Table 3.1 Comparison of polyphenol content between the average mg of phenolics per litre of the
'Tesco' Pure Apple Juice and the high polyphenol cider apple extract - nd idicates
compound was not detected
Compound
Mean (mg/phenolics)
Tesco Apple Juice High Polyphenol Extract
Chlorogenic acid
Phloretin
(-) Epicatechin
Quercetin rutinoside
Quercetin-3-glucoside
Querceti n-3-galactoside
Quercetin-3-xyloside
Quercetin-3-rhamnoside
72.13 1433.39
3.10
25.98
0.27
0.53
0.72
nd
nd
565.33
1120.79
22.82
120.27
39.08
20.99
37.46
3360.13Total 82.73
3.3.2 MS Fragmentation Pathways of Polyphenol Standards
MS allows identification of unknowns by observation of the fragment ions produced when a
compound enters the MS. When collision induced dissociation (CID) was performed on
polyphenol standards in the MS, common fragments were observed within the classes and
sometimes across the classes. The presence of functional groups on the molecules, such as
hydroxyl or methyl moieties, carboxylic acids or glycosides impact the characteristic way in
which polyphenols fragment. The position and degree of hydroxylation, methylation and
conjugation also affect the fragmentation. Figure 3.2 suggests five main fragmentation
pathways for the CID of flavonoids.
o
Figure 3.2 Schematic representation of five common fragmentation pathways observed for the CID
of flavonoids Hughes et al. 11491
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Flavonols
Direct infusion of quercetin and application of a collision energy of -24V, resulted in the
formation of product ions of mlz 179, mlz 151 and mlz 121, in addition to the precursor ion at
mlz 301 (Figure 3.3, A). The major product ions mlz 179 and mlz 151 resulted from
fragmentation pathway IV or retro-Diels Alder reaction; the B ring gives the ion at mlz 151
and the A ring and partial C ring give the ion at mlz 179 [23. 140. 149. 1731. The product ion of mlz
121 is formed from the B ring (Figure 3.3, C). Another possible fragment of mlz 165 is not
observed in this spectrum. The fragmentation pattern of myricetin, another member of the
flavonol class of flavonoids, which has an extra hydroxyl group on the B ring compared to
quercetin, reveals the same product ions (Figure 3.3, B). This time the minor spectral
component of mlz 165 was observed. Kaempferol fragments in the same way, losing its
methyl group and then behaving like quercetin. When there is a glycoside moiety present on
the molecule, this is lost first, and then the standard behaves like the aglycone. The loss of
HCO from the A ring and partial C ring can also give the ion at mlz 151.
Flavanols
The major product ion from the CID of (+) catechin and (-) epicatechin was mlz 245 (Figure
3.4, A); a loss of carbon dioxide from the molecule. The product ion of mlz 203, could
indicate fragmentation at pathway V. Fragments of mlz 179 and mlz 151 were also observed
as minor spectral components, as seen for the flavonols. Literature supports the presence of
these product ions in the spectra of (+) catechin and (_) epicatechin [73,77, 81, 1491.
Procyanidins
The structures of procyanidin Bland B2 are two units of (+) catechin and (-) epicatechin,
respectively, attached by C4 (C ring). Their fragmentation patterns are therefore related to
those of the flavanols; the presence of the flavonol monomer can be seen (mlz 289) (101) in
addition to the product ion indicating a loss of C02 (mlz 245), and the characteristic ions of
mlz 203, mlz 151 and mlz 179 caused by fragmentation at pathways V and IV, respectively
(Figure 3.4, B). These observations are supported by evidence from Hellstrom et al. (174)
Fragmentation pathway I also occurs after CID of many of the flavonoid standards, releasing
the A ring part of the molecule and resulting in the minor spectral component of mlz 109,
which appears in many EPI spectra (Figure 3.4, C).
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Phenolic acids
Phenolic acids, both hydroxybenzoic and hydroxycinnamic, fragment to lose the carboxylic
acid; for caffeic acid mlz 135 is the resulting product ion (Figure 3.5, A and C) [140). Another
hydroxycinnamic acid present in apples, p-coumaric acid, fragments to produce the major
product ion mlz 119, which corresponds to the loss of COOH. Fragmentation of esters of
hydroxycinnamic acids, such as chlorogenic acid, breaks the ester bond resulting in product
ions of the same mass as the individual compounds; fragmentation then continues as if for a
single acid [140).
Dihydrochalcones
Figure 3.5, B shows the fragmentation pattern produced by the dihydrochalcone, phloretin;
product ions of mlz 167 and mlz 123 were observed [72,99, 101, 1751. Phloridzin, a glycoside of
phloretin, behaves in the same way as glycosides of flavonols; the glycoside is loss on
fragmentation [99,101,175), and the compound behaves as the aglycone.
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3.3.3 Identification of Metabolites in Human Urine
3.3.3.1 Screening of Urine for Polyphenol Metabolites Derived from the High Polyphenol
Cider Apple Extract
As stated previously, 115 mass transitions were monitored for in the human urine samples. Of
this number, 53 showed a significant increase when test urine samples were compared with
control urine samples. Examples of mean data for two mass transitions are shown in Figures
3.6 and 3.7. The total peak area for all 53 mass transitions of interest in the test urine samples
was calculated, and a percentage for each mass transition was determined. Four mass
transitions accounted for over 10 % of the total area; the remainder were all below 5 %.
However, closer inspection of each individual EPI spectra and retention times for these 53
mass transitions of interest indicated that they may not be 53 distinct compounds. Anyone
metabolite eluting from the column may enter the MS and dissociate to produce several
product ions; different product ions for the same metabolite may have been detected here.
Figure 3.8 shows the extracted ion chromatograms for the mass transitions mlz 383 /207 and
mlz 383 I 163; two peaks were observed in each chromatogram, with similar retention times.
The EPI spectra of both peaks in both chromatograms show product ions of mlz 207 and mlz
163. This suggests that both these transitions occur from fragmentation of the same
metabolite. Experiments performed in the same way for all the 53 mass transitions concluded
with 25 possible distinct metabolites. Three of the analytes accounted for over 10 % of the
total area; the others accounted for less than 5 %. Tentative identities were assigned to each of
these possible metabolites, using retention times and EPI spectra (compared to standards
where appropriate). Metabolites were classified as conjugated metabolites, conjugated ring
fission metabolites and unidentified apple-related metabolites. Table 3.4 details the mass
transitions and their relative abundance in the urine. Evidence to support the identities of the
mass transitions proposed in the table is given in the remainder of the chapter. The percentage
areas given in Table 3.4 are not quantitative, as each metabolite may give a different response
by MS analysis. However, the percentages do represent an approximation by which the most
important metabolites may be identified.
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Figure 3.6 Mean peak area (n = 9) for mass transition m/z 705 / 353 monitored in control and test
urine. Error bars represent the standard deviation
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Figure 3.7 Mean peak area (n = 9) for mass transition m/z 545 I 465 monitored in control and test
urine. Error bars represent the standard deviation
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Extracted ion chromatogram of m/z 383 I 207 (A) and EPI spectrum of the major peak at
5.62 min (8). Extracted ion chromatogram of m/z 383 I 163 (C) and EPI spectrum of the
major peak at 5.59 min (D). LC/MS/MS conditions for all chromatograms include mobile
phases consisting of 0.01 % formic acid in H20 and MeCN; the initial flow rate was 0.225
ul/min increasing to 0.850 ul/min at 11.1 min for 2 min then returning to 0.225 "l/min for
the remainder of the analysis time. Gradient was as follows: (0, 10), (4, 40), (5, 46), (8,
48), (8.1,100), (13.1, JOO), (17, 0) and (17.1, 10) (time in min, % B). Column temperature
was 65°C.
3.3.3.2 Identification of Conjugated Metabolites in Human Urine
1. m/z 465/289 [(-/+) Epicatechin-3' or 4'-glucuronide - 0.4 % of total analyte areal
The extracted ion chromatogram for the mass transition mlz 465 /289 is shown in Figure 3.9;
a major peak was observed at a retention time of 5.25 min with several smaller peaks also
present. On MS2, the analyte fragmented with a 176 amu loss, characteristic of the cleavage
of a glucuronide unit. MS2 experiments with conjugated standards of polyphenols indicated
that the conjugate is readily lost on application of collision energy. Product ions of mlz 245
and mlz 179 were seen in this spectrum, in addition to mlz 289. These ions were also observed
after the CID of the polyphenolic standards (+) catechin and (-) epicatechin (see Figure 3.4).
This suggests that the identity of mlz 465 / 289 could be (+/-) catechin or (-1+) epicatechin
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glucuronide. Research by Gonzalez-Manzano et al. [166J characterising catechin sulfates and
glucuronides suggested fragmentation pathways and possible mlz values for fragments of
some (+) catechin glucuronides, conjugated on the A and B ring (Figure 3.10). Comparing
these fragments with those in the EPI spectrum for the largest peak detected with the mass
transition mlz 465 I 289 (Figure 3.9), the same product ions of mlz 327 and mlz 381 were
observed. This suggests that the position of conjugation could be on the B ring, hence 3' or 4'
as these are the carbons with the hydroxyl groups attached.
The retention times of (+) catechin and (-) epicatechin standards are 3.65 and 4.32 min,
respectively. Only quercetin glucuronides were available for comparison, but if a comparison
is made between how the position of conjugation affects retention, it appears that conjugation
on the A ring results in earlier retention than the aglycone, and conjugation on the Bring
results in later elution (retention time of quercetin is 6.68 min; quercetin-3-glucuronide is 5.70
min; and quercetin-3'-glucuronide is 6.90 min [Table 2.3, Chapter 2]). Flavanols (such as (+)
catechin and (-) epicatechin) and flavonols (such as quercetin) are very similar in structure,
only differing by the addition of C = 0 on the C ring of the latter. Therefore, the retention
time phenomenon observed with flavonols could also apply to flavanols.
Thus, identification of the mass transition m/z 465 I 289 could be (+1-) catechin! (-1+)
epicatechin-3' or -4' -glucuronide. Since volunteers were given a test drink which contained a
high level of (-) epicatechin (-74 mg), it is more likely that the identification of the mass
transition is (-1+) epicatechin-3' or -4' glucuronide. It has been reported that in humans, (-)
epicatechin-3' -glucuronide is the major urinary glucuronide metabolite of epicatechin from
sources such as tea and cocoa [73, 83, 97J.
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Figure 3.9 Extracted ion chromatogram of m/z 465 / 289 (A) and EPI spectrum of the peak at 5.35
min (B). LC/MSIMS conditions were as described in Figure 3.8.
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Figure 3.10 MS2 fragmentation pathways of (+) catechin glucuronides in negative ionisation mode 11661
2. m/z 369/289 [(-1+) epicatechin-3' or 4'-sulfate - 0.9 % of total analyte area]
Figure 3.11 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 369 / 289. A major peak was observed at a retention time of 10.71 min, with some minor
peaks also present. MS2 yields the loss of 80 amu, which indicates cleavage of a sulfate from a
conjugate. Just as for glucuronide metabolites, sulfate moieties are readily fragmented from
conjugates in the MS. As seen for the previous mass transition, product ions of mlz 289, mlz
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245 and mlz 231 were observed in the EPI spectrum, indicating that it may be (+1-) catechin 1
(-1+) epicatechin sulfate. This metabolite has also been previously identified in human urine
after consumption of tea and cocoa [70,73, SI, S3, 1761.
Gonzalez-Manzano et al. [1661 report that just as for glucuronide conjugates, the pattern of
fragmentation denotes the position of the sulfate conjugate on the molecule. Comparing the
EPI spectra to the fragments suggested in Figure 3.12 indicates that the identity of mlz 369 1
289 is (+1-) catechin 1 (-1+) epicatechin-3' or 4'-sulfate. Retention times generally increase
with the addition of a sulfate moiety to the molecule [SI1. Only a standard of quercetin-3'-
sulfate was available for comparison in this study; its retention time was greatly increased
compared to the aglyone and glucuronides (retention time of quercetin was 6.68 min;
quercetin-3-glucuronide was 5.70 min; quercetin-3'-glucuronide was 6.90 min; and quercetin-
3' -sulfate was 17.3 min [Table 2.3, Chapter 2]).
Thus, identification of the mass transition m/z 369/289 is likely to be (+1-) (epi)catechin-3' or
-4' -sulfate. Since the volunteers were given a test drink which contained a high level of (-)
epicatechin (-74 mg), it is highly likely that the identification of mlz 369 1 289 is (-1+)
epicatechin-3' or -4' sulfate, exact structural conformation cannot be determined.
3. m/z 545 1465 (-1+) eplcatechin sulfoglucuronide - 0.2 % of total analyte area]
The extracted ion chromatogram and EPI spectra for the mass transition mlz 545 1 465 are
shown in Figure 3.13. The major peak detected has a retention time of 17.53 min; a minor
peak can be seen at 4.80 min with further unresolved peaks eluting after the major peak. MS2
fragmentation results in a loss of 80 amu, representing the cleavage of a sulfate moiety from a
conjugate. The late retention time of the mass transition also suggests the presence of a
sulfate. Studying the EPI spectrum, ions of mlz 369 and mlz 289 are observed, in addition to
mlz 465. These same product ions were seen in the EPI spectra of the previous two mass
transitions, mlz 465 / 289 and mlz 369 1 289 and so the identity of this metabolite could be
related to (-1+) epicatechin. Application of a greater collision energy (-60 to -90 eV),
produced ions of mlz 245,203, 179 and 271; all of which were observed in the spectra for (+)
catechin and (-) epicatechin standards (Figure 3.4), providing further support for the
suggestion of an (-1+) epicatechin conjugate.
103
The mass transition mlz 545 /465 represents a loss of 80 amu (sulfate moiety) and m/z 545 /
369 represents a loss of 176 amu (glucuronide moiety). Alternatively, mlz 545 / 369
represents a loss of 176 amu and mlz 369 / 289 represents a loss of 80 amu. These different
mass transitions suggest that the intact metabolite has both a sulfate and a glucuronide
attached, which are fragmented in the MS in either order. Therefore, evidence indicates that
the analyte could be an (-) epicatechin sulfoglucuronide. Roura et al. [81], also found evidence
of this metabolite in human urine after consumption of cocoa, however no structural
elucidation was performed, Using the data from Gonzalez-Manzano et al. [166], the presence of
mlz 217 and mlz 151 in the EPI spectrum of m/z 545 / 465 could indicate that the sulfate is
positioned on the A ring (Figure 3.12). However, presence of the ions of mlz 327 and 205 in
the EPI spectrum of mlz 545 / 465 give conflicting evidence as to the position of the
glucuronide (Figure 3.10); mlz 327 suggests B ring attachment and mlz 205 suggests A ring
attachment. No ion of mlz 313 was observed, which is seen with A ring attachment; Bring
attachment is more likely considering the previous identifications made.
The minor peak and unresolved peaks also observed in the extracted ion chromatogram are
present in lower concentrations than the threshold value so an EPI spectrum is not triggered;
product ions cannot be compared with those of the major peak.
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Figure 3.11 Extracted ion chromatogram of m/z 369 I 289 (A) and EPI spectrum of the peak at 10.71
min (B). LC/MS/MS conditions were as described in Figure 3.8.
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Figure 3.13 Extracted ion chromatogram of m/z 545 / 465 (A), EPI spectrum of the peak at 17.53 mill(B) and EPI spectrum of the peak at 17.53 min with application of greater collision
energy. LC/MS/MS conditions were as described in Figure 3.8.
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Further Confirmation of Identity of (-1+)Epicatechin Conjugates in Human Urine
Figure 3.14 A, shows the extracted ion chromatogram for (-) epicatechin monitored in control
0-24 h urine from volunteer 2. (-) Epicatechin has a retention time of 4 min, and does not
appear in this chromatogram. The peaks detected at around 17 min, do have some of the same
product ions as (-) epicatechin, and were previously identified in chapter 3 as being (-/+)
epicatechin sulfoglucuronide and an (-/+) epicatechin sulfate. Figure 3.14, B shows the
extracted ion chromatogram for the same urine sample after treatment with the enzyme
sulfatase; sulfatase does have some p-glucuronidase activity. In this chromatogram, the peaks
observed at around 17 min have decreased in height and a peak with the retention time of 4
min, proposed to be (-/+) epicatechin can be seen. This suggests that the enzymes have
cleaved the sulfate and glucuronide conjugates from the metabolites, leaving the aglycone (-)
epicatechin. This confirms the identity of the peaks at 17 min as being possible
sulfoglucuronide and sulfate conjugates of (-/+) epicatechin. Figure 3.14, C shows the
extracted ion chromatogram for the urine sample after treatment with the enzyme p-
glucuronidase, which only has glucuronidase activity. Once again, the peaks at around 17 min
have decreased and a peak at 4 min has been detected; (-/+) epicatechin. The peaks at 17 min
have not decreased as much as when treated with the sulfatase, and the MS signal for (-)
epicatechin is lower because the enzyme has not cleaved the sulfate conjugates, only the
glucuronide(s).
Although Figure 3.14 illustrates the deconjugation affect of the enzymes on the samples from
one individual, to produce the aglycone which was not present in the untreated sample, this
was not so well illustrated with all the volunteers. In some cases, although a peak always
appeared for (-/+) epicatechin, the peaks observed at around 17 min did not always decrease or
disappear. This indicates that some co-elution with other possible conjugates may be
occurring, which is supported by the presence of broad peaks in Figure 3.11 between 16 and
17 min.
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Figure 3.14 Extracted ion chromatograms monitoring for (-) epicatechin. 0-24 h control urine
contains no (-) epicatechin (A), 0-24 h urine after enzyme treatment with sulfatase (B)
(which also contains some II-glucuronidase activity) shows (-) epicatechin with a retention
time of 4 min and 0-24 h urine after enzyme treatment with II-glucuronidase (C), again
showing (-) epicatechin with a retention time of 4 min.
4. m/z 449/273 [phloretin-2'-glucuronide -14.5 % of total analyte area]
The extracted ion chromatogram and EPI spectra for the mass transition mlz 449 I 273 are
given in Figure 3.15. The major peak has a retention time of 7.93 min. On MS2, this analyte
fragmented with a 176 amu loss, characteristic of the cleavage of a glucuronide unit. Product
ions of mlz 315, mlz 167 and mlz 345 were observed, in addition to mlz 273. These product
ions also appeared after the fragmentation of the polyphenol standard phloretin (same collision
energy applied).
107
These spectra provide compelling evidence that the mass transition mlz 449 / 273 is the
metabolite phloretin glucuronide. Phloretin-2' -glucuronide has previously been reported in
human urine, plasma (72) and ileostomy fluid [8, 99) after consumption of cider and cloudy apple
juice, respectively. Marks et al. (72), report the presence of three structurally different phloretin
glucuronides; the most abundant was phloretin-2' -glucuronide (identified by co-
chromatography with an authentic standard). This corresponds to the position of
glycosylation, for example phloridzin is phloretin-2' -glucoside. Therefore, it is likely that mlz
449/273 is the metabolite phloretin-2' -glucuronide (Figure 3.16).
o 0
HO--VCOOH
HO OH
Figure 3.16 Chemical structure of phloretin-2' -O-p-glucuronide 1991
Further Confirmation of the Identity of Phloretin Conjugates in Human Urine
Results from the enzyme deconjuagtion of urine when monitoring for phloretin, indicated that
there were both phloretin glucuronides present and phloretin sulfates present, although no
sulfate conjugate has been identified as a major metabolite here. On treatment with the
enzyme sulfatase, the amount of phloretin detected in the urine increased and on treatment
with p-glucuronidase the amount of phloretin also increased, but to a lesser extent due to the
enzymes only cleaving the glucuronides and not both conjugates as with the sulfatase
enzymes.
Summary
The following conjugated metabolites have been identified in human urine;
1. (-/+) Epicatechin-3' or 4' -sulfate,
2. (-/+) Epicatechin-3' or 4'-glucuronide,
3. (-/+) Epicatechin sulfoglucuronide (sulfate on position 5 or 7, glucuronide on position
5, 7, 3' or 4')
4. Phloretin-2' -glucuronide
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Figure 3.15 Extracted ion chromatogram of m/z 449 1273 (A), EPI spectra of the peak at 7.93 min (B
and C) and EPI spectrum of the polyphenol standard phloretin (D). LC/MS/MS
conditions were as described in Figure 3.8.
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3.3.3.3 Identification of Conjugated Ring Fission Metabolites in Human Urine
1. m/z 383 1207 15- (3',4'-dihydroxyphenyl)-y-valerolactone glucuronide - 38.6 % of
total analyte area]
Figure 3.8 details the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 383 1207; the major peak has a retention time of 5.62 min, with a minor peak at 5.06 min.
This mass transition represents a loss of 176 amu, the result of cleavage of a glucuronide from
a conjugate. The EPI spectrum shows product ions of mlz 163 and 113, in addition to mlz 207,
which are not characteristic of any of the polyphenol standards analysed by LC/MS/MS. This
supports the idea that the product ions may be derived from metabolites produced from the
ring fission of polyphenols, which occurs due to the microorganisms in the gastrointestinal
tract.
Following ingestion of tea and cocoa, dihydroxyvalerolactone has been detected in both urine
and plasma, hypothesized to have originated from the breakdown of (_) epicatechin [77. 83. 177]
(Figure 3.17). Dihydroxyvalerolactone has a molecular weight of 208 (observed as mlz 207
under negative ionisation mode) and a major product ion of mlz 163. Figure 3.18 shows the
product ion spectra for a metabolite of (-) epicatechin, identified by Meng et al. [74] as 5 - (3',
4' - dihydroxyphenyl) -y- valerolactone, The presence of a minor product ion of mlz 123 in the
lower spectrum indicates a meta substituted dihydroxyphenyl structure; 5 - (3', 5'-
dihydroxyphenyl) -y- valerolactone [74]. There are no MS2 spectra for the analysis of
dihydroxyvalerolactone standards in the literature.
Since there is no product ion of mlz 123 in Figure 3.9, it can be proposed that the mass
transition mlz 383 I 207 is the metabolite 5 - (3', 4'- dihydroxyphenyl) -y- valerolactone
glucuronide. There are just two references to this metabolite in urine after consumption of
cocoa [83] and tea [73], but no structural conformation so either of the two structures proposed in
Figure 3.19 could be likely.
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Figure 3.19 Two possible structural conformations of dihydroxyphenyl glucuronide, adapted from
Sang et al. (73)
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2. mlz 287 / 207 [dihydroxyphenyl valerolactone sulfate - 39.0 % of total analyte
area)
Figure 3.20 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 287/207; a single major peak is detected at 16.91 min. The mass transition mlz 287/207
represents a loss of 80 amu, possibly corresponding to the cleavage of a sulfate; and a product
ion of mlz 163, is also observed. These product ions were also observed for the mass
transition mlz 383 / 207, and imply that the mass transition m/z 287 / 207 is a dihydroxy
valero lactone sulfate. There is no evidence to assign whether the sulfate moiety is attached at
the 3' or 4' position (Figure 3.21).
3. mlz 289 / 163 [dihydroxyphenyl valerolactone sulfate - 0.1 % of total analyte area)
Figure 3.22 details the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 289 / 163; a single major peak is detected at 16.97 min. A product ion of mlz 207 was
detected, in addition to mlz 163. These product ions were also detected with the mass
transitions m/z 383 / 207, m/z 367 / 207 and m/z 287 / 207 which were all tentatively identified
as conjugates of dihydroxyphenly valerolactone. This suggests that the mass transition mlz
289 / 163 is also a conjugate of dihydroxyphenyl valero lactone, possibly a sulfate as the mass
loss could indicate this. The slightly different fragmentation, i.e. the presence of the ion mlz
289, may indicate a different position of the sulfate on the molecule.
4. m/z 367 / 207 [dihydroxyphenyl valerolactone disulfate - 3.1 % of total analyte
area)
The extracted ion chromatogram and EPI spectra for the mass transition mlz 367 / 207 is given
in Figure 3.23. Two major peaks are observed at 3.96 min and 17.4 min, in addition to some
minor peaks. The mass transition mlz 367 /207 represents a loss of 160 amu, or possibly the
cleavage of two sulfate units. A product ion of m/z 163 is also seen in the EPI spectrum in
addition to mlz 207, which is shown more clearly when greater collision energy is applied
(Figure 3.23, C). These product ions appear identical to those detected for the mass transitions
mlz 287 / 207 and mlz 383 / 207, suggesting that mlz 367 / 207 is dihydroxyphenyl
valerolactone disulfate; this metabolite has not been detected in urine or plasma previously.
112
S. m/z 423 / 247 [3, 4-dibydroxypbenylacetic acid sulfoglucuronide - <0.1 % of total
analyte area)
The extracted ion chromatogram and EPI spectra for the mass transition mlz 423 / 247 are
given in Figure 3.24; many peaks were detected. This mass transition represents a loss of 176
amu, corresponding to the cleavage of a glucuronide unit. Product ions of mlz 343 and 167
were observed in addition to mlz 247. mlz 247/167 represents the loss of80 amu; cleavage of
a sulfate, therefore it is likely that this analyte has both a sulfate and a glucuronide present,
which fragment in the MS in either order. Further fragmentation at a higher collision energy,
gave a new product ion of mlz 123.
Comparison of these EPI spectra with those produced from the analysis of polyphenol
standards did not result in any matches or similarities. Although vanillic acid has the
precursor ion mlz 167, it fragments to m/z 108; a product ion not observed in Figure 3.24.
Phloretin has the product ion mlz 167, but the precursor ion of mlz 273 is not observed in
Figure 3.24. The literature reports the presence of 3, 4-dihydroxyphenylacetic acid in urine
after consumption of cocoa [82,831; this has the mass transition mlz 167 / 123 which is seen in
Figure 3.25. Evidence would therefore suggest that m/z 423 / 247 is the microbial derived
metabolite 3, 4-dihydroxyphenylacetic acid sulfoglucuronide; no data exist to assign structural
positions to the sulfate or glucuronide groups.
6. m/z SIS / 339 [dibydroxypbenylacetic acid glucuronide - 0.1 % of total analyte
area)
Figure 3.26 shows the extracted ion chromatogram and EPI spectrum for this mass transition;
a single peak is detected at a retention time of 1.47 min. This mass transition suggests a loss
of a glucuronide, as there is a difference of 176 amu between the two masses. A product ion
of mlz 167 can be seen in addition to mlz 339. No polyphenol standards analysed in this study
produced these fragments in their EPI spectra. Dihydroxyphenylacetic acid has the precursor
ion mlz 167, but it produces an ion of m/z 123 on fragmentation [82,831; not seen in Figure 3.26.
No literature supports the presence of an analyte with mlz 515 / 339, and the only conclusion
that can be made on its identity is that it probably has a glucuronide attached.
7. m/z 223 /193 [sinapic acid - < 0.1 % of total analyte area]
Figure 3.27 shows the extracted ion chromatogram and EPI spectrum for the precursor product
ion pair mlz 223/ 193. Several peaks can be seen; the sharpest and largest peak at 5.69 min
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and a broader peak at 9.05 min; all peaks show the same product ions in their EPI spectra.
Product ions of mlz 149 and mlz 121 are observed in the EPr spectrum in addition to mlz 193.
The polyphenol standard sinapic acid has the precursor product ion pair of mlz 223 / 149, and
fragments to give product ions ofmlz 208, mlz 193 and mlz 121. These spectra show the same
ions present, just at different intensities. The retention time for sinapic acid is 5.49 min, and
the analyte is 5.69 min, so there is a possibility that the mass transition mlz 223/193 is sinapic
acid. Sinapic acid has been found in the urine of humans after consumption of cereal bran
[178l, and is a major urinary metabolite of green coffee extract in humans [179l.
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Figure 3.21 Two possible structural conformations of dihydroxypbenyl valerolactone sulfate, taken
from Sang et al, 1731
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Figure 3.25 Structure of 3, 4-dihydroxyphenylacetic acid, taken from Urpi-Sarda et of. 1831
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Summary
Six conjugated ring fission metabolites and one non-conjugated ring fission metabolite have
been tentatively identified in urine;
1. 5 - (3', 4' -Dihydroxyphenyl) -1- valerolactone glucuronide,
2. Dihydroxyphenyl valerolactone disulfate,
3. Dihydroxyphenyl valerolactone sulfate (2 different structural conformations),
4. 3, 4 - Dihydroxyphenylacetic acid sulfoglucuronide.
5. Dihydroxyphenylacetic acid glucuronide,
6. Sinapic acid
3.3.3.4 Unidentified Apple Related Metabolites in Human Urine
Glucuronide and Diglucuronide Conjugates
1. m/z 409 1233 (unknown glucuronide conjugate - 0.2 % of total analyte area)
The extracted ion chromatogram and EPI spectrum for the mass transition mlz 409 / 233 are
given in Figure 3.28. Many peaks are observed all in low concentrations; the major peak
elutes early with a retention time of 1.44 min. This retention time is the same or very near the
solvent front, and so the EPI spectrum may not be as clean as many of the others, which leads
to some uncertainty in the identification. The mass transition mlz 409/233 indicates a loss of
176 mass units, or cleavage of a glucuronide unit. Product ions of mlz 191 and mlz 175 are
observed, in addition to mlz 233, which do not correspond to any polyphenol standards
analysed in this study. Therefore, in terms of identification it can be hypothesized that the
mass transition mlz 409 / 233 is a metabolite with a glucuronide attached, but it cannot be
further identified by the data presented here. There are no references to this mass transition or
product ions in the literature.
2. m/z 653 /477 (unknown diglucuronide conjugate - 0.6 % of total analyte area)
Figure 3.29 details the extracted ion chromatogram and EPI spectrum for mlz 653 / 477. A
single broad peak was detected at a retention time of 10.4 min. This mass transition represents
the loss of 176 amu, corresponding to the cleavage of a glucuronide. The EPI spectrum shows
product ions of mlz 477 and mlz 301. The mass transition mlz 301 is a further loss of 176 amu,
indicating the possibility of a second glucuronide attached to the molecule. Greater collision
energy was applied to fragment the ions further and a comparison was made with the EPI
spectrum of quercetin, which also produces a precursor ion at mlz 301 in negative ionisation
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mode. Product ions of mlz 179, mlz 151 and mlz 273 seen for quercetin, indicate that the two
spectra are very different. Therefore, it can be suggested that the mass transition mlz 653/477
is a diglucuronidated metabolite, but there is not enough evidence to suggest any further
identification. There is no supporting evidence in the literature either.
Sulfoglucuronide Conjugates
1. m/z 4641 288 [unknown sulfoglucuronide conjugate - 0.1 % of total analyte area]
Figure 3.30 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 464 1288; one major peak was detected at 17.1 min, and several other minor peaks were
also observed. This mass transition represents the loss of 176 amu, or cleavage of a
glucuronide. Product ions of mlz 384 and mlz 208 were seen in the EPI spectrum, in addition
to mlz 288. The transition mlz 464 1 384 is a loss of 80 amu, representing the cleavage of a
sulfate. Fragments indicate the sulfate and glucuronide units can be lost in either order.
Further fragmentation yielded a product ion of mlz 163/164, which was also seen in the
fragmentation of dihydroxyphenyl valero lactone conjugates. However, the spectra do not look
the same when compared with those of the dihydroxyphenyl valerolactone conjugates, and
therefore the mass transition mlz 464 1 288 is unlikely to be a dihydroxyvalerolactone
conjugate. There is likely to be a sulfate and glucuronide present on the molecule, but further
identification of this analyte is not possible.
2. m/z 425/345 [unknown sulfoglucuronide conjugate - 0.2 % of total analyte area)
Figure 3.31 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 425 1345; a major peak was observed at a retention time of 4.82 min and several minor
peaks were also seen. This mass transition represents a loss of 176 amu, or cleavage of a
glucuronide. The EPI spectrum shows product ions of mlz 345 and mlz 234, in addition to mlz
249. The mass transition mlz 425 / 345 represents a loss of 80 amu, or cleavage of a sulfate
unit. There is no mention of a metabolite with this fragmentation pattern in the literature, and
therefore other than suggesting that there is a sulfate and a glucuronide unit attached, no
further identification can be made.
3. m/z 557/477 [unknown sulfoglucuronide conjugate - 0.1 % of total analyte area)
Figure 3.32 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 557 / 477; the major peak has a retention time of 17 min, and several minor peaks were
also detected. This mass transition represents a loss of 80 amu, indicating the cleavage of a
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sulfate. Analysis of the EPI spectrum shows product ions of mlz 381 and m/z 187 which
suggests that the mass transition mlz 557 / 477 has a sulfate attached, but there is not enough
evidence to propose an identity. The EPI spectrum does not correspond with the previous
unidentified metabolite either, despite both having the product ion of mlz 477. There is no
evidence of this mass transition being detected or identified in the literature.
Sulfate Conjugates
1. m/z 271 / 191 [unknown sulfate conjugate < 0.1 % of total analyte area]
The extracted ion chromatogram and EPr spectrum for the mass transition mlz 271 / 191 are
shown in Figure 3.33; there are three major peaks at retention times 1.13, 1.73 and 16.99 min.
The fist two peaks have retention times which are the same or very near to the solvent front, so
the EPI spectrum of the peak at 16.99 min was used for identification. The mass transition mlz
271 / 191 represents the loss of 80 amu, or cleavage of a sulfate. There are no further
characteristic product ions observed in the spectrum, so an identity for this analyte cannot be
proposed. The literature does not report the presence of an analyte of this mass transition after
consumption of polyphenol related food and drink items.
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Figure 3.28 Extracted ion chromatogram of m/z 409 1233 (A) and EPI spectrum of the peak at 1.44
min. LC/MSIMS conditions were as described in Figure 3.8.
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Figure 3.33 Extracted ion chromatogram of m/z 271 I 191 (A) and EPI spectrum of peak at 16.99 min
(B). LC/MS/MS conditions were as described in Figure 3.8.
Methyl Sulfate Conjuagtes
1. m/z 264/169 [unknown methyl sulfate conjugate - 0.3 % of total analyte area]
The extracted ion chromatogram and EPI spectrum for this mass transition is given in Figure
3.34; one major peak was detected at 16.97 min, and several minor peaks can also be seen.
The EPI spectrum indicates a product ion of mlz 184 in addition to mlz 169; the latter product
ion represents a loss of 80 amu, corresponding to the cleavage of a sulfate. The mass
transition mlz 184 1 169 represents the loss of 15 amu, and could indicate cleavage of a methyl
group. The precursor ion for the polyphenol standard gallic acid is mlz 169, but the
characteristic product ion of mlz 125 seen with this standard is not observed in the EPI
spectrum given in Figure 3.32. No polyphenol standards analysed in this study gave these
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product ions upon MS2 fragmentation. The metabolite with the mass transition mlz 264 / 169
is likely to have a sulfate and methyl group present on the molecule, but any further
identification is not possible with the data presented here. There is no evidence provided in
the literature to help identify this metabolite, either.
2. m/z 248/ 168 [unknown methyl sulfate conjugate - 0.1 % of total analyte area]
Several peaks were observed in the extracted ion chromatogram for the mass transition mlz
248/ 168, which is given in Figure 3.35 in addition to the EPI spectrum. This mass transition
represents a loss of 80; cleavage of a sulfate. Product ions detected after MS2 included mlz
124, mlz 153 and mlz 204 in addition to mlz 168. The same product ions were noted in the EPI
spectra from all the peaks in the extracted ion chromatogram, however their intensities varied.
The product ion of mlz 204 could represent the loss of a carboxylic acid (44), as could mlz 168
/ 124. The mass transition mlz 168/ 153 represents the loss of 15 amu, or possibly cleavage of
a methyl group. Further identification of this metabolite is not possible with the data
presented here; all that can be hypothesized is that there is likely to be a sulfate and a methyl
group present on the molecule. There is no evidence in the literature to support the presence
or identity of this analyte.
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Figure 3.34 Extracted ion chromatogram of m/z 264 I 169 (A) and EPI spectrum of the peak at 16.97
min (B). LCIMS/MS conditions were as described in Figure 3.8.
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min (B). LC/MS/MS conditions were as described in Figure 3.8.
Unknown Conjuagtes
In some cases, after CID of the unknown metabolites, no fragments common to polyphenols
were observed in the spectra. Thus, it was concluded that these metabolites may not be of
polyphenolic origin, and are therefore beyond the scope of this project; they remain
unidentified.
1. m/z 577 1289 [1.5% of total analyte area]
Figure 3.36 shows the extracted ion chromatogram and EPI spectrum for this precursor
product ion pair; a major peak was detected at a retention time of 1.12 min, with several
smaller peaks between 16 and 17 min. Product ions of mlz 305, mlz 175, mlz 273 and m/z 159
were observed in the EPI spectrum, in addition to mlz 289. The polyphenol standards
procyanidin Bl and B2 have mass transitions mlz 577 1 289, and have identical EPI spectra to
each other (Figure 3.36 C). However, the spectra from these polyphenol standards do not
match that of the unknown metabolite detected in urine. The retention time of the major peak
is on or very close to the solvent front, so interference from other compounds may have
affected the EPI spectrum; the minor peaks are present in a low concentration so the EPI
spectra of these is also unreliable. Therefore, it is not possible to propose an identity for this
mass transition, based on the data supplied here. There are no characteristic losses of certain
masses which have been observed with analytes and standards previously, and therefore this
analyte may not be of polyphenol origin. The literature lacks any further information on such
a metabolite.
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2. m/z 384 / 304 [0.2 % of total analyte area]
The extracted ion chromatogram and EPI spectrum for this mass transition are shown in
Figure 3.37; three peaks are observed with retention times of 16.59, 16.94 and 10.3 min, most
significant first. This mass transition represents a loss of 80 amu, indicating cleavage of a
sulfate. A product ion of mlz 245 is seen in the EPI spectrum of the peak at 10.3 min, in
addition to mlz 304. The product ion of mlz 245 was observed in the EPI spectra of (-)
epicatechin and related conjugates, but the precursor ion of this standard (mlz 289) was not
detected, so it is unlikely that it is flavanol related. The mass transition mlz 384 /304 contains
masses of an even nature, something not observed with any of the polyphenolic metabolites
which have been tentatively identified so far. This may indicate that the metabolite is not of
polyphenol origin, but further identification is not possible. There is no data in the literature to
support the presence or identity of this metabolite.
A 1.9.4
r.rz
1.8,4
1.1><4
U,4
1.2""
s
i- 1.0eJ
'! 8000.0
.s
6000.0
4000.0
2000.0
4.11
0.0
C
B 1.8,4
1.6,~
1.4,~
l.2.~
e-
.» I.O,~
C'
.~
8000.0
.5
6000.0
16.87
~OOO.O
2Offil.0
A7.6J
18 50
304.9
174.9
2M3.
lr 272.9226.1j.2J~T I ~18.8_..j3J.8
100 I~O 200 2~0 300 J~O ~OO ~~O ~OO
Dl/z.:.mu
10 12 14
Time. min
7.0.~
6.~e~
6.0,~
5.::e-3
~.Of~
".5t~
s 4.0e~
-;.
3,5e~
''$.
<
! 3.0,5
2.::,,5
2.0e!\
I.~;
1.0.;;
::i.Oe"
I
161.0
12;.0... 203.1
7;;.1
21 .2
407.0
.1
137. .1 H.
289.1
,I /~. 9. 339.0
71
hi
~o 100 1;;0 200 2;;0 300 JSO JOO ~;;O ;;00 ;;;;0 600
milo, UUIU
Figure 3.36 Extracted ion chromatogram of m/z 577 I 289 (A), EPI spectrum of the peak at 1.12 min
(B) and EPI spectrum of the polyphenol standard procyanidin Bl (C). LC/MS/MS
conditions were as described in Figure 3.8.
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Summary
In summary, ten urinary metabolites have been partly identified, with elimination of possible
identities in some cases, but further identification was not possible with the data presented.
The following mass transitions were not present in high enough concentrations in the urine
samples analysed to provide EPr spectra, and therefore even part identification has not been
possible; mlz 737 1481, mlz 273 1208, mlz 705 I 353 and mlz 529 I 449 (in total < 0.15 % of
the total analyte area).
3.3.4 Identification of Metabolites in Human Plasma
Human plasma samples were analysed by LC/MSIMS using the same MRM method as for the
human urine samples, tabulated across Tables 2.12 - 2.14, chapter 2. Out of 115 mass
transitions, eleven showed a significant increase when test plasma samples were compared to
control plasma samples. After observation of retention times and EPI spectra, these were
determined as 11 distinct metabolites. The total peak area for the 11 metabolites of interest
was calculated, and a percentage for each metabolite was determined (the values for the area
are not quantitative, just as for the urine). Four mass transitions accounted for over ten percent
of the total area; the remainder were below seven percent. The process of identification was
performed as for urinary metabolites and tentative identities were assigned to each of these
metabolites. Metabolites were classified as aglycones, conjugated metabolites, conjugated
ring fission metabolites and unidentified apple-related metabolites. Table 3.5 details the mass
transitions and their relative abundance in the plasma. Evidence to support the identities of the
mass transitions proposed in the table is given in the remainder of the chapter.
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3.3.4.1 Identification of Aglycone Metabolites in Human Plasma
1. m/z 273/167 [phloretin - 0.5 % of total analyte area)
Figure 3.38 shows the extracted ion chromatogram and EPI spectrum for the mass transition
m/z 273/167; one major peak was detected at 1.58 min, with two additional peaks at 7.23 and
8.48 min and several minor peaks. EPI spectra of all the peaks indicated product ions of mlz
179, mlz 123 and m/z 93 in addition to m/z 167; these ions were observed in the EPI spectrum
of the polyphenol standard phloretin, (r, of 7.2 min; same as observed for the metabolite).
This suggests that phloretin may have been detected in the plasma; derived from phloretin-2'-
glucuronide detected in the urine. Marks et al. [72], report the presence of phloretin in ileal
fluid after consumption of cider, but not in plasma. Kahle et al. [8.99], also report the presence
of the glucuronide conjugate of phloretin in the ileal fluid of volunteers after consumption of
cloudy apple juice; plasma was not analysed in either study.
1. m/z 163/119 [p-coumaric acid -1.9 % of total analyte area)
The extracted ion chromatogram and EPI spectrum for the mass transition mlz 163 / 119 are
given in Figure 3.39; several peaks were detected with the major one eluting at 5.09 min.
Product ions of mlz 93 and m/z 119 were observed in the EPI spectrum; both of which were
previously detected with the polyphenol standard p-coumaric acid, which had a retention time
of 5.1 min. These data suggest that the mass transition m/z 163 1 119 detected in plasma, is the
metabolite p-coumaric acid, which was not found in urine. Urpi-Sarda et al. (83), report the
presence of p-coumaric acid in the plasma of human volunteers after consumption of cocoa.
Summary
It has been possible to identify two aglycone metabolites in human plasma;
I. Phloretin
2. p-Coumaric acid
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3.3.4.2 Identification of Conjugated Metabolites in Human Plasma
1. m/z 465/289 [(-1+) epicatechin-3'-glucuronide -7.2 % of total analyte area]
Figure 3.40 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 465/289; a major peak of retention time 5.27 min was observed. The EPI spectrum shows
product ions of mlz 427, m/z 327 and mlz 245 in addition to mlz 289. This mass transition was
also observed in urine, where it was identified as (-1+) epicatechin-3'-glucuronide. Exactly the
same product ions are observed from fragmentation of the analyte in the plasma compared to
the urine; it can therefore be hypothesised that this metabolite is also found in the plasma.
Evidence in the literature supports the presence of (-) epictechin-3'-glucuronide in the plasma
of humans after consumption of polyphenol containing food and drink [83,971.
2. m/z 369/289 [(-1+) epicatechin- 3' or 4' - sulfate - 2.6 % of total analyte area]
The extracted ion chromatogram and EPI spectrum for this mass transition is given in Figure
3.41; several peaks were observed with retention times of between 16.5 and 17.5 min. This
mass transition represents a loss of 80 amu, corresponding to cleavage of a sulfate. Product
ions of mlz 245, mlz 231, m/z 187 and mlz 277 were also observed in the EPI spectrum. This
mass transition and corresponding product ions were also observed in urine, where the identity
was proposed as (-1+) epicatechin- 3' or 4' - sulfate. Data suggest that the metabolite is also
found in plasma. Lee et al. [76], found the presence of sulfated epicatechin in the plasma of
humans, contrary to reports by Roura et al. [81] which suggest that only the glucuronidated
form is found.
Summary
Two conjugated metabolites have been tentatively identified in human plasma; both of which
were also detected in urine.
1. (-/+) Epicatechin-3' -glucuronide
2. (-/+) Epicatechin-3' or 4' -sulfate
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3.3.4.3 Identification of Conjugated Ring Fission Metabolites in Human Plasma
1. m/z 247 / 167 [3, 4-dibydroxypbenylacetic acid sulfate - 21.1 % of total analyte
area]
Figure 3.42 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 247 I 167; several peaks were observed the majority of which have retention times of
around 15 to 16 min. This mass transition represents the loss of 80 amu, corresponding to the
cleavage of a sulfate unit. The EPI spectrum indicates product ions of mlz 123, m/z 149, mlz
184 and mlz 212, in addition to mlz 167, which are identical to the ones observed with the
metabolite mlz 423 1247 found in urine, which was identified as 3, 4-dihydroxyphenylacetic
acid sulfoglucuronide. This would suggest that 3, 4-dihydroxyphenylacetic acid sulfate
(without the glucuronide) is found circulating in the plasma; however there is no evidence to
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indicate the position of the sulfate. There is no data in the literature to support the identity or
presence of this analyte in plasma.
2. m/z 383 I 207 [5 - (3', 4' -dibydroxypbenyl valerolactone) - ., - glucuronide -
15.8 % of total analyte area]
The extracted ion chromatogram and EPI spectrum for the mass transition mlz 383 I 207 are
given in Figure 3.43; two peaks were observed, a minor peak with a retention time of 5.53 min
and a major peak at 5.77 min. This mass transition represents a loss of 176 amu,
corresponding to the cleavage of a glucuronide unit. A product ion of mlz 163 was also noted
in the EPI spectrum. The mass transition mlz 383 I 207 with the same fragmentation pattern,
was detected in urine where the metabolite was identified as 5 - (3', 4' -dihydroxyphenyl
valerolactone) - ., - glucuronide. Evidence suggests this is also present in the plasma. Urpi-
Sarda et al. [83], report the presence of this metabolite in human plasma after the consumption
of cocoa.
3. m/z 287 I 207 [dibydroxypbenyl valerolactone sulfate - 15.2 % of total analyte
area]
Figure 3.44 shows the extracted ion chromatogram and EPI spectrum for the mass transition
mlz 287 I 207; peaks were detected with retention times of around 13 min and 16 to 17 min.
This mass transition represents a loss of 80 amu, indicating the cleavage of a sulfate from a
conjugate. The EPI spectrum shows a product ion of mlz 163, in addition to mlz 207, which
were also observed in urine, where the analyte was identified as dihydroxyphenyl
valerolactone sulfate; evidence suggests the presence of this analyte in plasma, also. Urpi-
Sarda et al. [83] did not fmd this metabolite in plasma, only in urine.
Summary
Three conjugated ring fission metabolites have been identified in human plasma;
1. 3, 4 - Dihydroxyphenylacetic acid sulfate
2. 5 - (3', 4' - Dihydroxyphenyl) - y - valerolactone glucuronide
3. Dihydroxyphenyl valerolactone sulfate
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3.3.4.4 Unidentified Apple Related Metabolites in Human Plasma
1. m/z 381/301 (unknown sulfate conjugate - 32.7 % of total analyte area)
The extracted ion chromatogram and EPI spectrum for the mass transition mlz 381 / 301 are
given in Figure 3.45; several peaks were observed with retention times from 14.5 min to 17.5
min. The EPI spectrum of the peak at 16.62 min is given, but all the peaks yield the same ions
which are obviously common to other metabolites in the sample, hence why there are many
unresolved peaks. On MS2 the analyte fragmented with an 80 amu loss, characteristic of the
cleavage of a sulfate. The polyphenol standard of quercetin-3' -sulfate has the same mass
transition, but when the EPI spectra are compared, other product ions do not correspond. Both
quercetin and quercetin-3' -sulfate yield product ions of mlz 179 and mlz 151, which are not
observed in the EPI spectra of the analyte. The standard of quercetin-3' -sulfate also has a
similar retention time of 17.3 min. Product ions ofmlz 255 and mlz 291 were observed in the
EPI spectrum of mlz 381 /301, which were not seen for quercetin-3' -sulfate, but another ion of
mlz 229 was observed. There are no reports of an analyte with this mass transition or common
product ions in the literature, and so it is not possible to identify this metabolite from data
presented here. It is also important to note that although the percentage area of this mass
transition is the largest of any detected in the plasma samples, this metabolite does not show
the greatest increase when test peak area is compared to control peak area. The metabolite
also accounts for the largest peak area in the control samples.
1. m/z 289 / 124 (unknown conjugate - 1.3 % of total analyte area)
Figure 3.46 details the extracted ion chromatogram and EPI spectrum for this mass transition;
the major peak detected had a retention time of 2.13 min. (-) Epicatechin has the precursor ion
mlz 289, but characteristic product ions of mlz 245 and mlz 203 seen with this flavanol are
absent in the EPI spectrum of the analyte. Likewise, the product ion of mlz 124 is not seen in
the EPI spectrum of (-) epicatechin. Evidence suggests that the mass transition mlz 289 / 124
is not (-) epicatechin, even though they also have similar retention times. No further
identification can be made. Factors contributing to the uncertainty of the identification of this
analyte include presence in a low concentration and the peak detected is on or very near the
solvent front.
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3. m/z 353/191 [unknown conjugate - 0.6 % of total analyte area]
The extracted ion chromatogram and EPI spectrum for the mass transition mlz 353 / 191 are
given in Figure 3.47; the major peak had a retention time of 4.21 min. The EPI spectrum of
the peak at 4.21 min shows product ions of mlz 295 and mlz 315 in addition to m/z 191. The
polyphenol standard chlorogenic acid has the same precursor / product ion mass pairs as seen
for this unknown metabolite, but observation of the fragmentation pattern of this standard
revealed that they are very different. The mass transition mlz 353 / 191 detected in plasma
cannot be chlorogenic acid. Further identification of this metabolite cannot be made from data
presented here, or from the literature.
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Figure 3.45 Extracted ion chromatogram of m/z 381 1301 (A), EPI spectrum of the peak at 16.62 min
(B) and EPI spectrum of the polypbenol standard quercetin-3' -sulfate (C). LC/MS/MS
conditions were as described in Figure 3.8.
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Summary
Two metabolites have been detected in plasma for which an identity cannot be proposed. One
other mass transition, mlz 289 I 109, was not present in high enough concentrations to be
investigated further.
3.4 Overall Discussionand Conclusions
Summary
In total, nine urinary metabolites and seven plasma metabolites have been identified (Table
3.6), with a further twelve urinary and two plasma metabolites partly identified. Definitive
identification and structural elucidation was not always possible due to a lack of synthetic
standards for comparison, but strong evidence for identity has been provided by LC/MSIMS
analysis and MS2 fragmentation.
Table 3.6 Analytes identified in the urine and plasma of humans after the consumption of a high
polyphenol cider apple extract. Those marked with an asterix have been identified for the
first time in humans after apple consumption.
Metabolites Identified in Human Urine Metabolites Identified in Human Plasma
(_/+) Epicatechin-3'-glucuronide* (-/+) Epicatechin-Jvglucuronide"
(-/+) Epicatechin-J' or 4'-sulfate* (-/+) Epicatechin-3'-sulfate*
(_/+) Epicatechin sulfoglucuronide* Phloretin
Phloretin-2'-glucuronide Dihydroxyphenylacetic acid sulfate*
5 - (3',4'-Dihydroxyphenyl)-y-valerolactone glucuronide" 5 - (3',4'-Dihydroxyphenyl)-y-valerolactone glucuronide"
Dihydroxyphenyl valerolactone sulfate* Dihydroxyphenyl valerolactone sulfate"
Dihydroxyphenyl valero lactone disulfate" p-Coumaric acid*
3, 4-Dihydroxyphenylacetic acid sulfoglucuronide*
Sinapic acid"
Metabolites marked with an asterix in Table 3.6, have been identified in the urine and plasma
of humans for the first time after apple consumption. The only previously reported metabolite
of apples in humans is phloretin-2' -glucuronide [8,72, 99l.
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Fate of (-1+)Epicatechin in Humans Post Ingestion of a High Polyphenol Cider Apple Extract
Glucuronide and sulfate metabolites of (-/+) epicatechin were identified in human urine and
plasma, with the addition of a sulfoglucuronide conjugate present in the urine (Figure 3.48).
All metabolites detected in urine are derived from the blood, so it is likely that the
sulfoglucuronide conjugate of (-/+) epicatechin was present in the plasma also, but may have
been broken down into the sinlge glucuronide or sulfate conjugates.
Glucuronide and sulfate conjugates of (-) epicatechin have been previously detected in human
urine and plasma after ingestion of tea and cocoa; in this study, (-/+) epicatechin was found
exclusively in the conjugated form in both urine and plasma, (in agreement with the literature
[761) and (-/+) epicatechin conjugates accounted for 1.5% of the total analyte area in urine and
9.7 % of the total analyte area in plasma. The major urinary conjugates of (-/+) epicatechin
were the sulfate conjugates, accounting for 0.9 % of the total analyte area, followed by the
glucuronide conjugates (0.4 % of the total analyte area) and the sulfoglucuronide (0.2 % of the
total analyte area). The major plasma conjugate of (-/+) epicatechin was (-/+) epicatechin-3'-
glucuronide, which accounted for 7.2 % of the total analyte area. In the literature, (-)
epicatechin-3'-glucuronide has been reported to be the major plasma glucuronide of (-)
epicatechin in humans [73, 81, 97, 1691, which agrees with the data presented here; there are a
couple of reports of (-) epicatechin sulfoglucuronides in human biological samples, after
consumption of cocoa and chocolate [81, 1621.
Sulfate conjugates of (-/+) epicatechin are generally reported at higher concentrations than
glucuronide conjugates in both urine and plasma, up to twice [76, 811; in this research they
account for approximately 2.5 times the proportion of glucuronide conjugates in urine. In
plasma the opposite was observed; the glucuronide conjugates account for approximately three
times the sulfate conjugates. Up to four different (-) epicatechin glucuronides (83) and three
different (-) epicatechin sulfates have been reportedly detected in human urine after
consumption of food and beverages containing (-) epicatechin [83, 1691. In this study, (-1+)
epicatechin-3' or 4' -sulfate was identified in urine, corroborated by other reports of (-)
epicatechin metabolism [73,76,77,83,1691. In contrast to the findings presented here, Roura et al.
[811 report that only the glucuronide form of (-) epicatechin was found in plasma and not the
sulfate, after 40 g of cocoa powder was consumed by the volunteers. However, only one
blood sample was taken, 2 h after cocoa consumption so the presence of the sulfate may have
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been missed (time taken to maximum concentrations or excretion and biokinetic parameters
are discussed in chapter 4). Mullen et al. [1061 report the opposite; that sulfate conjugates of (-)
epicatechin were present in plasma and not glucuronides, after 109 of cocoa powder was
consumed by the volunteers (6.7 mg of (-) epicatechin). This may be due to the low
concentration of (-) epicatechin ingested; there is always competition between the phase II
metabolism reactions of glucuronidation and sulfation, and at low concentrations sulfation
predominates as it is a high affinity and low capacity pathway [Ill.
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Figure 3.48 Suggested metabolism pathway of (-1+) eplcatecbin in humans after consumption of a high
polyphenol cider apple extract. (-1+) Epicatechin-5 or 7-sulfate-3'-glucuronide was the
major urinary (-1+) epicatechin metabolite followed by (-1+) epicatechin-3' or 4'-sulfate
and (-1+) epicatechin-3'-glucuronide. In plasma, (-1+) epicatechln-St-glucuronlde was the
major (-1+) epicatechin metabolite, followed by (-1+) epicatechin-3' or 4'-sulfate. The
sulfoglucuronide conjugate of (-1+) epicatechin was not found in plasma.
A major difference between reports in the literature on epicatechin metabolism in humans and
this study, is that here no methylated conjugates of (-1+) epicatechin were detected as major
metabolites. This may be due to the difference in the source of the epicatechin, i.e. all the
reports use epicatechin as a preparation or in tea/cocoa; (-1+) epicatechin metabolism will
undoubtedly be affected by the matrix in which it is supplied. Another possibility is that the
pathway for methylation may have become saturated by the high dose of the (-1+) epicatechin
provided, or by the high dose of some of the other polyphenols in the cider apple extract.
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Methylated conjugates may indeed have been formed but not in proportionally large enough
concentrations to have warranted further investigation.
Some of the ring fission metabolites identified in this study may also have originated from the
action of the gut micro flora on (-/+) epicatechin; this is discussed at the end of this section.
Fate of Phloretin in Humans Post Ingestion of a High Polyphenol Cider Apple Extract
A glucuronide conjugate of phloretin, identified as phloretin-2' -glucuronide was detected in
the urine of humans after consumption of a high polyphenol cider apple extract; this
metabolite accounted for 14.5 % of the total analyte area making it the only non-ring fission
metabolite to make a considerable contribution to the metabolite profile. Marks et al. [72),
identified phloretin-2' -glucuronide in the urine and plasma of humans after consumption of
cider, in addition to two other phloretin glucuronides found in urine which could not be
structurally elucidated. They also found a sulfoglucuronide conjugate of phloretin, which was
not detected here. The presence of phloretin glucuronide in ileostomy fluid [8. 72, 99) suggests
that the liver and small intestine, not the large intestine, are responsible for formation of this
metabolite. No phloretin conjugates were detected in plasma, but the aglycone was identified
and accounted for 0.5 % of the total analyte area; this suggests rapid elimination of the
glucuronidated form from the plasma. Phloretin has been found in ileal fluid previously [8).
It has been reported that phloretin is only found in apple and apple related products [67), and
hence there is very limited information on its metabolism particularly in humans. However,
Ito et al. (80), identified its presence in urine samples collected after consumption of grapefruit
and orange juice, suggesting that its formation could be due to reductive opening of the C-ring
of naringenin by the gut micro flora. No naringenin was consumed in this study, so any
phloretin detected must have been supplied directly by the high polyphenol cider apple extract.
Some of the ring fission metabolites identified in this study may also have originated from the
action of the gut microflora on phloretin; this is discussed at the end of this section.
Fate ofChlorogenic Acid in Humans Post Ingestion of a High Polyphenol Cider Apple Extract
Various groups have reported that chlorogenic acid is stable during the passage through the
small intestine and will be subsequently hydrolysed by the gut microflora [99). In this study,
although no conjugates of chlorogenic acid were identified, some may have been detected.
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Increases in many of the peak areas for possible metabolites given in Tables 2.13 and 2.14,
chapter 2, were noted in urine and plasma samples, in particular metabolites which have been
tentatively identified as methylated and/or glucuronidated chlorogenic acid, methylated and/or
sulfated caffeic acid, methylated and/or sulfated ferulic acid, methylated and/or glucuronidated
ferulic acid and glucuronidated coumaric acid. The reason further investigation was not
performed on these metabolites and identity was not confirmed, is that the metabolites did not
show large enough differences between their peak areas when test samples were compared
with control samples. Those metabolites which did show significant differences between test
and control samples, still had peak areas which were much smaller than those for the
metabolites which were investigated further (they accounted for <0.01 % of the total analyte
area for all the MRM transitions monitored for).
In addition to these conjugates, some of the ring fission metabolites that have been identified
here may also have originated from chlorogenic acid; sinapic acid was detected in urine «0.1
% of the total analyte area) andp-coumaric acid (1.9 % of the total analyte area) was identified
in plasma. Figure 3.49 suggests the metabolism pathway for the formation of sinapic acid and
p-coumaric acid from chlorogenic acid. Observation of several peaks in the extracted ion
chromatogram with the same mlz as the tentatively identified p-coumaric acid could indicate
several conformations exist in the plasma. Urpi-Sarda et al. [83), report the presence of p-
coumaric acid in urine and plasma, and m-coumaric acid in urine, after consumption of cocoa.
In another study by the same research group [105), both m- and p-coumaric acids were found in
human urine after cocoa consumption; p-coumaric acid was seen to increase by 467 percent
compared to pre-dose levels. However, both these studies involved deconjugation of samples
with p-glucuronidase and sulfatase enzymes so some of the detail of the metabolite profiles
has been lost.
Chlorogenic acid is reported to be a constituent of coffee. In one study, after consumption of
green coffee extract containing 170 mg of chlorogenic acid [179], the major urinary phenolic
compounds detected were sinapic, gallic, p-hydroxybenzoic, and dihydrocaffeic acids; these
represented -85 % of the total amount of phenolic compounds in urine. In plasma, p-coumaric
acid was detected and accounted for 1.9 % of the total phenolics. Other simple phenolic acids
detected included caffeic, ferulic and isoferulic acids. The literature suggests that chlorogenic
acids are subjected to extensive metabolism in humans, and are well absorbed [78].
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Besides these two phenolic acids, some of the other ring fission metabolites identified in urine
and plasma may also have originated from the action of the gut microflora on chiorogenic
acid; this is discussed at the end of this section.
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Figure 3.49 Suggested metabolism pathway of chlorogenic acid in humans after consumption of a
high polyphenol cider apple extract; p-coumaric acid was detected in plasma and sinapic
acid was detected in the urine. Reactions involve the gut microflora.
Fate a/Quercetin in Humans Post Ingestion of a High Polyphenol Cider Apple Extract
The average dose of quercetin (in glycoside form) for each volunteer was 17.16 mg. This is
much lower than for the other polyphenols such as (-) epicatechin and phloretin. No quercetin
conjugates were detected in urine or plasma from this study, which suggests all the quercetin
consumed in the test drink was converted to the ring fission metabolites by gut microflora
(discussed later in this section), or that the levels were too low for detection. Urpi-Sarda et al.
[83], do not report the presence of quercetin conjugates in urine or plasma after administration
of 0.46 mg of quercetin (as glycosides) in cocoa. Dupont et al. [87], suggest extensive
methylation of quercetin occurs in humans after low levels of quercetin intake; the cider
143
consumed by the volunteers in their study contained 1.57 mg of quercetin (a small amount was
supplied as quercetin glycosides). At higher doses (such as those used in this study), they
report that the pathway for methylation becomes saturated, and this maybe why no methyl
conjugates are detected here. Volunteers for the study by Kahle et al. [8], consumed one litre
of cloudy apple juice containing between 0.2 and 3.9 mg of quercetin (as glycosides), but no
quercetin glucuronides or sulfates were detected. This is opposite to results following the
ingestion of onions, where methylated, monoglucuronide, diglucuronide, sulfoglucuronide and
sulfate conjugates of quercetin were identified in the urine and plasma [23,84] after consumption
of approximately 120 mg of quercetin glycosides. It has been established that absorption of
quercetin is more rapid after intake of onions, rich in glucosides, than after intake of apples
containing both glucosides and other glycosides. In particular, polyphenols linked to a
rhamnose moiety have to reach the colon to be hydrolysed by rhamnosidases of the micro flora
prior to absorption. The same probably applies to arabinose - quercetin-3-rhamnose and
quercetin-3-arabinose in ileostomy fluid, not glucoside [8].
Microbial Derived Metabolites of Polyphenols in Humans Post Ingestion of a High
Polyphenol Cider Apple Extract
In this study, colonic microbial derived metabolites accounted for the largest proportion of the
total phenolic metabolites in urine and plasma, which agrees with the findings ofUrpi-Sarda et
al. [83] In urine, ring fission metabolites accounted for at least 80 % of the total analyte area
identified and in plasma the figure was 54 %. Several microbial-derived metabolites were
identified in urine, such as glucuronide, sulfate and disulfate conjugates of dihydroxyphenyl
valerolactone, and a sulfoglucuronide of dihydroxyphenylacetic acid. Figure 3.50 suggests
some possible metabolism pathways for these species, from the polyphenols in apples.
Dihydroxyphenyl valero lactone glucuronide was identified in urine (38.6 % of the total
analyte area) and plasma (15.8 % of the total analyte area); hypothesized to be 5-(3', 4'-
dihydroxyphenyl)-y-valerolactone glucuronide, supported by Sang et al. [73] and Urpi-Sarda et
al. [83] , after consumption of tea and cocoa, respectively. The glucuronide could be positioned
on the 3' or 4' position, with the hydroxyl groups on the 3', 4' or 5' positions; no structural
conformation is given in either reference. Two dihydroxyvalerolactone sulfate conjugates
were tentatively identified in urine (39.0 % of the total analyte area) and plasma (15.2 % of the
total analyte area); conjugation could be on the 3' or 4' position, just as in the case of
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glucuronidation. Sang et al. [73] found two dihydroxyvalerolactone sulfates present in urine
(none in plasma) after the consumption of tea, one conjugated on the 3' position and one
conjugated on the 4' position, but which was which was not possible to confirm. In agreement
with these findings, Urpi-Sarda et al. [83], also found two dihydroxyvalerolactone sulfates
present in urine (again, none in plasma) after cocoa consumption. However, the authors report
that this particular conjugate did not show a significant change when control urine was
compared with test urine, due to large inter-individual variations. This contradicts the findings
in this study, where large increases in the presence of dihydroxyvalerolactone conjugates were
detected. Due to enzyme deconjugation experiments performed by research groups,
information on the conjugation possibilities of these ring fission metabolites is limited [741. A
dihydroxyphenyl valerolactone disulfate was also tentatively identified in urine in this study,
accounting for 3.1 % of the total analyte area. However, no other research groups present
information on a disulfate in urine or in plasma. The increased retention time of the major
peak detected in the chromatogram would also support the presence of two sulfate units.
Dihydroxyphenylacetic acid sulfate was identified as the major metabolite in the plasma,
accounting for 21.1 % of the total analyte area; the unconjugated form was observed in plasma
after cocoa consumption'V'. To the best of my knowledge, no other reports of this metabolite
in the literature are available for comparison. In addition to these conjugated ring fission
metabolites, dihydroxyphenylacetic acid sulfoglucuronide was detected in urine. Urpi-Sarda
et al. [83], report the presence of 3, 4-dihydroxyphenylacetic acid, 3-methoxy-4-
hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid and phenylacetic acid in human urine,
but no conjugates. Rios et al. [82], also found 3, 4-dihydroxyphenylacetic acid in urine, but the
authors only detailed phenolic acids rather than any conjugates. There is no evidence to
support or contradict the presence of a sulfoglucuronide conjugate of dihydroxyphenylacetic
acid in urine. It is important to highlight that any studies investigating the urinary and/or
plasma metabolites in humans after consumption of apples or apple related products, do not
report on bacterial ring fission metabolites or their possible conjugates [8,72.87,991.
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Figure 3.50 Microbial metabolites of apple polyphenols. Sulfate and sulfoglucuronide conjugates of
3,4-dihydroxyphenylacetic acid were detected in plasma and urine, respectively.
Glucuronide and sulfate conjugates of 3,4-dihydroxypbenylvalerolactolle were detected in
urine and plasma and a sulfoglucuronide conjugate was also identified in urine.
Hippuric acid is a common metabolite present in urine after the consumption of polyphenols
[87]. It is derived from either the microbial degradation of polyphenols in the colon followed
by hepatic conjugation with glycine, or by metabolism of catecholamine neurotransmitters.
Urpi-Sarda et al. [83], report the presence of 3-hydroxyhippuric acid and 4-hydroxyhippuric
acid in urine and plasma after cocoa consumption. This analyte was detected in urine, but
levels in test urine samples were not significantly higher than in control urine samples, so the
metabolite was not investigated any further.
Conclusions
This study reports the first time identification of nine urinary metabolites and seven plasma
metabolites in humans, after consumption of a high polyphenol cider apple extract. The
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discovery and identification of new apple polyphenol metabolites enhances our understanding
of how apple polyphenols are metabolised in the human body, and advances the area of
research. Findings in this study agree with what little available literature there is and provide
evidence of substantial phase II metabolism of apple polyphenols in humans by the detection
of conjugated, ring fission and conjugated ring fission metabolites in urine and plasma
samples. The metabolism of polyphenols results in many diverse metabolites; structure seems
key to the nature of the metabolites, with different classes producing characteristic products
due to distinct structures, hydroxylation patterns and the variety of bacterial microorganisms
inhabiting the gastrointestinal tract [46]. Intestinal microbiota have been shown to be very
important for the bioavailability and bioactivity of certain phenolic compounds [1801, and vary
greatly among individuals causing large inter-subject variations. Conjugated bacterial ring
fission products of polyphenol metabolism, accounted for the greatest proportion of
metabolites in the human urine and plasma.
It is difficult to ascertain the reason for the differences observed in metabolite profiles of
polyphenols reported, due to a wide variety of variables. Differences between studies include
variation in the dose of polyphenol and the source (tea or cocoa compared to apples), the
volunteers involved (i.e. gender, ethnicity, age and health status), the time points at which
plasma and urine samples are collected, the length of time the samples are stored for before
use, the method used to process the samples before analysis and the sensitivity/accuracy of the
LC/MS/MS method employed. This study was performed with great attention to detail,
thereby reducing as many sources of error as possible and producing results which have a high
level of confidence attached to them.
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Chapter Four
Biokinetics of Apple Polyphenol
Metabolites in Human Urine and
Plasma
Summary
In chapter 3, some major metabolites of apple polyphenols detected in human urine and
plasma samples were identified; this chapter evaluates some of the biokinetic parameters of
these metabolites which provides evidence for their origin and gives information on their rates
of absorption and excretion. The proportions of metabolites identified after the consumption
of the control apple juice and the high polyphenol cider apple extract (test phase) have been
compared and contrasted to reveal differences in the metabolic pathways at different
concentrations of polyphenol intake. This is the first time biokinetic data has been reported
for apple polyphenols in healthy humans.
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4.1 Introduction
This section first reviews intervention studies performed by other researchers with apples or
apple related material, and is followed by literature detailing information about polyphenols
that are contained in apples, but where the intervention studies have been conducted with other
food stuffs such as tea and cocoa.
4.1.1 AbsorptionJExcretioo Profiles of Apple Polypbeools
As mentioned in the previous chapter, literature concerned with apple intervention studies is
restricted to four papers [8,72,87,99]; two of which only report data for metabolites found in
ileostomy fluid [8,99]. Maximum excretions of polyphenols in ileostomy fluid occurred 2 h
after ingestion of the cloudy apple juice, and most of the polyphenols were already present in
the juice; an exception was the presence of D-(-) quinic acid (major metabolite) and phloretin
glucuronide (minor metabolite). No biokinetic data was provided in this study. Phloretin-2'-
glucuronide was found as the major metabolite in plasma, urine and ileostomy fluid by Marks
et al. [72] when comparing results from healthy volunteers and ileostomy patients after the
consumption of cider. Biokinetic data reported from both subject groups revealed no
statistical differences, which suggested that the principle site for the absorption of
dibydrochalcones from cider was the small intestine. The presence of the glucuronide
conjugate of phloretin reached a maximum 0.6 h after cider consumption in plasma, also
indicating rapid absorption in the small intestine; maximum excretion occurred in the 0-2 h
urine sample. After consumption of cider, Dupont et al. [87], report the presence of caffeic acid
and 3' -methyl quercetin in plasma, both of which were present in the ingested cider. In urine,
phloretin (present in the cider) and hippuric acid were detected, but enzyme deconjugation
experiments were performed so any detail on the conjugation of these and other metabolites
would have been lost. No biokinetic data was reported by these authors.
Using the data presented in these four papers it is only possible to form a limited
understanding of the metabolism of apple polyphenols. Although the studies performed with
ileostomy patients provided different data, no colonic metabolism can occur, hence data would
be absent for the large proportion of the metabolites from apple polyphenols formed by
colonic bacteria (as noted in chapter 3). Also, analysis methods utilised in previous studies
were often not fully validated leading in some cases to a lack of certainty as to identification
and to the accuracy of quantification. Many previous studies have used enzymes to
149
deconjugate polyphenol metabolites, and whilst this provides an overall estimate of
conjugation, it results in a lack of detail on specific polyphenol metabolite conjugation, for
example whether a glucuronide, sulfate or other conjugate has been formed.
4.1.2 AbsorptionlExcretion Profiles of Apple Polyphenols from Alternative Food
Sources
Catechins and their metabolites present in plasma and urine of volunteers after consumption of
tea, generally reach a maximum quickly; greatest excretion is between 0-4 h and highest
plasma levels occur around 2 h [57,75,169]. Van Het Hof et al. [57], compared the consumption
of black and green tea, with and without milk. Results indicated that green tea had three times
the concentration of catechins when compared to black tea, which was reflected in the results
of total catechins in the blood after consumption; milk showed no significant effects on these
levels. In another study comparing the ingestion of three different amounts of decaffeinated
green tea [75], a two fold increase in consumption levels produced a 3.4 fold increase in
maximum circulating levels of (-) epicatechin; however, a further increase in quantity ingested
did not produce a corresponding increase in plasma levels. The same effect was observed in
the urine. The authors reported that most of the catechins were present in the sulfated and
glucuronidated forms, but no biokinetic data was provided for these metabolites.
After consumption of cocoa in liquid form with milk or water, Mullen et al. (106), reported rare
biokinetic data for two conjugates of (-/+) epicatechin identified in the plasma; epicatechin
sulfate and methyl epicatechin sulfate. The maximum concentrations of these two metabolites
were observed at 1.4 and 1.0 h, and were slightly lower when cocoa was ingested with milk
compared to water, although not significantly. These metabolites were also identified in urine,
in addition to another epicatechin sulfate and a glucuronide; values calculated for the
proportion excreted as a percentage of what was ingested showed significant differences when
cocoa prepared with water was compared to cocoa prepared with milk. A lower value was
obtained after the cocoa-milk drink, suggesting components from the milk such as proteins,
may have interfered with the transport of polyphenolic metabolites or bound to them, reducing
their bioavailability. Absorption is affected by the matrix in which the polyphenols are
present in, and therefore adds further complexity to the evaluation ofbioavailability. Roura et
al. [176], reported that although the amounts of epicatechin metabolites identified in urine did
not significantly differ when milk was used to make the cocoa drink compared to water, the
milk did affect the profile of metabolites; sulfation was found to increase compared to
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glucuronidation in the first 6 h post ingestion. The ring position of these sulfate conjugates
was also noted to be different.
There is agreement throughout the literature that Tmaxvalues for (-1+) epicatechin in plasma as
the aglycone, are approximately 2 h, regardless of whether the epicatechin has been provided
by tea or cocoa [81, 162]. One intervention study comparing the biokinetic parameters for (_)
epicatechin after chocolate and cocoa intake [162], found maximum plasma concentrations were
very similar, however, higher levels of non-methylated (-) epicatechin were observed in the
plasma at 1 and 2 h post ingestion of cocoa compared to chocolate. After chocolate intake,
concentrations of methylated (-) epicatechin were higher at 2 and 4 h compared to cocoa
intake. This supports evidence provided by Roura et al. [176], that although maximum
concentrations of polyphenols and their metabolites do not necessarily change with different
food sources, the actual profile of the metabolites may change. In urine, these differences
were not replicated.
One point to mention when comparing (-1+) epicatechin metabolism from tea and cocoa, is
that cocoa also contains procyanidins which are in effect dimers, trimers, etc of (+1-) catechin
and (-1+) epicatechin and therefore could be the origin of some of the flavanol metabolites
observed in intervention studies carried out with cocoa.
After consumption of coffee, Stalmach et al. [78], provided some biokinetic data for
chlorogenic acids and their metabolites in human urine and plasma. Twelve
hydroxycinnamate derivatives were identified in plasma, with Tmax values of between 0.6 and
5.2 h; the time is indicative of the site of absorption, as explained in the previous chapter.
Early Tmaxvalues of between 0.6 and 1 h indicate absorption in the small intestine and are
observed for metabolites which have been formed by simple phase II metabolism reactions,
such as glucuronidation, sulfation and methylation. Longer values for the time taken to reach
maximum concentrations indicate large intestine absorption, and are observed for metabolites
produced as a result of greater transformations, for example those reactions of the colonic
micro flora such as ring fission. Major metabolites detected in the plasma, were those which
had the longest Tmaxvalues of between 4.7 and 5.2 h; most metabolites were eliminated from
the circulatory system rapidly, indicated by elimination half lives of between 0.3 and 1.9 h.
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4.1.3 AbsorptionlExcretion Profiles of Ring Fission and Conjugated Ring Fission
Metabolites
The identification of ring fission metabolites and their conjugates following consumption of
polyphenols is scarce, but quantitative or biokinetic data is even more elusive, particularly for
the conjugated ring fission metabolites. Urpi-Sarda et al., reported identification of some
metabolites of bacterial origin, after cocoa [83, 105] and almond [181] consumption (some
quantitative but no biokinetic data provided), Meng et al. [74], provided some evidence of the
formation of these metabolites after consumption of tea (quantitative and some biokinetic data
provided) and Rios et al. [82] showed some urinary excretion profiles for six ring fission
metabolites after chocolate consumption (quantitative data only).
After cocoa consumption [105], large increases in the excretion of many microbial-derived
phenolic metabolites were reported, the largest increases were observed with ferulic acid, P:
coumaric acid, 3-hydroxybenzoic acid and vanillic acid. Although percentage increases
compared to baseline levels are reported, no actual biokinetic data is given. Some quantitative
data for (-1+) epicatechin conjugates, ring fission and conjugated ring fission metabolites was
provided by a more recent study [83], (but still no biokinetic data) however, this study was
concerned with the regular consumption of cocoa throughout the experimental period and
therefore results will be different to those generated by a single dose; the ability of phenolic
compounds to modify the populations of microorganisms in the gut over time was previously
discussed in chapter 3. Conjugates ofhydroxyphenyl valerolactone significantly increased in
the urine and plasma of volunteers post cocoa consumption; maximum excretion was observed
3-6 h post dose. The longer time taken to reach maximum excretion increases the likelihood
that the metabolite is of bacterial origin.
Following green tea ingestion, 5- (3', 4'-dihydroxyphenyl) -"(- valerolactone was identified in
urine and plasma; maximum excretion occurred 3-6 h post dose and maximum plasma
concentrations were observed 5 h post dose [74]. This supports the findings of Urpi-Sarda et al.
[83] reported after cocoa consumption. Urine and plasma samples were both deconjugated with
enzymes prior to the analysis in this green tea intervention, which could be the reason no
conjugated ring fission metabolites were detected. Rios et al. [82], reported Tmall.values of
between 9 and 48 h for ring fission metabolites in urine, which is later than values reported
after tea or cocoa consumption. No conjugated ring fission products were identified, probably
due to enzyme deconjugation prior to analysis.
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Following the consumption of almonds, which contain (-) epicatechin and procyanidins
similar to apples, two glucuronide and one sulfate conjugate of hydroxyphenyl valerolactone
were identified in urine and plasma, in addition to hydroxymethoxyphenyl valero lactone
glucuronides and sulfates [1811. Samples were analysed before and after deconjugation with
enzymes for a more detailed account of metabolism. Levels of phenolic acids derived from
the further breakdown of these hydroxyphenyl valerolactones, were also reported.
Concentrations of all metabolites were given in the plasma and urine, where detected, but no
further biokinetic data was supplied. Due to sample collection at limited time-points (plasma
was taken at baseline, 2.5 h and 4.5 h after ingestion of the test food, and urine was collected
from 0-24 h) time profiles could not be constructed, which limits the information on
bioavailability which can be acquired from this study.
4.1.4 Summary
Limited biokinetic data for some polyphenol-related aglycones identified in human urine and
plasma has been reported in the literature, in addition to some data for conjugated metabolites.
However, quantitative and/or biokinetic data has not been detailed for ring fission and ring
fission conjugates of polyphenols. This review of the literature highlights the lack of
information available on the metabolism of polyphenols in humans; and the purpose of the
research reported here is to contribute to this poorly investigated area. Many new metabolites
have already been identified for the first time in humans, after the consumption of a high
polyphenol cider apple extract, in chapter 3, and the aim of this chapter is to further our
understanding of the metabolism of apple polyphenols by evaluating the biokinetics and
bioavailability of these metabolites.
There are several reasons for the absence of detailed information in the literature, firstly
human studies are rarely well designed and fail to take sufficient samples at a range of time-
points to obtain good pharmacokinetic type data. Sample taking requires a great deal of care
and attention to detail, in order to gain the most from the samples. Volunteer numbers arc
very often less than five, and high inter-subject variation is always observed, which has a
greater impact in small-number studies. The focus of studies is often very narrow; researchers
concentrate on one or two specific polyphenols or one class and fail to consider the broader
outcomes. Analytical measurements are not always appropriate, for example the analysis of
enzyme deconjugated urine and plasma samples may be carried out in conjunction with the
analysis of the unhydrolysed samples, but often it is performed instead, and serves only to
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conceal the detail. The literature is not comprehensive for any fruit, vegetable or food stuff,
especially for apples. This chapter attempts to address these shortcomings by applying a
validated analytical method to analyse urine and plasma samples from a human intervention
study specifically designed to investigate apple polyphenol metabolism and biokinetics.
4.1.5 Aim of the Chapter
To evaluate the biokinetic data in human urine and plasma following administration of a high
polyphenol cider apple extract to nine volunteers.
4.2 Methods
4.2.1 Summary of the Analytical Method used for the Analysis of Apple Polyphenol
Metabolites in Human Urine and Plasma Samples
Full details are provided in chapter 2, section 2.3. In summary, mobile phase A constituted of
0.01 % formic acid in H20 and mobile phase B was MeCN. A Gemini CI8 column
(Phenomenex, Macclesfield UK) of dimensions 100 x 3.0 mm and a 3 J.1mparticle size was
used at a temperature of 65°C. Urine was centrifuged at 3,000 rpm and 4 °C for 3 minutes
prior to analysis and plasma was extracted twice using a 3: 1 solvent: plasma liquid-liquid
extraction procedure with 0.1 mM ~OH in MeCN, prior to analysis.
4.2.2 Summary of the Human Intervention Study
Full details are provided in chapter 3, section 2.3. In summary, ten healthy male volunteers
were recruited for a two-phase blinded intervention study; the control phase involved
consumption of 'Tesco' Pure Apple Juice supplemented with water and the test phase
involved consumption of the same apple juice supplemented with a high polyphenol cider
apple extract (only nine volunteers completed both phases of the study; one volunteer dropped
out due to medical reasons). Baseline urine and plasma samples were taken before
consumption of the test material. Drinks were consumed within three min; urine samples were
collected in the following time periods, 0-4 h, 4-8 h and 8-24 h and plasma samples were
taken after 20, 30, 40 and 60 min, every half an hour until 4 h and then every hour until 8 h.
with a final sample 24 h post consumption. At least two weeks passed between each phase.
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4.2.3 Biokinetic Calculations for Apple Polyphenol Metabolites in Human Urine
Normally, in order to obtain biokinetic data, concentrations of metabolites in the biological
fluid would be plotted against time, but here only the extracted ion peak areas were available
for urine and plasma. Peak areas were used to represent concentration because of lack of
available standards; although the polyphenol metabolites have closely related structures, there
will still be differences in MS responses, so data for individual polyphenol metabolites will be
broadly comparable, but nevertheless represent an approximation. Total LC/MS/MS extracted
ion peak areas for each metabolite were calculated using the data for the total volume of urine
collected at each time-point, and therefore are directly proportional to the total excreted
amount of each polyphenol metabolite. Peak areas for individual metabolites are consistent
between the control apple juice and the high polyphenol cider apple extract and are therefore
directly comparable; responses vary between metabolites as mentioned previously, so a direct
comparison cannot be made. Mean peak area data (n = 9) were calculated from all the
volunteers and used to construct excretion profiles for the urinary metabolites. The time-
point at which maximum excretion of a particular metabolite occurred was defined as Tmax (h).
Kinetics determines changes over time which applies to concentrations or peak areas similarly.
The use of relative peak areas allows accurate measurement of the Tmax values for individual
metabolites as concentration data are not required in the calculation.
4.2.4 Biokinetic Calculations for Apple Polyphenol Metabolites in Human Plasma
As explained above, normally to determine biokinetic data, concentrations of metabolites in
the plasma would be plotted against time, but here only extracted ion peak areas were
available. Peak areas were used to represent concentration because of the lack of available
standards. Peak area versus time profiles for the metabolites identified in the plasma were
constructed from mean (n = 9) data. Peak areas for the metabolites identified in plasma
represent the amount of polyphenol metabolite in 1 mL of plasma, and so are different from
the peak areas of urinary metabolites. Although the polyphenol metabolites have similar
structures, there will be differences in MS responses, as observed for urinary metabolites. and
in addition there will also be differences in the recovery efficiencies of the individual
polyphenol metabolites from the plasma matrix. This suggests that caution should be taken
when attempting to make quantitative comparisons between the individual metabolite profiles.
However, the values of Tmax and apparent T 112 for individual metabolites are valid since
concentration data are not required in their calculation.
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Tmaxwas defined as the time taken in hours to reach the maximum concentration (Cmax)
observed in the plasma. Cmaxwas defined by the maximum peak area recorded for a particular
metabolite during the sampling time; where polyphenol standards were available Cmax values
(nM) were calculated using the mean value for the slope of the calibration curve for the
polyphenol standard in control plasma (matrix-matched). Normally, plasma T \I, or the
elimination half-life is determined following an intravenous bolus injection and represents the
time taken for the metabolite to be decrease to half of its maximum concentration in plasma.
However, in this study an oral 'dose' was given to the volunteers, so it was only possible to
estimate the elimination half-life. An estimate was given by examining the absorption
profiles; Tmaxrepresents the time of maximum concentration of the metabolite in the plasma
and indicates where the rate of absorption is equal to the rate of excretion, the point at which
the rate of excretion is greater than the rate of absorption must be used to calculate the
elimination half life. Therefore calculations were made from the slope of the graph at a
significantly later time, for example 1-2 h after the Tmax had been recorded.
Area under the curve (AUC) calculations, give a measure of bioavailability of the metabolites
under investigation. In this study, values were based on measured peak areas derived from
LC/MS/MS extracted ion peaks from the individual metabolites due to the lack of standards
mentioned previously. Once again, quantitative comparisons between metabolites rely on the
extraction efficiencies and the MS responses of the individual polyphenol metabolites being
the same; they will be similar due to the similarities in structures, but there will be variations,
which have been observed by examination of the calibration lines for each of the polyphenol
standards in plasma. Therefore, the values of the AUC calculations in this study are an
estimated measure of comparison between the major plasma metabolites identified. Both T \I,
and AUC values were calculated using Microsoft Excel.
4.3 Results and Discussion
4.3.1 Biokinetics of Apple Polypbenol Metabolites in Human Urine
Table 4.1 details the percentages of each of the identified polyphenol metabolites in the urine
samples collected at the various time-points; Tmax is the time-point at which the greatest
percentage of the analyte is recorded and is indicated by bold typeface. Table 4.2 gives the
percentage of each urinary polyphenol metabolite out of the total analyte area. for control and
test urine samples.
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Table 4.2 Summary of the mean (n = 9) values for the distribution of the metabolites identified in
urine collected at the four time-points after the consumption of a high polyphenol cider
apple extract by human volunteers; ± standard deviation. Tmal is indicated by bold
typeface.
Metabolites Identified in Human Urine
Percentage of Analyte in Urine Samples
Baseline 0-4 h 4-8 h 8-24 h
(-/+) Epicatechin-St-glucuronide 0.2 ± OJ 51.8 ± 35.2 27.5 ± 27.4 20.5 ± 23.2
(-/+) Epicatechin-Jvsulfate 0.1 ± 0.2 50.9± 40.7 33.4 ± 35.6 15.5 ± 30.1
(-/+) Epicatechin sulfoglucuronide < 0.1 ± < 0.1 35.8 ± 23.7 50.4 ± 30.0 13.8 ±9.1
Phloretin-2' -glucuronide < 0.1 ± < 0.1 60.8 ± 28.0 33.4 ± 24.5 5.9 ± 9.0
5 - (3',4'-Dihydroxyphenyl)-y-valerolactone glucuronide < 0.1 ± < 0.1 7.6 ± 10.7 56.5 ± 21.8 35.9 ± 23.7
Dihydroxyphenyl valero lactone sulfate 2.5 ± 6.2 12.5 ± 22.9 54.9 ± 41.7 30.2 ± 45.2
Dihydroxyphenyl valero lactone disulfate < 0.1 ± < 0.1 14.6 ± 26.2 55.8 ± 30.1 30.0 ± 32.8
3, 4-Dihydroxyphenylacetic acid sulfoglucuronide 17.2 ± 23.0 52.5 ± 31.4 7.1 ± 14.2 23.2 ± 35.6
Sinapic acid Metaboliteonly detectedin 3 volunteers.2 hadTmax at 8-24 h
Table 4.3 Summary of the mean (n = 9) percentage area for each of the metabolites identified in
control and test human urine samples following ingestion of 'Tesco' pure apple Juice
(control) and a high polyphenol cider apple extract (test).
Metabolites Identified in Human Urine
Control Test
(-/+) Epicatechin-3'-glucuronide 0.2 0.4
(-/+) Epicatechin-3'-sulfate 5.4 0.9
(-/+) Epicatechin sulfoglucuronide 0.1 0.2
Phloretin-2' -glucuronide 12.2 14.5
5 - (3',4'-Dihydroxyphenyl)-y-valerolactone glucuronide 11.4 38.6
Dihydroxyphenyl valerolactone sulfate 63.6 39.0
Dihydroxyphenyl valerolactone disulfate 0.5 3.1
3, 4-Dihydroxyphenylacetic acid sulfoglucuronide 0.1 <0.1
Sinapic acid 0 <0.1
Percentage of Total Analyte Area
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4.3.1.1 Biokinetics of Conjugated Metabolites in Human Urine
Mean (n = 9) maximum excretions of (-1+) epicatechin-3'-glucuronide and (-1+) epicatechin-3'
or 4' -sulfate were detected in the 0-4 h urine sample (Table 4.2). These metabolites continued
to be excreted in the 4-8 h and 8-24 h samples, the amount decreasing each time, Figure 4.1.
The literature reports that maximum excretion of conjugated metabolites of (-) epicatechin
from cocoa [106] and tea [169] were in the 0-2 h and 0-4 h urine samples, respectively; this is the
first time data has been reported for (-1+) epicatechin metabolites after the consumption of
apples. Levels of (-) epicatechin glucuronide and (-) epicatechin sulfate have been reportedly
detected in urine samples up to 24 h after tea consumption [73]. A decaffeinated green tea
intervention study undertaken by Van Het Hof et al. [51], reported that over 90 % of the
ingested (-) epicatechin was excreted within 8 h (mainly as sulfate and glucuronide
conjugates) and after 24 h the levels were below those of detection. Hence. the results
presented here are in agreement with previous published data. Maximum excretion for the
sulfoglucuronide conjugate of (-1+) epicatechin (not previously identified after other
intervention studies) was observed in the 4-8 h urine sample, later than for the other
conjugates of (-1+) epicatechin. Individual volunteers showed variation in their excretion
profiles for all these metabolites indicated by the large error bars which represent the standard
deviation (Figure 4.1, A-D). High inter-subject variation has been reported in the literature
with all studies of this kind [8, 83, 87,99].
Mean (n = 9) maximum excretion of phloretin-2' -glucuronide was also detected in the 0-4 h
urine sample (Table 4.2). Marks et al. [72], reported that the maximum excretion of phloretin-
2' -glucuronide post cider consumption was in the 0-2 h urine sample; this is the only paper to
my knowledge detailing the presence of this conjugate in the urine of healthy volunteers.
More data exists for the analysis of ileostomy fluid after consumption of apple-related
material; Kahle et al. [99], reported that maximum excretion of polyphenols such as
hydroxycinnamic acid derivatives (chlorogenic acid and coumaroylquinic acids).
dihydrochalcones (phloretin and phloretin-2'-xyloglucoside), (-) epicatechin and quercetin-3-
rhamnoside (present in the ingested apple juice) occurred at 2 h in ileostomy fluid. The only
new metabolite to be reported that was not present in the cloudy apple juice was phloretin-2'-
glucuronide, and this was also reported at maximum concentrations in the 0-2 h urine sample;
a further analytical study of the composition of ileostomy fluid collected from this study
158
showed that phloretin and the glucuronide conjugate only accounted for a minor proportion of
the metabolites [81.
Phloretin-2'-glucuronide accounted for the largest proportion (14.5 %) of analyte area in urine
(Table 4.3), of the non-ring fission metabolites identified after consumption of the high
polyphenol cider apple extract. This phenomenon was also observed after the consumption of
the control drink and was not much lower, (12.2 %); this suggests that the pathway of
formation of this metabolite is saturated at a low level of phloretin intake; the high polyphenol
cider apple extract provided around fifty times the quantity of phloretin than the supermarket
apple juice, but no such increase is observed in conjugated phloretin metabolites excreted.
The process of absorption is complex and there are a multitude of variables which could be
affecting the fate of the phloretin.
Proportional amounts of (-/+) epicatechin glucuronide and sulfoglucuronide are very similar
after the intake of both the control and the test drinks, but there is a greater proportion of (-/+)
epicatechin sulfate produced after consumption of the control drink when compared to the test
drink (Table 4.3). This supports the suggestion made previously in chapter 3, that the pathway
for the formation of sulfate conjugates is readily saturated, by low doses of polyphenols [Ill;
however, for the effects of saturation to be obvious, the data must be presented as actual
values rather than percentages of the metabolite pool, which is not possible here. The quantity
of (-/+) epicatechin ingested is approximately eleven times higher after the consumption of the
high polyphenol cider apple extract when compared to the supermarket apple juice. No
significant increase in the production of the glucuronide conjugate is noted, which would be
assumed if the sulfation pathway is saturated. One explanation for this could be that the low
concentration of (-/+) epicatechin is enough to saturate the phase II conjugation pathways, so
more passes through to the large intestine for bacterial colonic metabolism; a large increase in
these ring fission metabolites was observed.
4.3.1.2 Enzyme Deconjugation Experiments in Human Urine
These experiments were described in chapter 2, section 2.3.7, and involved deconjugation of
pooled test urine samples (0-24 h) with the enzymes sulfatase and p-glucuronidase, to obtain a
figure for the total amount of (-/+) epicatechin and phloretin sulfate and glucuronide
metabolites present in the urine (methyl conjugates will not be deconjugated). These two
polyphenols are the only ones measured in the high polyphenol cider apple extract that
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produced conjugates which were identified in the urine, and standards were also available for
them. The mean (n = 9) amounts of these two polyphenols ingested were 73.96 mg for (-)
epicatechin and 38.09 mg for phloretin.
Calculation of Total Proportion of (-1+) Epicatechin and Phloretin Metabolites in Human
Urine
Since the values for the peak area after treatment of sulfatase would have included cleavage of
all of the sulfate conjugates and some glucuronides (the source of the sulfatase contained some
~glucuronidase activity as well), this value was used as the total aglycone value for the 0-24 h
urine samples. Using the sum of the peak areas after treatment of sulfatase and p-
glucuronidase separately would have been an overestimate; calculated this way the value will
be an underestimate as not all the glucuronides will have been deconjuagted. However, due to
the use of pooled urine samples, the values have probably been overestimated as the same
volume of urine was taken from each time-point sample to make the pool, regardless of the
total volume, hence not accurately reflecting the relative contribution of each individual
metabolite because of the volume differences at each time period. This was an error in the
experimental design and therefore is only an approximation.
The mean (n = 9) excretion of sulfate, glucuronide and sulfoglucuronide conjugates of (-1+)
epicatechin was 37.8 mg, which represented 51.2 % of the ingested (-1+) epicatechin and the
mean (n = 9) excretion of phloretin sulfate, glucuronide and sulfoglucuronide conjugates was
19.2 mg, which corresponded to 50.4 % of the ingested phloretin (Table 4.4). These values
were calculated by taking the sum peak area for the polyphenol after enzyme treatment, for
each pooled urine sample from each volunteer (n = 9), and dividing by the slope of the
calibration graph of the polyphenol standard in blank plasma (matrix-matched) and then
multiplying by the molecular weight. These values do not consider any methylated derivatives
of either polyphenol which may have been present; these would not have been deconjugated
by sulfatase and ~-glucuronidase enzymes. The values are highly variable among the
volunteers for both polyphenols.
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Table 4.4 Mean (n = 9) excretion of conjugates of (-) epicatechin and phloretin in the pooled test
urine of volunteers (0-24 h) after treatment with sulfatase and p-glucuronidase ezymes, ±
standard deviation.
Aglycone Identified In Urine After
Enzyme Treatment Mean Excretion (mg)
% of Polyphenol
Ingested
(-1+) Epicatechin 37.8± 17.8 51.2 ± 9.3
Phloretin 19.2 ± 24.1 50.4 ± 24.4
Values in the literature for the percentage of (-) epicatechin excreted in the urine as
metabolites compared to the amount ingested, vary. For example, Mullen et al. [1061, reported
that 18.3 % of the ingested dose of flavon-Lols from a cocoa-water drink were excreted in the
urine of volunteers, compared to 10.5 % of the intake when milk was used to prepare the
drink, whilst Del Rio et al. (169), reported that 7.2 % of the ingested flavanols from tea were
excreted in urine and Baba et al. (162), reported that 29.8 % and 25.3 % of (-) epicatechin
ingested after cocoa and chocolate consumption, respectively, was excreted in urine. These
values are all derived from different food sources, different populations of volunteers and
different method of analysis, which could all contribute to the variation. The values for the
excretion of (-) epicatechin related metabolites after consumption of cocoa with and without
milk investigated in the same study, were significantly different and indicate that absorption of
polyphenols is affected by the matrix which they are consumed in, which may explain the
variation noted between apples, tea and cocoa. Components in the matrix may bind to
polyphenols, or interfere with their mechanisms of transport.
After consumption of cider, Marks et al. [72), reported that 5 % of the ingested dose was
excreted as phloretin metabolites in urine; the amount of phloretin-2'-glucuronide excreted
was equivalent to 4.2 % of the intake in healthy volunteers and 4.4 % of the intake in
ileostomy patients, and represented the most abundant phloretin conjugate. In total,
dihydrocha1cone metabolites accounted for 2.0 % of the total quantity of metabolites
determined in the 0-2 h urine samples for healthy volunteers in this study. In ileal fluid, the
phloretin glucuronides detected totalled 18.7 % of the ingested dose, while the phloretin
sulfoglucuronide and phloretin sulfates accounted for 3.6 and 3.0 % of the ingested dose,
respectively. After consumption of alcoholic cider, DuPont et al. [871, identified phloretin and
hippuric acid in the urine of healthy volunteers, but samples were subjected to deconjugation
with enzymes prior to the analysis so any conjugates would have been cleaved. Between 16
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and 26 % of the dose of phloretin (4.8 mg) was reportedly excreted in urine. Volunteers
consumed 5.5 and 8 times the amount of phloretin by consumption of the high polyphenol
cider apple extract in the present study, compared to the consumption of cider from the two
studies, respectively. The differences observed between the results may be due to the alcohol
present in the cider which would have affected the absorption of the polyphenols, the higher
dose administered or the matrices.
4.3.1.3 Biokinetics of Conjugated Ring Fission Metabolites in Human Urine
Maximum excretion of 5 - (3', 4' -dihydroxyphenyl) -y- valerolactone glucuronide, sulfate and
disulfate conjugates occurred in the 4-8 h urine sample (Table 4.2). Tmax is consistently later
for the ring fission metabolites and their conjugates, as they require time to travel the length of
the gastrointestinal tract and reach the colon, where metabolism by the microflora occurs.
This is the first time that kinetics have been established for these metabolites after apple
consumption. Literature reports Tmax values of between 3-6 h for dihydroxyvalerolactone
metabolites of (-) epicatechin [74. 76. 83] from tea and cocoa, which aggress with the data
presented here. One study concerned with an intervention where volunteers consumed tea and
a supplement of the three main catechins in the tea separately, [74] provided a time
concentration profile for a ring fission metabolite of (-) epicatechin, (5- (3',4'-
dihydroxyphenyl)-y-valerolactone), showing a maximum concentration of 4.7 J.1Min the 3-6 h
sample; the total excretion (0-24 h) of 5- (3', 4' -dihydroxyphenyl)-y-valerolactone ranged from
0.6 to 10 mg across the four volunteers. Enzyme deconjugation experiments were performed
on the urine samples from this study and so if this metabolite was conjugated, the information
has been lost. No other available literature reports a value for the total excretion of this ring
fission metabolite. Some other studies identifying this ring fission metabolite do not
deconjugate with enzymes prior to analysis, so identification of conjugates was possible, but
no kinetics were evaluated.
Maximum excretion of the other conjugated ring fission metabolite to be identified in human
urine, dihydroxyphenylacetic acid sulfoglucuronide, occurred in the 0-4 h urine sample (Table
4.2). Data for the identification and biokinetics of this metabolite have not previously been
reported post consumption of apples, or other food sources. The earlier Tmax observed with the
sulfoglucuronide conjugate of dihydroxyphenylacetic acid, suggests that this metabolite may
have been derived differently from the other metabolites. For example, after consumption of
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chocolate, the presence of vanillic acid in the 0-3 h urine sample suggests that it may have
originated from oxidation of the vanillin in the chocolate and not from microbes in the
gastrointestinal tract [821. There is evidence in the literature to support the finding that
dihydroxyphenylacetic acid is a characteristic major metabolite of procyanidins, which were
also present in the high polyphenol cider apple extract, but not from their monomers (i.e. (-)
epicatechin) [1801. Figure 3.50 in chapter 3 shows a possible metabolism pathway for the
formation of this metabolite, prior to conjugation. An excretion profile of 3,4-
dihydroxyphenylacetic acid given by Rios et al. [821, showed maximum excretion occurred in
the 9-24 h urine samples after chocolate consumption, which would indicate that the
difference in the matrices between the chocolate and the high polyphenol cider apple extract
could have altered the rate of formation of this metabolite.
After consumption of the control supermarket apple juice, dihydroxyphenyl valerolactone
sulfate accounted for the greatest percentage of the total analyte area (63.6 %), as shown in
Table 4.3. The glucuronide and disulfate conjugates accounted for 11.4 and 0.5 %,
respectively. However, after the consumption of the high polyphenol cider apple extract (test
phase), the proportions of metabolites were different. Glucuronide and sulfate conjugates of
dihydroxyphenyl valero lactone accounted for almost equal proportions of the total analyte
area, 38.6 and 39.0 %, respectively. This could be explained by the phenomenon mentioned
previously, the metabolic route for the formation of sulfate conjugates becomes readily
saturated, and so at higher levels of polyphenol ingestion, there is a shift towards the
production of glucuronide conjugates; the pathway for sulfation is a high affinity, low capacity
one [III. Urpi-Sarda et al. [831, reported increases in conjugates of hydroxyphenyl
valerolactones in urine after cocoa consumption, increases of 145 % were noted when
compared to the control; large inter-subject variation was observed between the concentrations
of dihydroxyvalerolactone sulfate in the urine of the volunteers and so this metabolite did not
register as increasing significantly. Large inter-subject variation was observed in the profiles
of the conjugated ring fission metabolites just as for the (-) epicatechin and phloretin
conjugates (Figure 4.2), and was much greater for the sulfate and disulfate conjugates of
dihydroxyphenyl valerolactone, than for the glucuronide. The excretion profile of 5 - (3', 4'-
dihydroxyphenyl) -y- valerolactone glucuronide represents the lowest inter-individual
variation of all the metabolites identified in urine; in particular, the 4-8 h sample shows that
peak area values for the nine volunteers were very similar. This may suggest that the pathway
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for sulfate formation is saturated by different concentrations of polyphenols, depending on the
individual, but the pathway for the formation of glucuronides is more consistent.
4.3.1.4 Biokinetics of Non-Conjugated Ring Fission Metabolites in Human Urine
Maximum excretion of sinapic acid occurred in the 8-24 h urine sample (Figure 4.3),
suggesting formation by colonic bacteria. Levels in the control urine samples from all
volunteers were below the limit of detection. Sinapic acid was only found to be present in the
urine of three volunteers; two showed maximum excretion in the 8-24 h sample and one in the
0-4 h sample; this metabolite shows large inter-individual variation maybe due to formation by
populations of bacteria which may be present in some individuals, but not others. Sinapic acid
has been detected in the urine of volunteers post coffee consumption, but Tmall was not
determined [179]; levels increased by an average of 12.6 fold, compared to control samples.
After cocoa consumption, Urpi-Sarda et al. [105], reported increases in the excretion of many
microbial-derived phenolic metabolites; the largest percentage increases were noted for ferulic
acid (619 %),p-coumaric acid (467 %), 3-hydroxybenzoic acid (413 %) and vanillic acid (265
%). From the schematic of the possible formation of these phenolic metabolites given in
chapter 3 (Figure 3.50), it can be seen that sinapic acid may be a further metabolite of
dihydroxyphenyl valero lactone, p-coumaric and ferulic acid. The cocoa intervention study
involved regular consumption of cocoa, which as evidence exists to support the theory that
polyphenols have the ability to modify the population of microorganisms in the gut. may have
also affected the metabolites produced (previously discussed in chapter 3).
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Figure 4.3 Bar graph representing the presence of sinapic acid in control and test urine samples.
Error bars represent the standard deviation (n = 9)
4.3.1.5 Biokinetics of Unidentified Apple Related Metabolites in Human Urine
Table 4.5 summarises the time at which maximum excretion for each of the unidentified or
partly identified metabolites occurred and details the percentage area for each of the
metabolites detected in the control and test urine.
When maximum excretion for an unknown or partly identified metabolite occurs between 0-4
h, it is likely that the metabolite has been produced as a result of phase II reactions, and the
polyphenol has been conjugated with a methyl, sulfate or glucuronide, or a combination of one
or more of these functional groups. The later Tmax values indicate that the metabolite is more
likely to be a ring fission metabolite or conjugate of a ring fission metabolite; the result of
bacterial action in the colon, for example the sulfoglucuronide conjugates detected. Values for
the percentage of total analyte areas for the control and the test urine samples are very similar,
with a few exceptions. The proportion of sulfate conjugates is higher in the control urine
samples, than in the test urine samples; in total sulfate conjugates represent 4.9 % of the total
analyte area for urine samples collected after the control phase of the study and only 1.] % of
the total analyte area after the consumption of the high polyphenol cider apple extract (test
phase). In particular, the sulfoglucuronide conjugate with the mass transition mlz 425 / 345
and the methyl sulfate conjugates with the mass transitions mlz 264 / 169 and mlz 248 / 168
show the greatest increases. This further supports the evidence for the saturation of the
pathway forming sulfate conjugates at low polyphenol concentrations, due to its high affinity
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and low capacity. However, actual quantitative values are required for confirmation of this
effect, rather than proportions.
Table4.S Summary of the mean (n = 9) Tmax and percentage area for each of the metabolites
detected in control and test human urine samples following ingestion of 'Tesco' pure
apple juice (control) and a high polyphenol cider apple extract (test).
Unidentified Metabolites in Human Urine TIDal(h)
Percentage of Total Analyte Area
Control Test
Glucuronide conjugate mlz 409 / 233 4-8 0.2 0.2
Glucuronide conjugate mlz 515 / 339 4-8 0.1 0.1
Diglucuronide conjugate m/z 653/477 0-4 0.7 0.6
Sulfate conjugate mlz 557 /477 8-24 0.4 0.1
Sulfate conjugate mlz 289 1163 0-4 < 0.1 0.1
Sulfate conjugate mlz 384 I 304 0-4 0.1 0.2
Sulfoglucuronide conjugate mlz 464 / 288 8-24 0.2 0.1
Sulfoglucuronide conjugate mlz 425 / 345 8-24 1.9 0.2
Methyl sulfate conjugate mlz 264 1169 8-24 1.5 0.3
Methyl sulfate conjugate mlz 248 /168 4-8 0.8 0.1
mlz 577 / 289 4-8 0.2 1.5
mlz271/119 4-8 0.1 < 0.1
mlz 737 I 481 0-4 < 0.1 < 0.1
mlz 705 / 353 4-8 0.1 < 0.1
mlz 529 I 449 0-4 0.1 < 0.1
4.4.1 Biokinetics of Apple Polyphenol Metabolites in Human Plasma
The phannacokinetic data for the metabolites detected in human plasma are summarised and
presented in Table 4.6. Data represent mean values (n = 9); plasma profiles for identified and
unidentified metabolites are given in Figures 4.4,4.5 and 4.6. The Aue values for each of the
metabolites detected after consumption of the control apple juice and the high polyphenol
cider apple extract have also been given. Table 4.7 details the percentage area for each of the
metabolites detected in control and test plasma samples.
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4.4.1.1 Biokinetics of Aglycone Metabolites in Human Plasma
Profiles for these metabolites are given in Figure 4.4, A and B. The two aglycones identified
in plasma, phloretin and p-coumaric acid, showed mean maximum concentrations in the
plasma within 1 h, and have elimination half lives of around 2 h (Table 4.6). The glucuronide
conjugate of phloretin was identified in urine, which suggests that the glucuronides are rapidly
eliminated from the body which leaves free phloretin circulating in the plasma. However, one
study by Marks et al. [721, does report the presence of phloretin-2' -glucuronide in the plasma;
Tmaxwas 0.6 h, Cmaxwas 73 oM and T \/2 was 0.7 h.
The maximum concentration of p-coumaric acid in the plasma reported here before I h
indicates that this phenolic compound has probably not originated from microbial action in the
colon, as previously suggested. Since p-coumaroylquinic acids are present in large quantities
in apples [101, 1461, it can be assumed that they are also present in this high polyphenol cider
apple extract (although not measured). The biokinetics reported suggest that the small
intestine is the principle site for the absorption of the dihydrochalcones and hydroxycinnamic
acids from this cider apple extract. One recently published study reported the presence of
phloretin and p-coumaric acid in the plasma of healthy male volunteers after the consumption
of organically and conventionally produced apples [182], however, samples were subjected to
enzyme deconjugation prior to LC/MS analysis, so any possible conjugates would have been
cleaved. The study reported a Cmaxof 13 ± 5 oM and a Tmaxof 1.7 h ± 1.2 h for phloretin, and
a Cmaxof 35 ± 12 oM and a Tmaxof 3 h ± 0.8 h for p-coumaric acid. The maximum plasma
concentrations reported for both these aglycones are considerably lower than values obtained
in the present study, and times taken to reach the maximum concentrations are slightly earlier
in the present study compared with those reported for the organically and conventionally
grown apples. The differences are probably due to a different ingested level (the high
polyphenol cider apple extract provided approximately three times the concentration of
phloretin than the apples contained) and also suggest that the matrix in which the polyphenols
are supplied in is affecting the bioavailability; the high polyphenol cider apple extract is in a
liquid form and may be metabolised more rapidly than the apples, which require further
breakdown of the food stuff. The time taken to consume 1 kg of apples will also impact the
results; the drink in this present study was consumed within 3 min, but the consumption of the
apples is assumed to have taken much longer than this although the data for this is not reported
in the published paper. Apart from this paper, comparable studies on the biokinetics of p-
coumaric acid after the consumption of apples or apple products have not yet been published.
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Farah et al. (179), reported values for p-coumaric acid in the plasma of healthy volunteers after
the consumption of 170 mg of chlorogenic acids in decaffeinated green coffee; Tmax occurred
at 2.5 h ± 1.8 and Cmax was 0.4 J.1M± 0.03. These values are similar to those obtained in the
present study, although the amount of p-coumaric acid present in the green coffee and the
cider apple extract were not quantified so the ingested values cannot be compared. Urpi-Sarda
et al., also reported the presence of p-coumaric acid in the plasma of volunteers, post cocoa (83)
and almond (181) consumption; Cmax values were 0.03 nM ± 0.01 and 19.14 nM ± 2.66,
respectively. However, both these values are not significantly greater than the values obtained
after analysis of the control samples; p-coumaric acid was not reported to be present in either
food stuff ingested which could account for the differences between these studies and the data
presented here.
When the presence of these aglycones are compared after consumption of the control
supermarket apple juice and the high polyphenol cider apple extract, the proportion of
phloretin remains very similar but the proportion of p-coumaric acid is higher after the control
drink (Table 4.7). The AUC values given in Table 4.6 show that phloretin has increased
approximately 3.4 fold after consumption of the test drink compared to the control and p-
coumaric acid has increased approximately 2.1 fold after consumption of the test drink
compared to the control. These are relatively minor increases compared to the difference in
the polyphenol concentrations between the two drinks, and compared to the increases
observed with other metabolites monitored.
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Table 4.7 Summary of the mean (n = 9) percentage area for each of the metabolites Identified in
control and test human plasma samples following ingestion of'Tesco' pure apple juice
(control) and a high polyphenol cider apple extract (test).
Metabolites Identified in Human Plasma
Percentage of Total Analyte Area
Control Test
< 0.1 7.2
3.0 2.6
0.3 0.5
31.1 21.1
0.5 15.8
6.4 15.2
4.5 1.9
48.8 32.7
0.6 0.6
0.3 0.1
(-/+) Epicatechin-Ss-glucuronide
(-/+) Epicatechin-3'-sulfate
Phloretin
Dihydroxyphenylacetic acid sulfate
5 - (3',4'-Dihydroxyphenyl)-y-valerolactone glucuronide
Dihydroxyphenyl valerolactone sulfate
p-Coumaric acid
Sulfate conjugate mlz 381 /301
Unknown conjugate mlz 353/ 191
Unknown conjugate mlz 289 /109
4.4.1.2 Biokinetics of Conjugated Metabolites in Human Plasma
The profiles for these metabolites are given in Figure 4.4, C and O. The mean time taken to
reach maximum concentration in the plasma for the conjugates of (-1+) epicatechin are very
similar, 1.4 h ± 0.5 h for the glucuronide and 1.2 h ± 1.0 for the sulfate (Table 4.6); both
conjugates are the result of phase II metabolism reactions and it would be expected that these
values would be close. This is the first time biokinetic data for metabolites of (-1+)
epicatechin have been reported after the consumption of apples. These values are consistent
with the maximum concentration of the metabolites in the urine, 0-4 h. Values for the
elimination half lives are difficult to compare, as much more variation between volunteers was
observed for the sulfate conjugate, so only a single value could be obtained from the mean
profile (Figure 4.4, D). It can be suggested that the time taken for the excretion of (-1+)
epicatechin-3' or 4' -sulfate is slightly extended when compared to the glucuronide, but this
value is possibly an overestimate.
There is agreement throughout the literature that Tmax values for (-1+) epicatechin in plasma
are around 2 h, regardless of whether the epicatechin has been provided by tea or cocoa [81. 1621;
this is in regards to epicatechin produced as a result of enzyme deconjugation experiments,
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and so represents the free aglycone. In an intervention study performed by Van Het Hof et at.
[57), the bioavailability of tea catechins in the blood of healthy human volunteers, after
consumption of black and green tea, with and without milk were investigated. Analysis of
both types of tea indicated that the green tea had three times the concentration of total
catechins when compared to the black tea, which was reflected in the results of the total
catechins in the blood after consumption; Cmax for total catechins was 0.55 11Mafter ingestion
of green tea and 0.17 11Mafter black tea, milk showed no significant effects on these levels.
Tmax was 2.3 h ± 0.2 h for green tea and 2.2 h ± 0.2 h for black tea; values determined in the
present study are earlier than these reported data, suggesting the matrices of tea and apples are
affecting the absorption differently. In another study investigating the bioavailability of tea
catechins [75), (-) epicatechin reached a maximum concentration in the plasma between 1.4 h ±
0.6 h post dose in volunteers. Most of the catechins were present in their sulfate and
glucuronidated forms, although no pharmacokinetic data is provided for these metabolites.
Some biokinetic data for (-1+) epicatechin sulfate and methyl epicatechin sulfate, identified in
plasma after cocoa consumption, are provided by Mullen et at. (106). The dose of epicatechin
was 6.7 mg supplied in the form of a cocoa drink with either water or milk, Tmax for (-)
epicatechin sulfate was 1.4 h ± 0.2 h and 1.3 h ± 0.2 h with water and milk, respectively, and
Tmax for methyl epicatechin sulfate was 1.0 h ± 0.2 h and 1.3 h ± 0.2 h with water and milk,
respectively. The values for the sulfate conjugate are consistent with the findings in the
present study, despite the differences in the source of the epicatechin. Cmax values were 83 nM
and 77 nM for (-) epicatechin sulfate with water and milk, respectively, and 60 nM and 50 nM
for methyl epicatechin sulfate with water and milk, respectively. The values obtained with
water and with milk were not significantly different. Tmax values for (-) epicatechin sulfate
were 1.5 h ± 0.1 h with water and 2.0 h ± 0.2 h with milk; values were significantly different
suggesting milk was causing the metabolite to remain in the circulatory system for longer.
Although cocoa is a different matrix to apples, the longer elimination half life reported in the
present study suggests a slight overestimate has been made.
Roura et at. (81), reported that after ingestion of 54.4 mg of (-) epicatechin, Cmax was
approximately 0.63 11M in five healthy volunteers, and Baba et at. (162), reported a
concentration of 4.9 11Mafter a 220 mg dose of (-) epicatechin; the (-) epicatechin was
consumed as a cocoa drink in both studies. In the study by Baba et al. [162], the bioavailability
of (-) epicatechin from cocoa was investigated by feeding chocolate and cocoa (both
containing 220 mg of (-) epicatechin) to five volunteers. Similar Cmax values for (-)
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epicatechin from both food sources were reported; 4.77 JlM after chocolate intake and 4.92
JlM after cocoa intake. One noteable difference were the levels of non methylated (-)
epicatechin in the plasma; at I and 2 h post ingestion of the test materials the levels were
higher after cocoa intake compared to chocolate intake, at 2 and 4 h after ingestion of the test
materials the concentrations of methylated (-) epicatechin were much higher after chocolate
intake compared to coca intake. Other metabolites did not show significant differences
between the test foods.
Comparing the proportions of these conjugated metabolites of (-) epicatechin after control and
test drink consumption (Table 4.7), indicates that significantly more of the glucuronide
conjugate is detected after consumption of the high polyphenol cider apple extract compared
to the supermarket apple juice, and that the reverse is true of the sulfate conjugate (Table 4.7).
AVC values reported in Table 4.6 indicate that (-) epicatechin-3'-glucuronide has increased
575 fold (the largest increase of any metabolite detected in the present study), compared to an
increase of 2.3 fold noted with (-) epicatechin-3' or 4'-sulfate. This suggests once again the
possibility of saturation of the sulfate forming pathway, resulting in a shift towards
glucuronidation. The high polyphenol cider apple extract contained over eleven times the
amount of (-) epicatechin than the control drink, however increases in conjugates of (-)
epicatechin represent a much greater increase. Consumption of three different amounts of
decaffeinated green tea, 1.5 g, 3.0 g and 4.5 g were investigated by Yang et al. [751; after 3.0 g
of tea solids were consumed, increases in the Cmax and AVC for (-) epicatechin were 3.4 fold
and 3.8 fold, respectively, compared to the dose of 1.5 g, but further increases were not
observed after the dose of 4.5 g. The authors reported that it was unexpected that these values
increased more than two fold after doubling the amount of catechins ingested, and surprising
that a further increase was not observed after the higher dose. The authors suggested a
possible saturation effect for the capacity of the plasma to take up or bind catechins; from data
reported in the present study it appears that the capacity of the plasma to take up (-)
epicatechin from apples is greater than observed with tea.
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4.4.1.3 Biokinetics of Conjugated Ring Fission Metabolites in Human Plasma
The profiles for these metabolites are given in Figure 4.5. Table 4.6 indicates that the Tmax for
both the glucuronide and sulfate conjugates of 3', 4'-dihydroxyphenylvalerolactone are
similar, 6.3 h and 5.7 h, respectively. This is the first time that biokinetic data for these
conjugated ring fission metabolites has been provided after consumption of apples. These
Tmax times correspond with the maximum concentration of the metabolites in urine, both
appearing in the 4-8 h sample. The later times recorded for these metabolites compared to the
conjugates of (-) epicatechin, further demonstrate their formation in the colon by microbial
action. Post green tea ingestion containing 200 mg of (-) epicatechin, Meng et al. [74], reported
that peak plasma levels of 3', 4' -dihydroxyphenylvalerolactone appeared at around 5 h and
were approximately 0.36 JlM. Enzyme deconjugation experiments were performed so no data
for conjugates of this metabolite were provided. Some quantitative data was provided for
conjugates of dihydroxyphenyl valerolactone in plasma, by Urpi-Sarda et al. [831 after cocoa
and almond [181] consumption. Post cocoa consumption, two glucuronide conjugates were
detected and concentrations in the plasma were reported as 39.1 nM ± 14.1 and 113.9 nM ±
34.5; these showed significant increases to the control samples. After almond consumption,
glucuronide conjugates were only detected in the urine; a sulfate conjugate was quantified in
plasma Cmax was 368.2 nM ± 224.4, but this value did not show much increase when
compared to control samples.
The metabolite, 3, 4-dihydroxyphenylacetic acid sulfate, appears earlier in the plasma, with a
Tmax of 1.3 h; it also reached maximum concentration earlier in the urine, in the 0-4 h sample.
This could indicate that it is formed via a different route to microbial action, possibly from the
direct cleavage of procyanidins, as mentioned previously. Urpi-Sarda et al. [831, reported a
concentration of 0.11 nM ± 0.02 for 3, 4-dihydroxyphenylacetic acid in plasma after cocoa
consumption, but the increase compared to the control samples was only small. Post almond
consumption [1811, levels of this metabolite waere reported as 385.8 nM ± 30.0, which again
did not show much difference when compared with control plasma samples.
Comparisons of the proportions of these conjugated ring fission metabolites in plasma after
consumption of the control apple juice and high polyphenol cider apple extract (Table 4.7),
showed the same pattern as for the metabolites in urine. After the control drink, 5 - (3', 4'-
dihydroxyphenyl valerolactone) - y - glucuronide accounted for 0.5 % of the total analyte area,
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compared to 6.4 % for the sulfate; after test drink consumption, the glucuronide and sulfate
conjugates accounted for approximately equal proportions of the total analyte area (15.8 and
15.2 %, respectively). The metabolite 3, 4-dihydroxyphenylacetic acid sulfate, also accounted
for a greater percentage of the total analyte area after control drink consumption, compared to
the test drink. The Ave values given in Table 4.6 indicate that 5 - (3', 4' -dihydroxyphenyl
valero lactone) - 'Y - glucuronide has increased by 177 fold and the sulfate conjuagte has
increased by 26.1 fold; the metabolite 3, 4-dihydroxyphenylacetic acid sulfate showed a 2.7
fold increase. This further supports the theory for the saturation of the sulfate pathway at low
concentrations of polyphenols, explained previously.
4.4.1.4 Biokinetics of Unidentified Apple Related Metabolites in Human Plasma
Profiles for these unidentified metabolites are given in Figure 4.6. The times taken for
maximum concentration of these metabolites indicate that they are absorbed in the small
intestine, and not as a result of microbial action in the gut. Their elimination half lives also
indicate that they are rapidly eliminated from the body. The partly identified sulfate
metabolite with the mass transition mlz 381 I 301 represents 48.8 % of the total analyte area
for metabolites after the consumption of the control drink, but only 32.7 % of the area after
test drink consumption (Table 4.7), which has been seen for all of the other metabolites
containing a sulfate moiety. The Ave values reported in Table 4.6 indicate that the mass
transition mlz 381 I 301 increased 3.2 fold after test drink consumption compared to after
control drink consumption, which is a similar increase as that observed with (-1+) epicatechin-
3' or 4' -sulfate. The two unidentified metabolites with mass transitions mlz 353 I 191 and mlz
289 I 109 represent the same proportion of the total analyte area after the control drink as for
the test drink (Table 4.7); AVe values (Table 4.6) indicate an increase of 1.4 and 3.4 fold, for
the two mass transitions, respectively.
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4.5 Conclusions
This is the first report that details the biokinetic parameters for the major urinary and plasma
metabolites of apple polyphenols in humans; not only does it include data on conjugated
metabolites such as (-) epicatechin glucuronide and sulfate, but it also discusses data for the
ring fission metabolites and conjugated ring fission metabolites. There are substantial
differences in the absorption and elimination of different flavonoids and their metabolites,
shown by the varied kinetic parameters which are summarised in Table 4.8. The
bioavailability of individual polyphenols is strongly influenced by their chemical structures
[181]
Apple polyphenols undergo extensive metabolism in the human digestive system to produce
an array of metabolites, predominately conjugates of ring fission compounds. These ring
fission metabolites have been synthesised by the microflora inhabiting the gastrointestinal
tract, indicated by their later Tmax values; current hypotheses suggest these compounds are
then conjugated in the mucosal cells of the gastrointestinal tract, before entering the
circulatory system. Further processing is also possible in the liver as these metabolites pass
through the hepatic portal vein; methylation, deconjugation and conjugation reactions could all
be feasible.
The most abundant metabolite identified in human urine after consumption of the high
polyphenol cider apple extract was the ring fission metabolite 3', 4' -dihydroxyphenyl
valerolactone sulfate (39.0 %), followed by the glucuronide conjugate (38.6 %); in plasma, 3,
4-dihydroxyphenylacetic acid sulfate predominated (21.1 %), followed by 5- (3', 4'-
dihydroxyphenyl valerolactone) -y- glucuronide (15.8 %) and sulfate conjugates (15.2 %).
This indicates that a limited amount of metabolism occurs in the upper gastrointestinal tract
and liver producing conjugates of (-) epicatechin, while the majority of the metabolism for
apple polyphenols occurs in the large intestine; in urine, over 81 % of the metabolites
identified were derived from bacterial action in the gut, in plasma the figure was over 54 %.
Resulting metabolites are eliminated within 24 h, shown by their short elimination half lives
and suggests that regular consumption is necessary for their accumulation in the human body.
Evidence of maximum plasma concentrations for metabolites such as phloretin, p-coumaric
acid and 3, 4-dihydroxyphenylacetic acid sulfate occurs half an hour after test drink
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consumption, implying that absorption is fairly rapid. Initial plasma concentration peaks and
early values calculated for Tmax confirm the early absorption of compounds in the small
intestine. Later peaks in concentrations and longer values for Tmax indicate absorption of the
compound through the large intestine and/or recycling through digestive fluids. More than
eight hundred bacterial species inhabit the human intestinal tract, impacting the health and
nutritional status of the host [183]. The majority of the bacteria are present in the colon;
concentrations of up to 1012 cells have been recorded per gram of faeces and 99 % of these
bacteria are anaerobic [44]. A balanced composition of gut microflora confers benefits to the
host, whereas microbial imbalances are associated with metabolic and immune related
diseases [184.185], such as inflammatory bowel disease and colorectal cancer.
As mentioned in previous chapters, the composition of microorganisms in the gastrointestinal
tract can be influenced by diet among other factors, but in general the composition of an adults
gut consists of mainly Bacteroides, followed by several genera belonging to the division
Firmicutes, such as Eubacterium, Ruminococcus and Clostridium, and the genus
Bifidobacterium. Transformations by these microbes via esterase, glucosidase, demethylation,
dehydroxylation and decarboxylation activities, directly affect the bioavailability of
polyphenols in the diet. The intestine is the preferred site of absorption of these bacterial
products and enterohepatic circulation, discussed previously in this chapter, ensures their
presence in plasma is extended compared to that of the parent compounds, before final urinary
excretion.
Inter-Subject Variation
The length of time taken for food to be absorbed and eliminated depends on a huge number of
factors, such as the type of food matrix, other dietary constituents consumed with the item
under investigation, and many individual factors such as age, gender, rate of metabolism,
health status, diet and gut inhabitants. In this study, it was observed that for most of the major
metabolites of apple polyphenols, variation is mainly restricted to proportions, times taken to
reach maximum levels or time taken for excretion; variation in the actual types of metabolites
produced seems to occur only for the more minor metabolites. With such a small number of
volunteers it is difficult to make any conclusions regarding the differences observed, and the
data shows more similarities than differences.
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Summary
The most important findings from the present study include the identification of predominately
conjugated ring fission metabolites in the urine and plasma of volunteers; evaluation of their
biokinetics indicates that their production is dependent on the colonic microflora. Also, much
evidence has been provided to support the theory that at low concentrations of polyphenol
intake, more sulfate conjugates are produced; the pathway is one of high affinity and low
capacity. Following ingestion of higher intakes of polyphenols, this pathway becomes
saturated, and glucuronide conjugates predominate. It has also been demonstrated that at the
higher polyphenol intakes, the levels and proportions of metabolites do not necessarily
increase; some increases are observed but they do not represent the same fold increases as the
intakes, some are much greater and others are not.
Although the data presented here has been reported for the first time after the consumption of
apples in humans, the data supports some of the evidence provided by researchers
investigating different food sources which contain similar polyphenols; any variations
identified can be attributed to the differences in the food sources of the polyphenols, the
matrices and other foods consumed with the test items. This data extends the very limited
research already published following apple consumption, particularly in healthy volunteers,
and advances the area of understanding of the metabolism of apple polyphenols in humans.
182
~Q
U
,.
e
=is:
1:1
•e
:I
=
.9
~
·c
;J
c,.
e
:I
=
.9
o
v
~
0"':
NO
~
O~
NOO
.....a-
~~
00"
,
;...,
,
c
:B(,)*B U
"'."(,) .-
.- CQ..o
~ ...
,...._::I
+ (,)
..._ ::I
-..!..-'bo
.,..
t--
.....
a-
N
00,
..,.
N
o
~8
......a-
a-OOr-r-
~
~oo
~o
(,)
c
~
.....
N
-M
1"
o
00,
..,.
~
.~
::s
(,)
::s
"EO,
N
C
.~
o
f
(,)
c
00
o
-H
00
o
M
00
-
*."
.~
(,)
.!ij
E
s
u
~
o
V
.......
o
V
o
*-e
.~
(,)
.~
c
Vi
Chapter Five
Conclusions
Summary
The development of the novel and validated LC/MS/MS method detailed in the present study
for the identification of a whole range of metabolites of apple polyphenols, in human
biological fluids, represents a significant contribution to this area of research. In addition to
providing evidence for the identification of new major and minor urinary and plasma
metabolites of apple polyphenols, some biokinetics of these metabolites have been reported
and used to evaluate absorption and excretion of these compounds. This has not been
previously reported in the literature. The methods utilised in this research have wider
applications for the study of polyphenols from other dietary sources, including tea and cocoa
derived polyphenols.
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5.1 Analytical Methodology
The analytical method developed in the present study has made many improvements over
existing methodologies; a full range of aglycones, conjugated metabolites, ring fission
metabolites and conjugated ring fission metabolites of apple polyphenols have all been
detected and the majority identified, in both human plasma and urine using the same single
method. Validation was successfully performed, which lends credibility to the quality of the
results reported. Great care and attention to detail were applied in the development of the
method, which is reflected in the quality of the results obtained. Good quality data requires
good experimental design and properly validated methodology. There is potential for wider
applications of this method; it could be applied to any study involving polyphenols not just
those using apples.
This is a complex and difficult area of research, indicated by the lack of studies detailing the
metabolism of polyphenols, particularly from apples, in healthy humans. Analysis of this
range of phenolic metabolites in biological samples in just a single analytical run makes this
method unique; the only other comprehensive report of urine and plasma metabolites, in this
case post cocoa consumption, uses one method for the determination of conjugated
metabolites and one for the identification of ring fission metabolites [83]. One of the strengths
of the method presented here is the broad range of polyphenolic compounds and their
metabolites which can be detected and identified; many researchers focus on one group of
flavonoids, in particular the catechins from either tea [57. 73-75. 77. 169] or cocoa [81. 106. 176].
However, use of a more specific method containing less MRM transitions, would have
increased the sensitivity which may have enabled more minor metabolite constituents to be
detected and identified, increasing its usefulness further. There are always compromises to be
made when developing a method and this method demonstrates a balance between many of the
important characteristics of a method which increase its usefulness and suitability. Another
positive approach of the method is that analysis time is short; a further compromise as
extension of the LCIMSIMS run time would increase overall analysis time, which has its draw
backs, but it would mean that the sulfate conjugates, which appear to have much longer
retention times under the current conditions, would have more time to elute, and better
separation would be apparent. One paper reporting the analysis of conjugated and ring fission
metabolites in human urine and plasma after almond consumption, utilises a method taking
over 120 min [181].
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One of the major limitations with the methods reported presently is the lack of commercially
available standards to provide definitive identifications and quantitative data. Under the
circumstances, the metabolite identifications proposed and the biokinetic data reported here is
of the best possible standard and has significantly contributed to the understanding of the
metabolism of apple polyphenols in humans. If time and funds were not placing constraints
on the research, it may have been possible to organise some synthesis of apple polyphenol
metabolites, such as some of the conjugates of (-1+) epicatechin and ring fission products
which could have been used to finely tune the MS for the specific detection of these
metabolites and further improve detection levels. Presence of these compounds in the
'spiking' solution would also have allowed validation parameters to be determined for these
metabolites, currently it can only be assumed that they behave in a similar way to their
aglycone or glycosylated forms due to similarities in structures. Standards would also have
enabled quantitative values to be placed on biokinetic data, such as area under the curve which
would have given a better estimate ofbioavailability.
One particularly challenging area of the method development was performing the validation
and calculating the effect of the urine and plasma matrices on the polyphenols and their
metabolites. Most of the available papers reporting data on the identification and lor
quantification of polyphenol metabolites in human urine and plasma do not undertake any
validation procedures, because it is time consuming and complex, but this represents a major
weakness in the literature [57,72,73,75,77,83, 106, 169. 1811. An estimate of the effect of urine and
plasma matrices on the ionisation of polyphenols in the MS has been given in the present
study, although because each and every plasma and urine sample is different, it is impossible
to put an absolute value on the suppression or enhancement effects of each polyphcnol. The
efficiency of ionisation was affected differently, depending on the class of polyphenol being
analysed although similarities were apparent due to common structural features and
similarities in response factors (slopes of the calibration curves). Thus, the metabolites of
polyphenols such as the sulfate and glucuronide conjugates and the ring fission metabolites
will probably be affected by the matrix differently to the aglycones and glycosides. This
highlights another area where standards for all the possible metabolites would have
contributed greatly to the research. The extraction of the polyphenols and their metabolites
from plasma would also have been improved by the inclusion of more standards.
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A further strength of the research presented here, is the well-designed human intervention
study, purposely designed to produce good biokinetic data. This involved collection of many
samples after control and test drink consumption, to provide detailed profiles of the changes in
concentrations of the metabolites in urine and particularly those in plasma. The majority of
intervention studies in the literature do not collect as many samples for plasma [57,72,74,75,871,
sometimes only one or two samples [76,81,83,97,1811 which limits the information which can be
concluded from the studies; some reports are solely concerned with urinary analysis [73,77,1691,
Accurate timings and rapid processing of the samples contributed to the high quality data
produced. One major limitation with the intervention study was the small number of
volunteers that participated; greater numbers would reduce the effects of inter-individual
variations and provide better quality data. Numbers of volunteers used for intervention studies
reported in the literature are generally smaller than the sample size used presently, commonly
two to nine [72-74, 77, 81, 106, 162, 1811, although some do use larger sample sizes of eighteen to
forty-two [75,83, lOS, 169]. Additional urine collection time-points would also have improved the
data on the excretion pattern of apple polyphenol metabolites, and defining an amount of
water for consumption per time-point by each volunteer would have kept sample volumes
more consistent.
5.2 Identification of Apple Polyphenol Metabolites in Human Urine
and Plasma
The identification of polyphenol metabolites achieved in this study has contributed to the
research area greatly; confirmation of the presence of known metabolites of apples such as
conjugates of (-) epicatechin and phloretin has been provided, in addition to the identification
of novel metabolites not previously reported after apple consumption, The use of Le, MS and
LC/MSIMS for the identification of these metabolites provides a strong argument for their
presence in biological fluids. The combination of enzyme deconjugation experiments to gain
total aglycone concentrations excreted and analysis without enzyme treatment, enables the
detail of conjugation for these metabolites to be investigated and structural conformations to
be proposed; many other researchers only analyse samples post enzyme deconjugation which
results in loss of these details [74-77,87,105,1771. Many of the metabolites identified presently are
also relevant to other dietary materials, and the methods used to obtain this information could
have many wider applications. One limitation to the identification of the metabolites of apple
polyphenols, relates to the lack of commercially available standards,
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As mentioned previously, the identification of the metabolites of polyphenols in the literature
is mainly concerned with the conjugates of flavanols, such as (-) epicatechin. Recently, there
has been a move towards the identification of the ring fission products of microbial action in
the gut, and their conjugates. Literature published in the last half of 2009 [83, 105, 181), shows the
increasing trend for the analysis of these metabolites, as their importance to bioavailability and
understanding the full metabolism of polyphenols has been realised. This supports the
direction of the current research and it can be predicted that much more research in this area
will follow over the coming years.
5.3 Biokinetics of Apple Polyphenol Metabolites in Human Urine
and Plasma
The execution of the detailed and appropriate human intervention study reported presently, the
attention to detail in the sample handling and the rigorous use of the LC/MS/MS method
allowed the determination of high quality biokinetic data for the metabolites of apple
polyphenols in human urine and plasma; this data has not previously been published. This
data extends the information in the literature already available for apple polyphenols, which is
scarce and only relates to the analysis of compounds already present in the ingested apple-
related material, or to a single glucuronide conjugate of phloretin identified, or to volunteers
with an ileostomy. This data also compares well with biokinetic data published for the same
polyphenols present in different food sources, such as tea and cocoa, but does also indicate
some differences partly due to the food matrices. Finally, additional information on novel
metabolites of bacterial origin has been provided to give a better understanding of the
absorption of apple polyphenols. The techniques and methods utilised for the determination of
the biokinetic data, can be applied to other areas also, suggesting a much wider application.
Again, the main limitation to the biokinetic data reported for apple polyphenol metabolites is
the lack of commercially available standards, which has been discussed previously,
The trend towards the identification of the microbial metabolites of polyphenol metabolism in
humans in the later part of last year, as discussed in the previous section, will lead to further
studies in the area of the biokinetics of these metabolites, which is currently greatly under-
researched. This will enhance the understanding of the absorption and excretion of
polyphenols, and may also be applied to the metabolism of drug-related material.
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5.4 Future Work
Over the course of this study, new literature concerning the identification of the ring fission
and conjugated ring fission metabolites of polyphenol metabolism in humans has been
published, using new LCIMS/MS methodologies and new food sources, such as the recent
publication with almonds [181]. Two papers were published one concerning the fate of apple
polyphenols in healthy humans [72] and one in subjects with an ileostomy [99] since
commencing this research; prior to this very little was known. These papers concerned with
apple polyphenol metabolism are far from comprehensive and indicate how much the research
carried out presently was required. Recently, the focus has moved away from experiments
with the aglycone and glycosylated forms of polyphenols found in food and beverages, as
research indicated it was the metabolites of these compounds that are actually transported
around the circulatory system, reach the tissues and contribute to beneficial heath effects
hypothesised to result from diets high in fruit and vegetables. The trend towards microbial
metabolite analysis supports the direction of this current work, and highlights the need for
more research in this area to be undertaken; a viewpoint expressed by Del Rio et al. [1861 in a
publication last month.
Some additional work could be performed to enhance the results of this study and further
investigate the metabolism of apple polyphenols. LCIMS3 would have provided further detail
on the fragmentation pathways and the inclusion of synthesised standards would have enabled
more confirmed identifications and quantitative data to be reported. The accurate mass of the
novel metabolites could have been determined by the use of time of flight mass spectrometry
(TOF), which would also have contributed further to the validity of the identification. The use
of NMR techniques coupled to LC and MS may also be of use in determining metabolite
identities, particularly isomeric forms.
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